<?xml version="1.0" encoding="UTF-8" ?><xml><records><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>107</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">107</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Abramczyk, M. L.</style></author><author><style face="normal" font="default" size="100%">Carvalho, W. B.</style></author><author><style face="normal" font="default" size="100%">Carvalho, E. S.</style></author><author><style face="normal" font="default" size="100%">Medeiros, E. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Hospital São Paulo, Federal University of São PauloSão Paulo, Brazil</style></auth-address><titles><title><style face="normal" font="default" size="100%">Nosocomial infection in a pediatric intensive care unit in a developing country</style></title><secondary-title><style face="normal" font="default" size="100%">The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Braz J Infect Dis</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Braz J Infect Dis</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Braz J Infect Dis</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">375-380</style></pages><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">Brazil</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">developing country</style></keyword><keyword><style face="normal" font="default" size="100%">epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infant</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care</style></keyword><keyword><style face="normal" font="default" size="100%">length of stay</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">preschool child</style></keyword><keyword><style face="normal" font="default" size="100%">Child, Preschool</style></keyword><keyword><style face="normal" font="default" size="100%">Developing Countries</style></keyword><keyword><style face="normal" font="default" size="100%">Epidemiologic Methods</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Intensive Care Units, Pediatric</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2003</style></year></dates><isbn><style face="normal" font="default" size="100%">14138670 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: Determine the rate and outcome of nosocomial infection (NI) in pediatric intensive care unit patients in a developing country. DESIGN: Prospective cohort study using the Centers for Disease Control and Prevention definitions to diagnose nosocomial infection and NNISS (National Nosocomial Infection Surveillance System) methodology. SETTING: São Paulo Hospital - Universidade Federal de São Paulo - Brazil, a 700-bed teaching hospital with an 8-bed pediatric intensive care unit. PARTICIPANTS: All 515 children consecutively admitted to the pediatric intensive care unit from April 1996 to October 1997. RESULTS: The NI incidence was 18.3% and the mean infection rate per 1,000 patient days was 46.1; the ventilator-associated pneumonia rate was 18.7 per 1,000 ventilator days; the central line-associated bloodstream infection rate was 10.2 per 1,000 central line days; and the urinary tract catheter-associated infection rate was 1.8 per 1,000 catheter days. Pneumonia was the most common NI (31.6%), followed by bloodstream infections (17.3%), and surgical site infection (17.3%). Gram-negative bacterias were the most common pathogens identified in the NIs (54.8%), followed by Gram-positive bacterias (23.8%), and yeasts. CONCLUSION: Pneumonia was the most common type of NI. A high incidence of ventilator-associated pneumonia and central line-associated bloodstream infections was found, whereas the urinary tract catheter-associated infection rate was low. Gram-negative bacterias were the most common etiologic agents identified in the unit, and yeasts were frequently found. Pediatric patients have characteristics of their own, with major differences when compared to the adult population.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :60&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Abramczyk, M.L.</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-2142797504&amp;doi=10.1590%2fS1413-86702003000600004&amp;partnerID=40&amp;md5=99af8086b4f896c9f7d437ff3f13cc89</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">14636476</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1590/S1413-86702003000600004</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>108</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">108</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alidjinou, E. K.</style></author><author><style face="normal" font="default" size="100%">Sane, F.</style></author><author><style face="normal" font="default" size="100%">Firquet, S.</style></author><author><style face="normal" font="default" size="100%">Lobert, P. E.</style></author><author><style face="normal" font="default" size="100%">Hober, D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Laboratoire de Virologie EA3610, CHU de Lille, Faculté de Médecine, Université de Lille, Lille, FR-59037, France</style></auth-address><titles><title><style face="normal" font="default" size="100%">Resistance of Enteric Viruses on Fomites</style></title><secondary-title><style face="normal" font="default" size="100%">Intervirology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Intervirology</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Intervirology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Intervirology</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Intervirology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Intervirology</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">205-213</style></pages><volume><style face="normal" font="default" size="100%">61</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Enteric viruses</style></keyword><keyword><style face="normal" font="default" size="100%">Environment</style></keyword><keyword><style face="normal" font="default" size="100%">Fomites</style></keyword><keyword><style face="normal" font="default" size="100%">Inactivation</style></keyword><keyword><style face="normal" font="default" size="100%">Survival</style></keyword><keyword><style face="normal" font="default" size="100%">disinfectant agent</style></keyword><keyword><style face="normal" font="default" size="100%">heavy metal</style></keyword><keyword><style face="normal" font="default" size="100%">Adenoviridae</style></keyword><keyword><style face="normal" font="default" size="100%">Astroviridae</style></keyword><keyword><style face="normal" font="default" size="100%">enteric virus</style></keyword><keyword><style face="normal" font="default" size="100%">Enterovirus</style></keyword><keyword><style face="normal" font="default" size="100%">fomite</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis A virus</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">Norovirus</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">Review</style></keyword><keyword><style face="normal" font="default" size="100%">Rotavirus</style></keyword><keyword><style face="normal" font="default" size="100%">ultraviolet irradiation</style></keyword><keyword><style face="normal" font="default" size="100%">virus survival</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">gastroenteritis</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">microbial viability</style></keyword><keyword><style face="normal" font="default" size="100%">virology</style></keyword><keyword><style face="normal" font="default" size="100%">virus inactivation</style></keyword><keyword><style face="normal" font="default" size="100%">virus infection</style></keyword><keyword><style face="normal" font="default" size="100%">Disease Transmission, Infectious</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Virus Diseases</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><publisher><style face="normal" font="default" size="100%">S. Karger AG</style></publisher><isbn><style face="normal" font="default" size="100%">03005526 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Human enteric viruses are associated with several clinical features, especially gastroenteritis. Large amounts of these viruses can be released in the environment and spread to people. Enteric viruses are nonenveloped viruses and have displayed good survival in the environment. They can be significantly resistant in food and water but also on fomites, and this is thought to play a role in transmission, leading to sporadic cases or outbreaks. The survival of enteric viruses on fomites relies on many factors including the virus itself, fomite properties, and extrinsic environmental factors such as temperature or relative humidity. Several reports in the literature have found an association with gastroenteritis cases or outbreaks and fomites naturally contaminated by enteric viruses. However, the study of virus survival following natural contamination is challenging, and most published studies are laboratory based, using experimental contamination. In addition, recent and detailed data on the resistance of each of the main enteric viruses on fomites are scarce. Many approaches, both physical and chemical, can be used to inactivate enteric viruses, the efficacy of which depends on the virus and the disinfection conditions. © 2017 S. Karger AG, Basel.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;CODEN: IVRYA&#xD;Correspondence Address: Hober, D.; Laboratoire de Virologie EA3610, CHU de Lille, Faculté de Médecine, Université de LilleFrance; email: didier.hober@chru-lille.fr</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064252196&amp;doi=10.1159%2f000448807&amp;partnerID=40&amp;md5=da84a63933ac9713ffe8757e6b042d28</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">28614823</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1159/000448807</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>109</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">109</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Altman, D. G.</style></author><author><style face="normal" font="default" size="100%">Bland, J. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Medical Statistics Laboratory, Imperial Cancer Research Fund, London WC2A 3PX, United Kingdom&#xD;Department of Public Health Sciences, St George&apos;s Hospital Medical School, London SW17 0RE, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Statistics notes: Absence of evidence is not evidence of absence</style></title><secondary-title><style face="normal" font="default" size="100%">BMJ</style></secondary-title><alt-title><style face="normal" font="default" size="100%">BMJ</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMJ</style></full-title><abbr-1><style face="normal" font="default" size="100%">BMJ</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">BMJ</style></full-title><abbr-1><style face="normal" font="default" size="100%">BMJ</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">485</style></pages><volume><style face="normal" font="default" size="100%">311</style></volume><number><style face="normal" font="default" size="100%">7003</style></number><keywords><keyword><style face="normal" font="default" size="100%">octreotide</style></keyword><keyword><style face="normal" font="default" size="100%">streptokinase</style></keyword><keyword><style face="normal" font="default" size="100%">calculation</style></keyword><keyword><style face="normal" font="default" size="100%">clinical trial</style></keyword><keyword><style face="normal" font="default" size="100%">heart infarction</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">mortality</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">sampling</style></keyword><keyword><style face="normal" font="default" size="100%">sclerotherapy</style></keyword><keyword><style face="normal" font="default" size="100%">short survey</style></keyword><keyword><style face="normal" font="default" size="100%">statistical analysis</style></keyword><keyword><style face="normal" font="default" size="100%">treatment outcome</style></keyword><keyword><style face="normal" font="default" size="100%">varicosis</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical Research</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical Trials</style></keyword><keyword><style face="normal" font="default" size="100%">Data Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Measurement</style></keyword><keyword><style face="normal" font="default" size="100%">Methodological Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Research Methodology</style></keyword><keyword><style face="normal" font="default" size="100%">Statistical Regression</style></keyword><keyword><style face="normal" font="default" size="100%">Validity</style></keyword><keyword><style face="normal" font="default" size="100%">Controlled Clinical Trials</style></keyword><keyword><style face="normal" font="default" size="100%">Data Interpretation, Statistical</style></keyword><keyword><style face="normal" font="default" size="100%">Randomized Controlled Trials</style></keyword><keyword><style face="normal" font="default" size="100%">Sample Size</style></keyword><keyword><style face="normal" font="default" size="100%">Statistics</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1995</style></year></dates><isbn><style face="normal" font="default" size="100%">09598138 (ISSN)</style></isbn><notes><style face="normal" font="default" size="100%">Cited By :916&#xD;Export Date: 26 March 2020</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84971580244&amp;doi=10.1136%2fbmj.311.7003.485&amp;partnerID=40&amp;md5=9e79fd7fedb0d119a96d00e80c13dcca</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">7647644</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1136/bmj.311.7003.485</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>110</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">110</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Anderson, D. C.</style></author><author><style face="normal" font="default" size="100%">Trinder, K.</style></author><author><style face="normal" font="default" size="100%">Mitchell, K.</style></author><author><style face="normal" font="default" size="100%">Mitchell, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Perkins+Will, Toronto, ON, Canada&#xD;EOS Surfaces, LLC, Norfolk, VA, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Architectural Armor: Preventive Biocidal Surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Health Environments Research and Design Journal</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Health Environ. Res. Des. J.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Health Environments Research and Design Journal</style></full-title><abbr-1><style face="normal" font="default" size="100%">Health Environ. Res. Des. J.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Health Environments Research and Design Journal</style></full-title><abbr-1><style face="normal" font="default" size="100%">Health Environ. Res. Des. J.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">162-164</style></pages><volume><style face="normal" font="default" size="100%">10</style></volume><number><style face="normal" font="default" size="100%">5</style></number><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">SAGE Publications Inc.</style></publisher><isbn><style face="normal" font="default" size="100%">19375867 (ISSN)</style></isbn><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Anderson, D.C.; Perkins+Will, 672 Dupont St #500, Canada; email: diana.anderson@utoronto.ca</style></notes><work-type><style face="normal" font="default" size="100%">Letter</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032341773&amp;doi=10.1177%2f1937586717725225&amp;partnerID=40&amp;md5=cf9f1b5a610eb9b05b2374cfec56bc11</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">29056094</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1177/1937586717725225</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>112</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">112</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Benamu, E.</style></author><author><style face="normal" font="default" size="100%">Deresinski, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Infectious Diseases, Department of Medicine, University of Colorado, Aurora, United States&#xD;Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Vancomycin-resistant enterococcus infection in the hematopoietic stem cell transplant recipient: An overview of epidemiology, management, and prevention</style></title><secondary-title><style face="normal" font="default" size="100%">F1000Research</style></secondary-title><alt-title><style face="normal" font="default" size="100%">F1000 Res.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">F1000Research</style></full-title><abbr-1><style face="normal" font="default" size="100%">F1000 Res.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">F1000Research</style></full-title><abbr-1><style face="normal" font="default" size="100%">F1000 Res.</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">7</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Bacteremia</style></keyword><keyword><style face="normal" font="default" size="100%">Hematopoietic stem cell transplantation</style></keyword><keyword><style face="normal" font="default" size="100%">Vancomycin resistant enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">beta lactam antibiotic</style></keyword><keyword><style face="normal" font="default" size="100%">dalbavancin</style></keyword><keyword><style face="normal" font="default" size="100%">dalfopristin</style></keyword><keyword><style face="normal" font="default" size="100%">daptomycin</style></keyword><keyword><style face="normal" font="default" size="100%">fosfomycin</style></keyword><keyword><style face="normal" font="default" size="100%">linezolid</style></keyword><keyword><style face="normal" font="default" size="100%">oritavancin</style></keyword><keyword><style face="normal" font="default" size="100%">quinupristin</style></keyword><keyword><style face="normal" font="default" size="100%">tedizolid</style></keyword><keyword><style face="normal" font="default" size="100%">telavancin</style></keyword><keyword><style face="normal" font="default" size="100%">tigecycline</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial colonization</style></keyword><keyword><style face="normal" font="default" size="100%">clinical feature</style></keyword><keyword><style face="normal" font="default" size="100%">disease surveillance</style></keyword><keyword><style face="normal" font="default" size="100%">drug half life</style></keyword><keyword><style face="normal" font="default" size="100%">enterococcal infection</style></keyword><keyword><style face="normal" font="default" size="100%">food and drug administration</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">immunosuppressive treatment</style></keyword><keyword><style face="normal" font="default" size="100%">incidence</style></keyword><keyword><style face="normal" font="default" size="100%">infection prevention</style></keyword><keyword><style face="normal" font="default" size="100%">infection risk</style></keyword><keyword><style face="normal" font="default" size="100%">minimum inhibitory concentration</style></keyword><keyword><style face="normal" font="default" size="100%">mortality</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">outcome assessment</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">Review</style></keyword><keyword><style face="normal" font="default" size="100%">risk assessment</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin resistant enterococcus infection</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><publisher><style face="normal" font="default" size="100%">Faculty of 1000 Ltd</style></publisher><isbn><style face="normal" font="default" size="100%">20461402 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Vancomycin-resistant enterococcus (VRE) is now one of the leading causes of nosocomial infections in the United States. Hematopoietic stem cell transplantation (HSCT) recipients are at increased risk of VRE colonization and infection. VRE has emerged as a major cause of bacteremia in this population, raising important clinical questions regarding the role and impact of VRE colonization and infection in HSCT outcomes as well as the optimal means of prevention and treatment. We review here the published literature and scientific advances addressing these thorny issues and provide a rational framework for their approach. © 2018 Benamu E and Deresinski S.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :3&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Benamu, E.; Division of Infectious Diseases, Department of Medicine, University of ColoradoUnited States; email: esther.benamu@ucdenver.edu</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85039956346&amp;doi=10.12688%2ff1000research.11831.1&amp;partnerID=40&amp;md5=b10f69f4b6492d08dc05ae6c8d89c8fd</style></url></related-urls></urls><custom7><style face="normal" font="default" size="100%">3</style></custom7><electronic-resource-num><style face="normal" font="default" size="100%">10.12688/f1000research.11831.1</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>113</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">113</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Besold, A. N.</style></author><author><style face="normal" font="default" size="100%">Culbertson, E. M.</style></author><author><style face="normal" font="default" size="100%">Culotta, V. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg, School of Public Health, 615 N. Wolfe Street, Baltimore, MD 21205, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">The Yin and Yang of copper during infection</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Biological Inorganic Chemistry</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Biol. Inorg. Chem.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Biological Inorganic Chemistry</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Biol. Inorg. Chem.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Biological Inorganic Chemistry</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Biol. Inorg. Chem.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">137-144</style></pages><volume><style face="normal" font="default" size="100%">21</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">CTR1</style></keyword><keyword><style face="normal" font="default" size="100%">Immunity</style></keyword><keyword><style face="normal" font="default" size="100%">Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Metallothioneins</style></keyword><keyword><style face="normal" font="default" size="100%">copper exporting adenosine triphosphatase</style></keyword><keyword><style face="normal" font="default" size="100%">copper zinc superoxide dismutase</style></keyword><keyword><style face="normal" font="default" size="100%">cytochrome c oxidase</style></keyword><keyword><style face="normal" font="default" size="100%">protein S 100</style></keyword><keyword><style face="normal" font="default" size="100%">reactive oxygen metabolite</style></keyword><keyword><style face="normal" font="default" size="100%">ceruloplasmin</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial colonization</style></keyword><keyword><style face="normal" font="default" size="100%">Candida albicans</style></keyword><keyword><style face="normal" font="default" size="100%">ceruloplasmin blood level</style></keyword><keyword><style face="normal" font="default" size="100%">copper blood level</style></keyword><keyword><style face="normal" font="default" size="100%">cryptococcosis</style></keyword><keyword><style face="normal" font="default" size="100%">Cryptococcus neoformans</style></keyword><keyword><style face="normal" font="default" size="100%">CTR1 gene</style></keyword><keyword><style face="normal" font="default" size="100%">CTR4 gene</style></keyword><keyword><style face="normal" font="default" size="100%">detoxification</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">gene</style></keyword><keyword><style face="normal" font="default" size="100%">host pathogen interaction</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">innate immunity</style></keyword><keyword><style face="normal" font="default" size="100%">lung alveolus macrophage</style></keyword><keyword><style face="normal" font="default" size="100%">Mycobacterium tuberculosis</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">pathogenesis</style></keyword><keyword><style face="normal" font="default" size="100%">pneumococcal infection</style></keyword><keyword><style face="normal" font="default" size="100%">pneumonia</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">protein expression</style></keyword><keyword><style face="normal" font="default" size="100%">Review</style></keyword><keyword><style face="normal" font="default" size="100%">Saccharomyces cerevisiae</style></keyword><keyword><style face="normal" font="default" size="100%">Streptococcus pneumoniae</style></keyword><keyword><style face="normal" font="default" size="100%">tuberculosis</style></keyword><keyword><style face="normal" font="default" size="100%">animal</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial infection</style></keyword><keyword><style face="normal" font="default" size="100%">blood</style></keyword><keyword><style face="normal" font="default" size="100%">metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">mycosis</style></keyword><keyword><style face="normal" font="default" size="100%">Animals</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mycoses</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer Verlag</style></publisher><isbn><style face="normal" font="default" size="100%">09498257 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Copper is an essential micronutrient for both pathogens and the animal hosts they infect. However, copper can also be toxic in cells due to its redox properties and ability to disrupt active sites of metalloproteins, such as Fe-S enzymes. Through these toxic properties, copper is an effective antimicrobial agent and an emerging concept in innate immunity is that the animal host intentionally exploits copper toxicity in antimicrobial weaponry. In particular, macrophages can attack invading microbes with high copper and this metal is also elevated at sites of lung infection. In addition, copper levels in serum rise during infection with a wide array of pathogens. To defend against this toxic copper, the microbial intruder is equipped with a battery of copper detoxification defenses that promote survival in the host, including copper exporting ATPases and copper binding metallothioneins. However, it is important to remember that copper is also an essential nutrient for microbial pathogens and serves as important cofactor for enzymes such as cytochrome c oxidase for respiration, superoxide dismutase for anti-oxidant defense and multi-copper oxidases that act on metals and organic substrates. We therefore posit that the animal host can also thwart pathogen growth by limiting their copper nutrients, similar to the well-documented nutritional immunity effects for starving microbes of essential zinc, manganese and iron micronutrients. This review provides both sides of the copper story and evaluates how the host can exploit either copper-the-toxin or copper-the-nutrient in antimicrobial tactics at the host-pathogen battleground. © 2016 SBIC.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :38&#xD;Export Date: 26 March 2020&#xD;CODEN: JJBCF&#xD;Correspondence Address: Culotta, V.C.; Department of Biochemistry and Molecular Biology, Johns Hopkins University Bloomberg, School of Public Health, 615 N. Wolfe Street, United States; email: vculott1@jhu.edu</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84954522499&amp;doi=10.1007%2fs00775-016-1335-1&amp;partnerID=40&amp;md5=4a8d4a1b55601de5365713b2f0401650</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">26790881</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s00775-016-1335-1</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>114</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">114</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bhalla, A.</style></author><author><style face="normal" font="default" size="100%">Pultz, N. J.</style></author><author><style face="normal" font="default" size="100%">Gries, D. M.</style></author><author><style face="normal" font="default" size="100%">Ray, A. J.</style></author><author><style face="normal" font="default" size="100%">Eckstein, E. C.</style></author><author><style face="normal" font="default" size="100%">Aron, D. C.</style></author><author><style face="normal" font="default" size="100%">Donskey, C. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Infectious Diseases Division, University Hospitals of Cleveland, Cleveland, OH, United States&#xD;Infectious Diseases Section, L.S. Cleveland Vet. Aff. Med. Ctr., Cleveland, OH, United States&#xD;Department of Pediatrics, Madigan Army Medical Center, Tacoma, WA, United States&#xD;Department of Medicine, University Hospitals of Cleveland, Cleveland, OH, United States&#xD;Infection Control Department, L.S. Cleveland Vet. Aff. Med. Ctr., Cleveland, OH, United States&#xD;Ctr. for Qual. Improvement Research, L.S. Cleveland Vet. Aff. Med. Ctr., Cleveland, OH, United States&#xD;Infectious Diseases Section, L.S. Cleveland Vet. Aff. Med. Ctr., 10701 East Boulevard, Cleveland, OH 44106, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Acquisition of Nosocomial Pathogens on Hands after Contact with Environmental Surfaces Near Hospitalized Patients</style></title><secondary-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">164-167</style></pages><volume><style face="normal" font="default" size="100%">25</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">vancomycin</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial transmission</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium culture</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium isolate</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">hand</style></keyword><keyword><style face="normal" font="default" size="100%">hospital patient</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Ohio</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2004</style></year></dates><isbn><style face="normal" font="default" size="100%">0899823X (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">We examined the frequency of acquisition of bacterial pathogens on investigators&apos; hands after contacting environmental surfaces near hospitalized patients. Hand imprint cultures were positive for one or more pathogens after contacting surfaces near 34 (53%) of 64 study patients, with Staphylococcus aureus and vancomycin-resistant Enterococcus being the most common isolates.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :291&#xD;Export Date: 26 March 2020&#xD;CODEN: ICEPE&#xD;Correspondence Address: Donskey, C.J.; Infectious Diseases Section, L.S. Cleveland Vet. Aff. Med. Ctr., 10701 East Boulevard, Cleveland, OH 44106, United States</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-1342332684&amp;doi=10.1086%2f502369&amp;partnerID=40&amp;md5=68694e4ea4ec9697c881e63b32c8ac83</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">14994944</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1086/502369</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>115</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">115</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bleichert, P.</style></author><author><style face="normal" font="default" size="100%">Meyer, H.</style></author><author><style face="normal" font="default" size="100%">Grass, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Sanitätsakademie der Bundeswehr, Institut für Mikrobiologie der Bundeswehr, Neuherbergstr. 11, München, 80937, Germany</style></auth-address><titles><title><style face="normal" font="default" size="100%">Inactivation of bacteria and viruses by metallic copper-surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Hygiene + Medizin</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Hyg. Med.</style></alt-title><short-title><style face="normal" font="default" size="100%">Inaktivierung von bakterien und viren durch metallische kupferflächen</style></short-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Hygiene + Medizin</style></full-title><abbr-1><style face="normal" font="default" size="100%">Hyg. Med.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Hygiene + Medizin</style></full-title><abbr-1><style face="normal" font="default" size="100%">Hyg. Med.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">192-198</style></pages><volume><style face="normal" font="default" size="100%">40</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antimicrobial surfaces</style></keyword><keyword><style face="normal" font="default" size="100%">Contact-killing</style></keyword><keyword><style face="normal" font="default" size="100%">Free of lamination massive</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">Massive metallic copper</style></keyword><keyword><style face="normal" font="default" size="100%">Metallic copper materials</style></keyword><keyword><style face="normal" font="default" size="100%">Nosocomial infections</style></keyword><keyword><style face="normal" font="default" size="100%">VBNC-state</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><publisher><style face="normal" font="default" size="100%">mhp-Verlag GmbH</style></publisher><isbn><style face="normal" font="default" size="100%">01723790 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Nosocomial infections pose a severe challenge for hospital hygiene. Use of metallic copper surfaces free of lamination reduce the numbers of infectious agents on bacteria and viruses and also result in fewer nosocomial infections. In this study the antimicrobial efficacy of massive, metallic copper surfaces was investigated against bacteria and viruses. Further, it was tested if metallic copper induces the viable but not culturable (VBNC) state in bacteria or if the bacteria are inactivated completely. Method: Antimicrobial efficacy was investigated using the so called dry method (also known as &quot;contact-killing&quot;). Test surfaces were laminate-free, pure copper and as control surfaces stainless steel was employed. Organisms tested included methicillin-resistant Staphylococcus aureus (MRSA) and Escherichia coli, as well as bacterial and viral agents of risk group 3 (Burkholderia pseudomallei, Burkholderia mallei, Brucella melitensis, Yersinia pestis, Francisella tularensis, vaccinia- and monkeypox-viruses). For investigating possible VBNC induction, MRSA and E. coli were used. Results: All bacteria and viruses upon contact to metallic copper were inactivated up to 7-log units within 5 minutes. Additionally, it was demonstrated that copper completely inactivated E. coli and MRSA, respectively. Conclusion: Massive metallic copper surfaces have antimicrobial efficacy against a variety of gram-negative and -positive bac-dieteria as well as viruses. E. coli and MRSA were completely inactivated and thus failed to enter the VBNC state. However, copper surfaces will not be able to replace established and effective hygiene measures such as chemical hand and surface disinfection but instead will serve as an additional module aimed at prevention of infections.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :2&#xD;Export Date: 26 March 2020&#xD;CODEN: HYMED&#xD;Correspondence Address: Grass, G.; Sanitätsakademie der Bundeswehr, Institut für Mikrobiologie der Bundeswehr, Neuherbergstr. 11, Germany; email: gregorgrass@bundeswehr.org</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957796902&amp;partnerID=40&amp;md5=5661fdfb35c270ce49e44686ed7424a8</style></url></related-urls></urls><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">German</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>116</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">116</key></foreign-keys><ref-type name="Serial">57</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Bonadonna, L.</style></author><author><style face="normal" font="default" size="100%">Briancesco, R.</style></author><author><style face="normal" font="default" size="100%">Coccia, A. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, Rome, 00161, Italy</style></auth-address><titles><title><style face="normal" font="default" size="100%">Analysis of microorganisms in hospital environments and potential risks</style></title><secondary-title><style face="normal" font="default" size="100%">SpringerBriefs in Public Health</style></secondary-title><alt-title><style face="normal" font="default" size="100%">SpringerBriefs Public Health</style></alt-title></titles><pages><style face="normal" font="default" size="100%">53-62</style></pages><keywords><keyword><style face="normal" font="default" size="100%">Hospital environment</style></keyword><keyword><style face="normal" font="default" size="100%">Indoor air quality</style></keyword><keyword><style face="normal" font="default" size="100%">Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Microorganisms</style></keyword><keyword><style face="normal" font="default" size="100%">Pathogens</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">21923698 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">This report provides information on indoor air quality and on associated potential risks in hospitals. Spread and persistence of microbial communities in hospital environments are of huge interest to public health. Hospitals are characterized by high infective risk, firstly cause of the compromised immunologic conditions of the patients that make them vulnerable to bacterial, viral, parasitological and fungal opportunistic infections. Evidence suggests that microbial agents spread through air, surfaces, aerosol and hands. If surfaces may act as a reservoir for some pathogens, hands are an important transmission route. Airborne and aerosolized waterborne microorganisms are taken into consideration, and their presence into the hospital environments is reviewed. © The Author(s) 2017.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Bonadonna, L.; Department of Environment and Health, Istituto Superiore di Sanità, Viale Regina Elena 299, Italy; email: lucia.bonadonna@iss.it</style></notes><work-type><style face="normal" font="default" size="100%">Book Chapter</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029165520&amp;doi=10.1007%2f978-3-319-49160-8_5&amp;partnerID=40&amp;md5=88629e01c4b5a370410b17f8f75708c0</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-49160-8_5</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>117</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">117</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Borkow, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Cupron Scientific, Hasadnaot 10, Herzelia Pituach 46728, Israel</style></auth-address><titles><title><style face="normal" font="default" size="100%">Safety of using copper oxide in medical devices and consumer products</style></title><secondary-title><style face="normal" font="default" size="100%">Current Chemical Biology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Curr. Chem. Biol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Current Chemical Biology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Curr. Chem. Biol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Current Chemical Biology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Curr. Chem. Biol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">86-92</style></pages><volume><style face="normal" font="default" size="100%">6</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Biocide</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical trials</style></keyword><keyword><style face="normal" font="default" size="100%">Copper oxide</style></keyword><keyword><style face="normal" font="default" size="100%">Medical devices</style></keyword><keyword><style face="normal" font="default" size="100%">Safety</style></keyword><keyword><style face="normal" font="default" size="100%">Skin</style></keyword><keyword><style face="normal" font="default" size="100%">antibacterial activity</style></keyword><keyword><style face="normal" font="default" size="100%">antiviral activity</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">delayed hypersensitivity</style></keyword><keyword><style face="normal" font="default" size="100%">experimental guinea pig</style></keyword><keyword><style face="normal" font="default" size="100%">experimental model</style></keyword><keyword><style face="normal" font="default" size="100%">experimental pig</style></keyword><keyword><style face="normal" font="default" size="100%">experimental rabbit</style></keyword><keyword><style face="normal" font="default" size="100%">exposure</style></keyword><keyword><style face="normal" font="default" size="100%">face</style></keyword><keyword><style face="normal" font="default" size="100%">foot</style></keyword><keyword><style face="normal" font="default" size="100%">fungicidal activity</style></keyword><keyword><style face="normal" font="default" size="100%">hand</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">medical device</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">product safety</style></keyword><keyword><style face="normal" font="default" size="100%">scanning electron microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">skin injury</style></keyword><keyword><style face="normal" font="default" size="100%">skin irritation</style></keyword><keyword><style face="normal" font="default" size="100%">skin toxicity</style></keyword><keyword><style face="normal" font="default" size="100%">thigh</style></keyword><keyword><style face="normal" font="default" size="100%">toxicity testing</style></keyword><keyword><style face="normal" font="default" size="100%">Acari</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year></dates><isbn><style face="normal" font="default" size="100%">22127968 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Copper has two key properties that make it an active ingredient in the medical devices currently being developed. First, copper is an essential trace element needed by humans, which plays a key role in many physiological processes in different tissues. For example, copper has been shown to be involved in angiogenesis and in wound healing. Second, copper has very potent antibacterial, antifungal, antiviral, and acaricidal properties. Recently, a novel technology has been developed that introduces copper oxide particles into polymeric materials, where they serve as a slow release source of copper ions. For example, by using this technology, copper oxide containing wound dressings that enhance wound healing; copper oxide containing antiviral respiratory masks that reduce the risk of infection; socks that protect from athlete&apos;s foot, and acaricidal bedding products that kill dust mites, have been developed. While copper oxide is used as the source of copper in mineral and vitamin supplements and is considered safe, its use in medical devices, as well as in industrial and consumer products, is novel. The current manuscript reviews the safety aspects of the use of copper oxide in products that come in contact with open and closed skin. Copper oxide products have been tested in 9 clinical trials and in several non-clinical studies and have been found to be non-irritating, non-sensitizing, and safe to use, with not even one adverse reaction recorded, both when in contact with intact and broken skin. This is in accordance with the extremely low risk of adverse reactions attributed to dermal exposure to copper. © 2012 Bentham Science Publishers.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :12&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Borkow, G.Hameyasdim 44, Gibton 76910, Israel; email: gadi@cupron.com</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84860301309&amp;partnerID=40&amp;md5=4f9b97ecab736ec9d28fe0c2e6b6f9d8</style></url></related-urls></urls><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>118</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">118</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Borkow, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Cupron Scientific, Hasadnaot 10, Herzelia 46733, Israel</style></auth-address><titles><title><style face="normal" font="default" size="100%">Using copper to fight microorganisms</style></title><secondary-title><style face="normal" font="default" size="100%">Current Chemical Biology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Curr. Chem. Biol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Current Chemical Biology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Curr. Chem. Biol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Current Chemical Biology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Curr. Chem. Biol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">93-103</style></pages><volume><style face="normal" font="default" size="100%">6</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Acaricidal</style></keyword><keyword><style face="normal" font="default" size="100%">Antiviral</style></keyword><keyword><style face="normal" font="default" size="100%">Biocide</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Fungicide</style></keyword><keyword><style face="normal" font="default" size="100%">Nosocomial infections</style></keyword><keyword><style face="normal" font="default" size="100%">Wound healing</style></keyword><keyword><style face="normal" font="default" size="100%">copper derivative</style></keyword><keyword><style face="normal" font="default" size="100%">breast milk</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">food poisoning</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">microorganism</style></keyword><keyword><style face="normal" font="default" size="100%">mycosis</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">review</style></keyword><keyword><style face="normal" font="default" size="100%">wound infection</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year></dates><publisher><style face="normal" font="default" size="100%">Bentham Science Publishers B.V.</style></publisher><isbn><style face="normal" font="default" size="100%">22127968 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">The manuscript reviews the biocidal mechanisms of copper and its current uses in the fight against transmission of health-associated (nosocomial) pathogens, foodborne diseases, dust mites loads and fungal and wound infections. The manuscript also discusses possible future applications such as filtration devices capable of deactivating contaminated blood products and breastmilk. © 2012 Bentham Science Publishers.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :24&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Borkow, G.; Cupron Scientific, Hasadnaot 10, Herzelia 46733, Israel; email: gadi@cupron.com</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84862598575&amp;doi=10.2174%2f187231312801254723&amp;partnerID=40&amp;md5=758b72a45e18058cb47688447b6f9828</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.2174/187231312801254723</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>119</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">119</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Borkow, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Cupron Inc., Hasadnaot 10, Herzelia, 46733, Israel</style></auth-address><titles><title><style face="normal" font="default" size="100%">Biocidal hard and soft surfaces containing copper oxide particles for the reduction of healthcare-acquired pathogens</style></title><secondary-title><style face="normal" font="default" size="100%">Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Use of Biocidal Surf. for Red. of Healthc. Acquired Infect.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">85-101</style></pages><volume><style face="normal" font="default" size="100%">9783319080574</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Health care</style></keyword><keyword><style face="normal" font="default" size="100%">Microorganisms</style></keyword><keyword><style face="normal" font="default" size="100%">Textiles</style></keyword><keyword><style face="normal" font="default" size="100%">Biocidal properties</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical settings</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">Indirect contact</style></keyword><keyword><style face="normal" font="default" size="100%">Infection rates</style></keyword><keyword><style face="normal" font="default" size="100%">Oxide particles</style></keyword><keyword><style face="normal" font="default" size="100%">Soft and hard surfaces</style></keyword><keyword><style face="normal" font="default" size="100%">Temperature and humidities</style></keyword><keyword><style face="normal" font="default" size="100%">Copper oxides</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319080574 (ISBN); 3319080563 (ISBN); 9783319080567 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">Potentially overlooked and neglected sources of healthcare-acquired pathogens are non-intrusive soft and hard surfaces located in clinical settings. Microbes can survive on bedding, uniforms, trays, bed rails and other such surfaces for days to months. Furthermore, on some of these surfaces, such as patient bedding, the microorganisms proliferate as textiles are an excellent substrate for bacterial and fungal growth. Additionally the temperature and humidity conditions present between the patients and these textiles are appropriate for microorganism multiplication. Bed making in hospitals can release large quantities of microorganisms into the air, which contaminate the surroundings. Thus soft and hard surfaces that are in direct or indirect contact with the patients can serve as a source of healthcare-acquired pathogens. Copper oxide impregnated materials have potent intrinsic biocidal properties. This manuscript reviews the laboratory and clinical studies that demonstrate that soft and hard surfaces containing copper oxide particles reduce bioburden and healthcare-acquired infection rates. © 2014 Springer International Publishing Switzerland. All rights are reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :2&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Borkow, G.; Cupron Inc., Hasadnaot 10, Israel</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928913682&amp;doi=10.1007%2f978-3-319-08057-4_5&amp;partnerID=40&amp;md5=463d6dba7ce1ced7f21dee537f434b7f</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-08057-4_5</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>120</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">120</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Borkow, G.</style></author><author><style face="normal" font="default" size="100%">Gabbay, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Cupron Inc., Jerusalem, Israel&#xD;Hameyasdim 44, Kfar Gibton 76910, Israel</style></auth-address><titles><title><style face="normal" font="default" size="100%">Copper as a biocidal tool</style></title><secondary-title><style face="normal" font="default" size="100%">Current Medicinal Chemistry</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Curr. Med. Chem.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Current Medicinal Chemistry</style></full-title><abbr-1><style face="normal" font="default" size="100%">Curr. Med. Chem.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Current Medicinal Chemistry</style></full-title><abbr-1><style face="normal" font="default" size="100%">Curr. Med. Chem.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">2163-2175</style></pages><volume><style face="normal" font="default" size="100%">12</style></volume><number><style face="normal" font="default" size="100%">18</style></number><keywords><keyword><style face="normal" font="default" size="100%">alloy</style></keyword><keyword><style face="normal" font="default" size="100%">antifouling agent</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">antinematodal agent</style></keyword><keyword><style face="normal" font="default" size="100%">cadmium</style></keyword><keyword><style face="normal" font="default" size="100%">chlorine</style></keyword><keyword><style face="normal" font="default" size="100%">chromium</style></keyword><keyword><style face="normal" font="default" size="100%">cobalt</style></keyword><keyword><style face="normal" font="default" size="100%">copper complex</style></keyword><keyword><style face="normal" font="default" size="100%">copper derivative</style></keyword><keyword><style face="normal" font="default" size="100%">copper ion</style></keyword><keyword><style face="normal" font="default" size="100%">copper sulfate</style></keyword><keyword><style face="normal" font="default" size="100%">double stranded DNA</style></keyword><keyword><style face="normal" font="default" size="100%">fungicide</style></keyword><keyword><style face="normal" font="default" size="100%">heavy metal</style></keyword><keyword><style face="normal" font="default" size="100%">iron</style></keyword><keyword><style face="normal" font="default" size="100%">molluscacide</style></keyword><keyword><style face="normal" font="default" size="100%">nickel</style></keyword><keyword><style face="normal" font="default" size="100%">protein tyrosine phosphatase</style></keyword><keyword><style face="normal" font="default" size="100%">silver</style></keyword><keyword><style face="normal" font="default" size="100%">single stranded DNA</style></keyword><keyword><style face="normal" font="default" size="100%">water</style></keyword><keyword><style face="normal" font="default" size="100%">zinc</style></keyword><keyword><style face="normal" font="default" size="100%">antiviral activity</style></keyword><keyword><style face="normal" font="default" size="100%">bactericidal activity</style></keyword><keyword><style face="normal" font="default" size="100%">cell membrane</style></keyword><keyword><style face="normal" font="default" size="100%">concentration (parameters)</style></keyword><keyword><style face="normal" font="default" size="100%">disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">DNA repair</style></keyword><keyword><style face="normal" font="default" size="100%">drug potency</style></keyword><keyword><style face="normal" font="default" size="100%">enzyme inhibition</style></keyword><keyword><style face="normal" font="default" size="100%">extracellular space</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">intracellular space</style></keyword><keyword><style face="normal" font="default" size="100%">liquid</style></keyword><keyword><style face="normal" font="default" size="100%">membrane damage</style></keyword><keyword><style face="normal" font="default" size="100%">microorganism</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">permeability barrier</style></keyword><keyword><style face="normal" font="default" size="100%">protein binding</style></keyword><keyword><style face="normal" font="default" size="100%">review</style></keyword><keyword><style face="normal" font="default" size="100%">solid</style></keyword><keyword><style face="normal" font="default" size="100%">tinea pedis</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Infective Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Biological</style></keyword><keyword><style face="normal" font="default" size="100%">Viruses</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2005</style></year></dates><isbn><style face="normal" font="default" size="100%">09298673 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Copper ions, either alone or in copper complexes, have been used to disinfect liquids, solids and human tissue for centuries. Today copper is used as a water purifier, algaecide, fungicide, nematocide, molluscicide as well as an antibacterial and anti-fouling agent. Copper also displays potent anti-viral activity. This article reviews (i) the biocidal properties of copper; (ii) the possible mechanisms by which copper is toxic to microorganisms; and (iii) the systems by which many microorganisms resist high concentrations of heavy metals, with an emphasis on copper. © 2005 Bentham Science Publishers Ltd.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :332&#xD;Export Date: 26 March 2020&#xD;CODEN: CMCHE&#xD;Correspondence Address: Borkow, G.Hameyasdim 44, Kfar Gibton 76910, Israel; email: gadi@cupron.com</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-23144446387&amp;doi=10.2174%2f0929867054637617&amp;partnerID=40&amp;md5=70026654d9e04d7913a22260f6adddce</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">16101497</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.2174/0929867054637617</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>121</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">121</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Borkow, G.</style></author><author><style face="normal" font="default" size="100%">Gabbay, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Cupron Inc., P.O. Box 10973, Greensboro, NC 27404, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Biocidal textiles can help fight nosocomial infections</style></title><secondary-title><style face="normal" font="default" size="100%">Medical Hypotheses</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Med. Hypotheses</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Medical Hypotheses</style></full-title><abbr-1><style face="normal" font="default" size="100%">Med. Hypotheses</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Medical Hypotheses</style></full-title><abbr-1><style face="normal" font="default" size="100%">Med. Hypotheses</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">990-994</style></pages><volume><style face="normal" font="default" size="100%">70</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">antibiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">biocide</style></keyword><keyword><style face="normal" font="default" size="100%">airborne infection</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">instrument sterilization</style></keyword><keyword><style face="normal" font="default" size="100%">medical staff</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">microorganism</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">protective equipment</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">textile</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Bedding and Linens</style></keyword><keyword><style face="normal" font="default" size="100%">Clothing</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Disinfectants</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Biological</style></keyword><keyword><style face="normal" font="default" size="100%">Models, Theoretical</style></keyword><keyword><style face="normal" font="default" size="100%">Risk</style></keyword><keyword><style face="normal" font="default" size="100%">Temperature</style></keyword><keyword><style face="normal" font="default" size="100%">Textiles</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria (microorganisms)</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year></dates><isbn><style face="normal" font="default" size="100%">03069877 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">The rates of nosocomial infections, especially by those caused by antibiotic resistant bacteria, are increasing alarmingly over the globe. Although more rigorous infection control measures are being implemented, it is clear that the current modalities to reduce nosocomial infections are not sufficient. Textiles are an excellent substrate for bacterial growth under appropriate moisture and temperature conditions. Patients shed bacteria and contaminate their pyjamas and sheets. The temperature and humidity between the patients and the bed are appropriate conditions allowing for effective bacterial proliferation. Several studies have found that personnel in contact with contaminated textiles were the source of transmission of the micro-organisms to susceptible patients. Furthermore, it has been reported that bed making in hospitals releases large quantities of micro-organisms into the air, which contaminate the immediate and non-immediate surroundings. Contaminated textiles in hospitals can thus be an important source of microbes contributing to endogenous, indirect-contact, and aerosol transmission of nosocomial related pathogens. We hypothesize that the use of antimicrobial textiles, especially in those textiles that are in close contact with the patients, may significantly reduce bioburden in clinical settings and consequently reduce the risk of nosocomial infections. These textiles should possess broad spectrum biocidal properties. They should be safe for use and highly effective against antibiotic resistant micro-organisms, including those that are commonly involved in hospital-acquired infections, and they should not permit the development of resistant micro-organisms to the active compound. © 2007 Elsevier Ltd. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :108&#xD;Export Date: 26 March 2020&#xD;CODEN: MEHYD&#xD;Correspondence Address: Borkow, G.; Cupron Inc., P.O. Box 10973, Greensboro, NC 27404, United States; email: gadi@cupron.com</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-40849106976&amp;doi=10.1016%2fj.mehy.2007.08.025&amp;partnerID=40&amp;md5=58da8b8236466ef5ef5a1c2dfc4d4953</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">17959322</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.mehy.2007.08.025</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>122</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">122</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Boyce, J. M.</style></author><author><style face="normal" font="default" size="100%">Potter-Bynoe, G.</style></author><author><style face="normal" font="default" size="100%">Chenevert, C.</style></author><author><style face="normal" font="default" size="100%">King, T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Miriam Hospital, Brown University, Providence, RI, United States&#xD;Division of Infectious Diseases, Miriam Hospital, 164 Summit Ave, Providence, RI 02906, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Environmental contamination due to methicillin-resistant Staphylococcus aureus: Possible infection control implications</style></title><secondary-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">622-627</style></pages><volume><style face="normal" font="default" size="100%">18</style></volume><number><style face="normal" font="default" size="100%">9</style></number><keywords><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium identification</style></keyword><keyword><style face="normal" font="default" size="100%">classification</style></keyword><keyword><style face="normal" font="default" size="100%">clothing</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">culture technique</style></keyword><keyword><style face="normal" font="default" size="100%">disease carrier</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">equipment</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">isolation and purification</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">methodology</style></keyword><keyword><style face="normal" font="default" size="100%">microbiological examination</style></keyword><keyword><style face="normal" font="default" size="100%">nonparametric test</style></keyword><keyword><style face="normal" font="default" size="100%">penicillin resistance</style></keyword><keyword><style face="normal" font="default" size="100%">prospective study</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus infection</style></keyword><keyword><style face="normal" font="default" size="100%">teaching hospital</style></keyword><keyword><style face="normal" font="default" size="100%">United States</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Typing Techniques</style></keyword><keyword><style face="normal" font="default" size="100%">Cell Culture Techniques</style></keyword><keyword><style face="normal" font="default" size="100%">Disease Reservoirs</style></keyword><keyword><style face="normal" font="default" size="100%">Equipment Contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, Teaching</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin Resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Microbial Sensitivity Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Patients&apos; Rooms</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Rhode Island</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcal Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Statistics, Nonparametric</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1997</style></year></dates><isbn><style face="normal" font="default" size="100%">0899823X (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE: To study the possible role of contaminated environmental surfaces as a reservoir of methicillin-resistant Staphylococcus aureus (MRSA) in hospitals. DESIGN: A prospective culture survey of inanimate objects in the rooms of patients with MRSA. SETTING: A 200-bed university-affiliated teaching hospital. PATIENTS: Thirty-eight consecutive patients colonized or infected with MRSA. Patients represented endemic MRSA cases. RESULTS: Ninety-six (27%) of 350 surfaces sampled in the rooms of affected patients were contaminated with MRSA When patients had MRSA in a wound or urine, 36% of surfaces were contaminated. In contrast, when MRSA was isolated from other body sites, only 6% of surfaces were contaminated (odds ratio, 8.8; 95% confidence interval, 3.7-25.5; P&lt;.0001). Environmental contamination occurred in the rooms of 73% of infected patients and 69% of colonized patients. Frequently contaminated objects included the floor, bed linens, the patient&apos;s gown, overbed tables, and blood pressure cuffs. Sixty-five percent of nurses who had performed morning patient-care activities on patients with MRSA in a wound or urine contaminated their nursing uniforms or gowns with MRSA Forty-two percent of personnel who had no direct contact with such patients, but had touched contaminated surfaces, contaminated their gloves with MRSA. CONCLUSIONS: We concluded that inanimate surfaces near affected patients commonly become contaminated with MRSA and that the frequency of contamination is affected by the body site at which patients are colonized or infected. That personnel may contaminate their gloves (or possibly their hands) by touching such surfaces suggests that contaminated environmental surfaces may serve as a reservoir of MRSA in hospitals.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :536&#xD;Export Date: 26 March 2020&#xD;CODEN: ICEPE&#xD;Correspondence Address: Boyce, J.M.; Division of Infectious Diseases, Miriam Hospital, 164 Summit Ave, Providence, RI 02906, United States</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0031229649&amp;partnerID=40&amp;md5=c85817fa975bf0b342e3afdf9d25c571</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">9309433</style></custom2><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>124</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">124</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cadenhead, C. D.</style></author><author><style face="normal" font="default" size="100%">Waggener, L. T.</style></author><author><style face="normal" font="default" size="100%">Goswami, B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">WHR Architects, 1111 Louisiana St., Floor. 26, Houston, TX 77002, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">The role of architecture and physical environment in hospital safety design</style></title><secondary-title><style face="normal" font="default" size="100%">Surgical Patient Care: Improving Safety, Quality and Value</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Surg. Patient Care: Improv. Safety, Quality and Value</style></alt-title></titles><pages><style face="normal" font="default" size="100%">159-183</style></pages><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319440101 (ISBN); 9783319440088 (ISBN)</style></isbn><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Cadenhead, C.D.; WHR Architects, 1111 Louisiana St., Floor. 26, United States; email: CCadenhead@whrarchitects.com</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85037825101&amp;doi=10.1007%2f978-3-319-44010-1_12&amp;partnerID=40&amp;md5=25e17a0defe2e789b618ecc28cee23d5</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-44010-1_12</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>125</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">125</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Carling, P. C.</style></author><author><style face="normal" font="default" size="100%">Parry, M. F.</style></author><author><style face="normal" font="default" size="100%">Bruno-Murtha, L. A.</style></author><author><style face="normal" font="default" size="100%">Dick, B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Medicine, Boston University School of Medicine, Boston, MA, United States&#xD;Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY, United States&#xD;Department of Medicine, Harvard University School of Medicine, Boston, MA, United States&#xD;CIC PromedicaHealth, Toledo, OH, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Improving environmental hygiene in 27 intensive care units to decrease multidrug-resistant bacterial transmission</style></title><secondary-title><style face="normal" font="default" size="100%">Critical Care Medicine</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Crit. Care Med.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Critical Care Medicine</style></full-title><abbr-1><style face="normal" font="default" size="100%">Crit. Care Med.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Critical Care Medicine</style></full-title><abbr-1><style face="normal" font="default" size="100%">Crit. Care Med.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">1054-1059</style></pages><volume><style face="normal" font="default" size="100%">38</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">Disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">Healthcare environmental hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">Healthcare-associated infections</style></keyword><keyword><style face="normal" font="default" size="100%">Multidrug-resistant bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Quality assurance</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial transmission</style></keyword><keyword><style face="normal" font="default" size="100%">correlation analysis</style></keyword><keyword><style face="normal" font="default" size="100%">education program</style></keyword><keyword><style face="normal" font="default" size="100%">hospital hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care unit</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">performance</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">prospective study</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year></dates><publisher><style face="normal" font="default" size="100%">Lippincott Williams and Wilkins</style></publisher><isbn><style face="normal" font="default" size="100%">00903493 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Objective: To determine the thoroughness of terminal disinfection and cleaning of patient rooms in hospital intensive care units and to assess the value of a structured intervention program to improve the quality of cleaning as a means of reducing environmental transmission of multidrug-resistant organisms within the intensive care unit. Design: Prospective, multicenter, and pre-and postinterventional study. Setting: Intensive care unit rooms in 27 acute care hospitals. Hospitals ranged in size from 25 beds to 709 beds (mean, 206 beds). Interventions: A fluorescent targeting method was used to objectively evaluate the thoroughness of terminal room cleaning before and after structured educational, procedural, and administrative interventions. Systematic covert monitoring was performed by infection control personnel to assure accuracy and lack of bias. Measurements and Main Results: In total, 3532 environmental surfaces (14 standardized objects) were assessed after terminal cleaning in 260 intensive care unit rooms. Only 49.5% (1748) of surfaces were cleaned at baseline (95% confidence interval, 42% to 57%). Thoroughness of cleaning at baseline did not correlate with hospital size, patient volume, case mix index, geographic location, or teaching status. After intervention and multiple cycles of objective performance feedback to environmental services staff, thoroughness of cleaning improved to 82% (95% confidence interval, 78% to 86%). Conclusions: Significant improvements in intensive care unit room cleaning can be achieved in most hospitals by using a structured approach that incorporates a simple, highly objective surface targeting method and repeated performance feedback to environmental services personnel. Given the documented environmental transmission of a wide range of multidrug-resistant pathogens, our findings identify a substantial opportunity to enhance patient safety by improving the thoroughness of intensive care unit environmental hygiene. © 2010 by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :105&#xD;Export Date: 26 March 2020&#xD;CODEN: CCMDC&#xD;Correspondence Address: Carling, P. C.; Department of Medicine, Boston University School of Medicine, Boston, MA, United States; email: pcarling@comcast.net</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-77950238348&amp;doi=10.1097%2fCCM.0b013e3181cdf705&amp;partnerID=40&amp;md5=1272f88faf7e8b870a82ba154658f961</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1097/CCM.0b013e3181cdf705</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>127</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">127</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cleave, C. V.</style></author><author><style face="normal" font="default" size="100%">Crans, D. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Chemistry, Colorado State University, Fort Collins, CO 80523, United States&#xD;Cell and Molecular Biology Program, Colorado State University, Fort Collins, CO 80523, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">The first-row transition metals in the periodic table of medicine</style></title><secondary-title><style face="normal" font="default" size="100%">Inorganics</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Inorganics</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Inorganics</style></full-title><abbr-1><style face="normal" font="default" size="100%">Inorganics</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Inorganics</style></full-title><abbr-1><style face="normal" font="default" size="100%">Inorganics</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">7</style></volume><number><style face="normal" font="default" size="100%">9</style></number><keywords><keyword><style face="normal" font="default" size="100%">First-row transition metals</style></keyword><keyword><style face="normal" font="default" size="100%">Metals in medicine</style></keyword><keyword><style face="normal" font="default" size="100%">Periodic table</style></keyword><keyword><style face="normal" font="default" size="100%">Speciation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><publisher><style face="normal" font="default" size="100%">MDPI Multidisciplinary Digital Publishing Institute</style></publisher><isbn><style face="normal" font="default" size="100%">23046740 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">In this manuscript, we describe medical applications of each first-row transition metal including nutritional, pharmaceutical, and diagnostic applications. The 10 first-row transition metals in particular are found to have many applications since there five essential elements among them. We summarize the aqueous chemistry of each element to illustrate that these fundamental properties are linked to medical applications and will dictate some of nature&apos;s solutions to the needs of cells. The five essential trace elements-iron, copper, zinc, manganese, and cobalt-represent four redox active elements and one redox inactive element. Since electron transfer is a critical process that must happen for life, it is therefore not surprising that four of the essential trace elements are involved in such processes, whereas the one non-redox active element is found to have important roles as a secondary messenger.. Perhaps surprising is the fact that scandium, titanium, vanadium, chromium, and nickel have many applications, covering the entire range of benefits including controlling pathogen growth, pharmaceutical and diagnostic applications, including benefits such as nutritional additives and hardware production of key medical devices. Some patterns emerge in the summary of biological function andmedical roles that can be attributed to small differences in the first-row transition metals. © 2019 by the authors.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Crans, D.C.; Department of Chemistry, Colorado State UniversityUnited States; email: Debbie.Crans@colostate.edu</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072575617&amp;doi=10.3390%2finorganics7090111&amp;partnerID=40&amp;md5=d4a1ad92c06adbbe69ed3b3bb66212a0</style></url></related-urls></urls><custom7><style face="normal" font="default" size="100%">111</style></custom7><electronic-resource-num><style face="normal" font="default" size="100%">10.3390/inorganics7090111</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>128</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">128</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Cruz, R.</style></author><author><style face="normal" font="default" size="100%">Vera, M.</style></author><author><style face="normal" font="default" size="100%">Faundes, N.</style></author><author><style face="normal" font="default" size="100%">González, N.</style></author><author><style face="normal" font="default" size="100%">Leiva, J.</style></author><author><style face="normal" font="default" size="100%">Flores, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Académico Laboratorio de Micología, Universidad de Valparaíso, Chile&#xD;Alumnos Escuela de Odontología, Universidad de Valparaíso, Chile&#xD;Alumnos Escuela de Medicina, Universidad de Valparaíso, Chile</style></auth-address><titles><title><style face="normal" font="default" size="100%">In vitro evaluation of the antimicrobial activity of a hand gel with copper nanomolecules</style></title><secondary-title><style face="normal" font="default" size="100%">Revista Argentina de Dermatologia</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Rev. Argent. Dermatol.</style></alt-title><short-title><style face="normal" font="default" size="100%">Evaluación in vitro de la actividad antimicrobiana de un gel para manos con nanomoléculas de cobre</style></short-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Revista Argentina de Dermatologia</style></full-title><abbr-1><style face="normal" font="default" size="100%">Rev. Argent. Dermatol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Revista Argentina de Dermatologia</style></full-title><abbr-1><style face="normal" font="default" size="100%">Rev. Argent. Dermatol.</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">98</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antimicrobial activity</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Gel</style></keyword><keyword><style face="normal" font="default" size="100%">alcohol</style></keyword><keyword><style face="normal" font="default" size="100%">chlorhexidine</style></keyword><keyword><style face="normal" font="default" size="100%">copper nanoparticle</style></keyword><keyword><style face="normal" font="default" size="100%">distilled water</style></keyword><keyword><style face="normal" font="default" size="100%">Article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial strain</style></keyword><keyword><style face="normal" font="default" size="100%">Candida albicans</style></keyword><keyword><style face="normal" font="default" size="100%">Candida parapsilosis</style></keyword><keyword><style face="normal" font="default" size="100%">culture medium</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus faecalis</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">experimental study</style></keyword><keyword><style face="normal" font="default" size="100%">gauze dressing</style></keyword><keyword><style face="normal" font="default" size="100%">growth inhibition</style></keyword><keyword><style face="normal" font="default" size="100%">hand gel</style></keyword><keyword><style face="normal" font="default" size="100%">healthcare associated infection</style></keyword><keyword><style face="normal" font="default" size="100%">in vitro study</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">Asociation Argentina de Dermatologia</style></publisher><isbn><style face="normal" font="default" size="100%">03252787 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Introduction: in the last few years the use of copper has been proposed as an alternative for reducing HAIs. Objective: To assess in vitro antimicrobial activity of a gel with copper nanomolecules on strains of Candida albicans , C. parapsilosis, Staphylococcus aureus, Enteroccus faecalis , Escherichia coli and Pseudomona aeruginosa. Materials and Methods: in vitro experimental study. Reference strains (ATCC) were seeded in growth medium and then four disks of sterile gauze impregnated with gel copper, chlorhexidine, gel alcohol and distilled water were placed in the culture. Halos were measured at 24, 48 hours and 7 days. Anova test and Tukey HSD test were used to statistical analysis. Results: for C. albicans and C. parapsilosis copper gel provided an inhibition at 24, 48 hours and 7 days, being higher than chlorhexidine (p &lt;0.001) in the case of C. albicans. For S. aureus, E. coli and P. aeruginosa copper gel showed a lower halo (p &lt;0.001) than chlorhexidine at 16 and 24 hours, however there was no inhibition at 48 hrs or 7 days. In E. faecalis no inhibition halo was found at any time. Conclusions: The copper gel showed in vitro activity for C. albicans and C. parapsilosis up to 7 days. Presented activity on S. aureus, E. coli and P. aeruginosa up to 24 hrs. It did not show antimicrobial activity against E. faecalis.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;CODEN: RADEB&#xD;Correspondence Address: Cruz, R.; Académico Laboratorio de Micología, Universidad de ValparaísoChile; email: rcruzchoappa@gmail.com</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85021297590&amp;partnerID=40&amp;md5=507c7ff8f01b568f8b225d9954bf59bb</style></url></related-urls></urls><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">Spanish</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>129</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">129</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dancer, S. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Scottish Ctr. Infect./Environ. Hlth., Clifton House, Clifton Place, Glasgow G3 7LN, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">10-15</style></pages><volume><style face="normal" font="default" size="100%">56</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Hospital cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">Mcrobiological standards</style></keyword><keyword><style face="normal" font="default" size="100%">Surface hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">meticillin</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial count</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium colony</style></keyword><keyword><style face="normal" font="default" size="100%">cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">environmental sanitation</style></keyword><keyword><style face="normal" font="default" size="100%">evidence based medicine</style></keyword><keyword><style face="normal" font="default" size="100%">food industry</style></keyword><keyword><style face="normal" font="default" size="100%">Gram negative bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">hospital hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">quantitative analysis</style></keyword><keyword><style face="normal" font="default" size="100%">risk assessment</style></keyword><keyword><style face="normal" font="default" size="100%">risk management</style></keyword><keyword><style face="normal" font="default" size="100%">standardization</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Colony Count, Microbial</style></keyword><keyword><style face="normal" font="default" size="100%">Decontamination</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">Sanitation</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2004</style></year></dates><isbn><style face="normal" font="default" size="100%">01956701 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Increasing numbers of hospital-acquired infections have generated much attention over the last decade. The public has linked the so-called &apos;superbugs&apos; with their experience of dirty hospitals, but the precise role of cleaning in the control of these organisms in unknown. Hence the importance of a clean environment is likely to remain speculative unless it becomes an evidence-based science. This proposal is a call for bacteriological standards with which to assess clinical surface hygiene in hospitals, based on those used by the food industry. The first standard concerns any finding of a specific &apos;indicator&apos; organism, the presence of which suggests a requirement for increased cleaning. Indicators would include Staphylococcus aureus, including methicillin-resistant S. aureus, Clostridium difficile, vancomycin-resistant enterococci and various Gram-negative bacilli. The second standard concerns a quantitative aerobic colony count of &amp;lt;5 cfu/cm2 on frequent hand touch surfaces in hospitals. The principle relates to modern risk management systems such as HACCP, and reflects the fact that pathogens of concern are widespread. Further work is required to evaluate and refine these standards and define the infection risk from the hospital environment. © 2003 The Hospital Infection Society. Published by Elsevier Ltd. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :263&#xD;Export Date: 26 March 2020&#xD;CODEN: JHIND&#xD;Correspondence Address: Dancer, S.J.; Scottish Ctr. Infect./Environ. Hlth., Clifton House, Clifton Place, Glasgow G3 7LN, United Kingdom; email: stephanie.dancer@scieh.csa.scot.nhs.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0346338099&amp;doi=10.1016%2fj.jhin.2003.09.017&amp;partnerID=40&amp;md5=18d1e6961fd9c530df966557b310c336</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">14706265</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.jhin.2003.09.017</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>130</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">130</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dancer, S. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Microbiology, Southern General Hospital, Glasgow, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Importance of the environment in meticillin-resistant Staphylococcus aureus acquisition: the case for hospital cleaning</style></title><secondary-title><style face="normal" font="default" size="100%">The Lancet Infectious Diseases</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Lancet Infect. Dis.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">The Lancet Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Lancet Infect. Dis.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">The Lancet Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Lancet Infect. Dis.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">101-113</style></pages><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">bacterial transmission</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium contamination</style></keyword><keyword><style face="normal" font="default" size="100%">cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">hospital hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">review</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus infection</style></keyword><keyword><style face="normal" font="default" size="100%">Carrier State</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental Monitoring</style></keyword><keyword><style face="normal" font="default" size="100%">Equipment and Supplies, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Housekeeping, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infection Control</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin Resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcal Infections</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year></dates><isbn><style face="normal" font="default" size="100%">14733099 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">In the UK, we continue to debate the importance of hospital cleaning in relation to increasing numbers of patients acquiring meticillin-resistant Staphylococcus aureus (MRSA). However, there is little direct evidence for the effectiveness of cleaning because it has never been afforded scientific status. Hospital hygiene is usually assessed visually, but this does not necessarily correlate with microbiological risk. A more robust case for hospital cleaning can be presented by considering the evidence for all the stages of the staphylococcal transmission cycle between human beings and their environment. Cleaning has already been accepted as an important factor in the control of other hardy environmental pathogens, such as Clostridium difficile, vancomycin-resistant enterococci, norovirus, and Acinetobacter spp. This Review will show why the removal of dirt might have more impact on the control of MRSA than previously thought. Introduction of additional cleaning services is easier than improvements in hand-hygiene compliance. © 2008 Elsevier Ltd. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :301&#xD;Export Date: 26 March 2020&#xD;CODEN: LIDAB&#xD;Correspondence Address: Dancer, S.J.; Department of Microbiology, Southern General Hospital, Glasgow, United Kingdom; email: stephanie.dancer@lanarkshire.scot.nhs.uk</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-38349121682&amp;doi=10.1016%2fS1473-3099%2807%2970241-4&amp;partnerID=40&amp;md5=8e47e0b169a6eb3e000bfc90fd47a747</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">17974481</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/S1473-3099(07)70241-4</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>131</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">131</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dancer, S. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">NHS Lanarkshire, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Environmental cleaning: The effect of cleaning on MRSA transmission risk</style></title><secondary-title><style face="normal" font="default" size="100%">Clinical Insights: Staphylococcus aureus Antibiotic Resistance</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Clin. Insights: Staphylococcus aureus Antibiot. Resist.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">63-71</style></pages><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><publisher><style face="normal" font="default" size="100%">Future Medicine Ltd.</style></publisher><isbn><style face="normal" font="default" size="100%">9781780843698 (ISBN); 9781780843711 (ISBN)</style></isbn><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Dancer, S.J.; NHS LanarkshireUnited Kingdom</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84957043604&amp;doi=10.2217%2fEBO.13.478&amp;partnerID=40&amp;md5=00d15d52cd42d361a24871994b4e60c4</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.2217/EBO.13.478</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>132</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">132</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dancer, S. J.</style></author><author><style face="normal" font="default" size="100%">White, L. F.</style></author><author><style face="normal" font="default" size="100%">Lamb, J.</style></author><author><style face="normal" font="default" size="100%">Kirsty, K. E.</style></author><author><style face="normal" font="default" size="100%">Robertson, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Microbiology, Hairmyres Hospital, Eaglesham Road, East Kilbride, United Kingdom&#xD;Department of Microbiology, Southern General Hospital, Govan Road, Glasgow, United Kingdom&#xD;Scottish MRSA Reference Laboratory, Stobhill Hospital, Glasgow, United Kingdom&#xD;Department of Statistics and Modelling Science, University of Strathclyde, Glasgow, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Measuring the effect of enhanced cleaning in a UK hospital: A prospective cross-over study</style></title><secondary-title><style face="normal" font="default" size="100%">BMC Medicine</style></secondary-title><alt-title><style face="normal" font="default" size="100%">BMC Med.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">BMC Medicine</style></full-title><abbr-1><style face="normal" font="default" size="100%">BMC Med.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">BMC Medicine</style></full-title><abbr-1><style face="normal" font="default" size="100%">BMC Med.</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">7</style></volume><keywords><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial strain</style></keyword><keyword><style face="normal" font="default" size="100%">clinical article</style></keyword><keyword><style face="normal" font="default" size="100%">cost benefit analysis</style></keyword><keyword><style face="normal" font="default" size="100%">genotype</style></keyword><keyword><style face="normal" font="default" size="100%">hospital hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">hospital management</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">length of stay</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus infection</style></keyword><keyword><style face="normal" font="default" size="100%">microbial contamination</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">outcome assessment</style></keyword><keyword><style face="normal" font="default" size="100%">sanitation</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial count</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium identification</style></keyword><keyword><style face="normal" font="default" size="100%">classification</style></keyword><keyword><style face="normal" font="default" size="100%">cluster analysis</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">crossover procedure</style></keyword><keyword><style face="normal" font="default" size="100%">epidemiology</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">hospital service</style></keyword><keyword><style face="normal" font="default" size="100%">isolation and purification</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">methodology</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">prospective study</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus infection</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Typing Techniques</style></keyword><keyword><style face="normal" font="default" size="100%">Colony Count, Microbial</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-Over Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental Microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Epidemiology, Molecular</style></keyword><keyword><style face="normal" font="default" size="100%">Great Britain</style></keyword><keyword><style face="normal" font="default" size="100%">Housekeeping, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin-Resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcal Infections</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year></dates><isbn><style face="normal" font="default" size="100%">17417015 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Increasing hospital-acquired infections have generated much attention over the last decade. There is evidence that hygienic cleaning has a role in the control of hospital-acquired infections. This study aimed to evaluate the potential impact of one additional cleaner by using microbiological standards based on aerobic colony counts and the presence of Staphylococcus aureus including meticillin-resistant S. aureus. Methods: We introduced an additional cleaner into two matched wards from Monday to Friday, with each ward receiving enhanced cleaning for six months in a cross-over design. Ten hand-touch sites on both wards were screened weekly using standardised methods and patients were monitored for meticillin-resistant S. aureus infection throughout the year-long study. Patient and environmental meticillin-resistant S. aureus isolates were characterised using molecular methods in order to investigate temporal and clonal relationships. Results: Enhanced cleaning was associated with a 32.5% reduction in levels of microbial contamination at hand-touch sites when wards received enhanced cleaning (P &lt; 0.0001: 95% CI 20.2%, 42.9%). Near-patient sites (lockers, overbed tables and beds) were more frequently contaminated with meticillin-resistant S. aureus/S. aureus than sites further from the patient (P = 0.065). Genotyping identified indistinguishable strains from both hand-touch sites and patients. There was a 26.6% reduction in new meticillin-resistant S. aureus infections on the wards receiving extra cleaning, despite higher meticillin-resistant S. aureus patient-days and bed occupancy rates during enhanced cleaning periods (P = 0.032: 95% CI 7.7%, 92.3%). Adjusting for meticillin-resistant S. aureus patient-days and based upon nine new meticillin-resistant S. aureus infections seen during routine cleaning, we expected 13 new infections during enhanced cleaning periods rather than the four that actually occurred. Clusters of new meticillin-resistant S. aureus infections were identified 2 to 4 weeks after the cleaner left both wards. Enhanced cleaning saved the hospital £30,000 to £70,000. Conclusion: Introducing one extra cleaner produced a measurable effect on the clinical environment, with apparent benefit to patients regarding meticillin-resistant S. aureus infection. Molecular epidemiological methods supported the possibility that patients acquired meticillin-resistant S. aureus from environmental sources. These findings suggest that additional research is warranted to further clarify the environmental, clinical and economic impact of enhanced hygienic cleaning as a component in the control of hospital-acquired infection. © 2009 Dancer et al.; licensee BioMed Central Ltd.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :171&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Dancer, S.J.; Department of Microbiology, Hairmyres Hospital, Eaglesham Road, East Kilbride, United Kingdom; email: stephanie.dancer@lanarkshire.scot.nhs.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-67649846501&amp;doi=10.1186%2f1741-7015-7-28&amp;partnerID=40&amp;md5=fce014aca151d89bc8731cf163c68c9d</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">19505316</style></custom2><custom7><style face="normal" font="default" size="100%">28</style></custom7><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/1741-7015-7-28</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>133</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">133</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Davies, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">De Montfort University, Leicester, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Healthcare textiles</style></title><secondary-title><style face="normal" font="default" size="100%">Waterproof and Water Repellent Textiles and Clothing</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Waterproof and Water Repel. Text. and Cloth.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">447-471</style></pages><keywords><keyword><style face="normal" font="default" size="100%">Absorbent</style></keyword><keyword><style face="normal" font="default" size="100%">Barrier</style></keyword><keyword><style face="normal" font="default" size="100%">Bio tolerance</style></keyword><keyword><style face="normal" font="default" size="100%">Healthcare</style></keyword><keyword><style face="normal" font="default" size="100%">Medical</style></keyword><keyword><style face="normal" font="default" size="100%">Repellence</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><publisher><style face="normal" font="default" size="100%">Elsevier Inc.</style></publisher><isbn><style face="normal" font="default" size="100%">9780081011348 (ISBN); 9780081012123 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">Healthcare can be seen as an area of rapid development for technical textiles. Materials are found in many hospital applications from wound dressings and bandaging materials to scaffolds for tissue engineering and implantable prostheses, all of which have very specific requirements. Textile use is prevalent and through innovation is continuously expanding within the healthcare and hygiene sector in both home and hospital environments.While healthcare today surpasses historical expectations, new healthcare problems pose new challenges to the ever-changing and quick-responding nature of the healthcare system. Textiles are playing an increasingly prominent role in this battle against Healthcare-Associated Infections (HCAIs), viruses, fungi and antibiotic resistant microbes, providing protection for both the patient and the medical personnel. Advances in textile engineering have also enabled many developments in the area of regenerative medicine with materials providing support either in vitro or in vivo due to their varied mechanical properties. Properties of medical textile materials are explored with a focus on those that provide barrier properties for use outside the body for wearable applications and those used internally to support regenerative medicine. © 2018 Elsevier Ltd. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :1&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Davies, A.; De Montfort UniversityUnited Kingdom</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042539795&amp;doi=10.1016%2fB978-0-08-101212-3.00015-0&amp;partnerID=40&amp;md5=c0821b546f68c6756d5849c6a15001ca</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/B978-0-08-101212-3.00015-0</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>134</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">134</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Doll, M.</style></author><author><style face="normal" font="default" size="100%">Stevens, M. P.</style></author><author><style face="normal" font="default" size="100%">Bearman, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Internal Medicine, Division of Infectious Diseases, VCU Medical Center, 1300 East Marshall St., North Hospital, 2 Flr., PB980019, Richmond, VA 23298, United States&#xD;Division of Infectious Diseases, Virginia Commonwealth University Medical Center, Richmond, VA, United States&#xD;Virginia Commonwealth University Health System, Richmond, VA, United States&#xD;VCUHS Epidemiology and Infection Control, North Hospital, 2nd Floor, 1300 East Marshall Street, Richmond, VA 23298-0019, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">New technologies for infection prevention</style></title><secondary-title><style face="normal" font="default" size="100%">Infection Prevention: New Perspectives and Controversies</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Infect. Prev.: New Perspect. and Controversies</style></alt-title></titles><pages><style face="normal" font="default" size="100%">55-66</style></pages><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319609805 (ISBN); 9783319609782 (ISBN)</style></isbn><notes><style face="normal" font="default" size="100%">Cited By :1&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Doll, M.; Department of Internal Medicine, Division of Infectious Diseases, VCU Medical Center, 1300 East Marshall St., North Hospital, 2 Flr., PB980019, United States; email: michelle.doll@vcuhealth.org</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034735994&amp;doi=10.1007%2f978-3-319-60980-5_7&amp;partnerID=40&amp;md5=54626db242791025544a16e22fb593aa</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-60980-5_7</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>135</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">135</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Drees, M.</style></author><author><style face="normal" font="default" size="100%">Snydman, D. R.</style></author><author><style face="normal" font="default" size="100%">Schmid, C. H.</style></author><author><style face="normal" font="default" size="100%">Barefoot, L.</style></author><author><style face="normal" font="default" size="100%">Hansjosten, K.</style></author><author><style face="normal" font="default" size="100%">Vue, P. M.</style></author><author><style face="normal" font="default" size="100%">Cronin, M.</style></author><author><style face="normal" font="default" size="100%">Nasraway, S. A.</style></author><author><style face="normal" font="default" size="100%">Golan, Y.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Tufts-New England Medical Center, Tufts University, Boston, MA, United States&#xD;Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA, United States&#xD;School of Medicine, Tufts University, Boston, MA, United States&#xD;Tufts University, Medford, MA, United States&#xD;Christiana Care Health System, Center for Outcomes Research, 131 Continental Dr., Ste 202, Newark, DE 19713, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci</style></title><secondary-title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Clin. Infect. Dis.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Clin. Infect. Dis.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Clin. Infect. Dis.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">678-685</style></pages><volume><style face="normal" font="default" size="100%">46</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">antibiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">beta lactamase inhibitor</style></keyword><keyword><style face="normal" font="default" size="100%">carbapenem derivative</style></keyword><keyword><style face="normal" font="default" size="100%">cephalosporin derivative</style></keyword><keyword><style face="normal" font="default" size="100%">clindamycin</style></keyword><keyword><style face="normal" font="default" size="100%">metronidazole</style></keyword><keyword><style face="normal" font="default" size="100%">penicillin G</style></keyword><keyword><style face="normal" font="default" size="100%">quinolone derivative</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic sensitivity</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial colonization</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium contamination</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium culture</style></keyword><keyword><style face="normal" font="default" size="100%">confidence interval</style></keyword><keyword><style face="normal" font="default" size="100%">enterococcal infection</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">hazard ratio</style></keyword><keyword><style face="normal" font="default" size="100%">hospital admission</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection risk</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care unit</style></keyword><keyword><style face="normal" font="default" size="100%">leukemia</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">multivariate analysis</style></keyword><keyword><style face="normal" font="default" size="100%">pollution</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">proportional hazards model</style></keyword><keyword><style face="normal" font="default" size="100%">risk assessment</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin resistant Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">aged</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial infection</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">drug effect</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">isolation and purification</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">middle aged</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental Microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Gram-Positive Bacterial Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Intensive Care Units</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Vancomycin Resistance</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year></dates><isbn><style face="normal" font="default" size="100%">10584838 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background. Patients colonized with vancomycin-resistant enterococci (VRE) frequently contaminate their environment, but the environmental role of VRE transmission remains controversial. Methods. During a 14-month study in 2 intensive care units, weekly environmental and twice-weekly patient surveillance cultures were obtained. VRE acquisition was defined as a positive culture result &gt;48 h after admission. To determine risk factors for VRE acquisition, Cox proportional hazards models using time-dependent covariates for colonization pressure and antibiotic exposure were examined. Results. Of 1330 intensive care unit admissions, 638 patients were at risk for acquisition, and 50 patients (8%) acquired VRE. Factors associated with VRE acquisition included average colonization pressure (hazard ratio [HR], 1.4 per 10% increase; 95% confidence interval [CI], 1.2-1.8), mean number of antibiotics (HR, 1.7 per additional antibiotic; 95% CI, 1.2-2.5), leukemia (HR, 3.1; 95% CI, 1.2-7.8), a VRE-colonized prior room occupant (HR, 3.1; 95% CI, 1.6-5.8), any VRE-colonized room occupants within the previous 2 weeks (HR, 2.5; 95% CI, 1.3-4.8), and previous positive room culture results (HR, 3.4; 95% CI, 1.2-9.6). In separate multivariable analyses, a VRE-colonized prior room occupant (HR, 3.8; 95% CI, 2.0-7.4), any VRE-colonized room occupants within the previous 2 weeks (HR, 2.7; 95% CI, 1.4-5.3), and previous positive room culture results (HR, 4.4; 95% CI, 1.5-12.8) remained independent predictors of VRE acquisition, adjusted for colonization pressure and antibiotic exposure. Conclusions. We found that prior room contamination, whether measured via environmental cultures or prior room occupancy by VRE-colonized patients, was highly predictive of VRE acquisition. Increased attention to environmental disinfection is warranted. © 2008 by the Infectious Diseases Society of America. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :167&#xD;Export Date: 26 March 2020&#xD;CODEN: CIDIE&#xD;Correspondence Address: Drees, M.; Christiana Care Health System, Center for Outcomes Research, 131 Continental Dr., Ste 202, Newark, DE 19713, United States; email: mdrees@christianacare.org</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-39749120490&amp;doi=10.1086%2f527394&amp;partnerID=40&amp;md5=3a66dbac160de87202976952208576bd</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">18230044</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1086/527394</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>136</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">136</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Dunne, S. S.</style></author><author><style face="normal" font="default" size="100%">Ahonen, M.</style></author><author><style face="normal" font="default" size="100%">Modic, M.</style></author><author><style face="normal" font="default" size="100%">Crijns, F. R. L.</style></author><author><style face="normal" font="default" size="100%">Keinänen-Toivola, M. M.</style></author><author><style face="normal" font="default" size="100%">Meinke, R.</style></author><author><style face="normal" font="default" size="100%">Keevil, C. W.</style></author><author><style face="normal" font="default" size="100%">Gray, J.</style></author><author><style face="normal" font="default" size="100%">O&apos;Connell, N. H.</style></author><author><style face="normal" font="default" size="100%">Dunne, C. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Centre for Interventions in Infection, Inflammation and Immunity (4i) and Graduate Entry Medical School, University of Limerick, Limerick, Ireland&#xD;Faculty of Technology, Satakunta University of Applied Sciences, Rauma, Finland&#xD;Department of Surface Engineering and Optoelectronics, Jozef Stefan Institute, Ljubljana, Slovenia&#xD;Department of Bèta Sciences and Technology, Zuyd University of Applied Sciences, Heerlen, Netherlands&#xD;Department of Infection Control and Prevention, University Hospital Schleswig-Holstein, Lübeck, Germany&#xD;Centre for Biological Sciences, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, United Kingdom&#xD;Birmingham Children&apos;s Hospital, Birmingham, United Kingdom&#xD;Clinical Microbiology, University Hospital Limerick, Dooradoyle, Limerick, Ireland</style></auth-address><titles><title><style face="normal" font="default" size="100%">Specialized cleaning associated with antimicrobial coatings for reduction of hospital-acquired infection: opinion of the COST Action Network AMiCI (CA15114)</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">250-255</style></pages><volume><style face="normal" font="default" size="100%">99</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antimicrobial coatings</style></keyword><keyword><style face="normal" font="default" size="100%">Antimicrobial resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">Effluent</style></keyword><keyword><style face="normal" font="default" size="100%">Hygiene practices</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">biocide</style></keyword><keyword><style face="normal" font="default" size="100%">nanocoating</style></keyword><keyword><style face="normal" font="default" size="100%">disinfectant agent</style></keyword><keyword><style face="normal" font="default" size="100%">biosafety</style></keyword><keyword><style face="normal" font="default" size="100%">consensus</style></keyword><keyword><style face="normal" font="default" size="100%">disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">environmental health</style></keyword><keyword><style face="normal" font="default" size="100%">health care management</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection prevention</style></keyword><keyword><style face="normal" font="default" size="100%">instrument sterilization</style></keyword><keyword><style face="normal" font="default" size="100%">life cycle</style></keyword><keyword><style face="normal" font="default" size="100%">light exposure</style></keyword><keyword><style face="normal" font="default" size="100%">material coating</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">Note</style></keyword><keyword><style face="normal" font="default" size="100%">physical parameters</style></keyword><keyword><style face="normal" font="default" size="100%">practice guideline</style></keyword><keyword><style face="normal" font="default" size="100%">repeat procedure</style></keyword><keyword><style face="normal" font="default" size="100%">sunlight</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">environmental microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Europe</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">hospital service</style></keyword><keyword><style face="normal" font="default" size="100%">interview</style></keyword><keyword><style face="normal" font="default" size="100%">prevention and control</style></keyword><keyword><style face="normal" font="default" size="100%">procedures</style></keyword><keyword><style face="normal" font="default" size="100%">surface property</style></keyword><keyword><style face="normal" font="default" size="100%">Disease Transmission, Infectious</style></keyword><keyword><style face="normal" font="default" size="100%">Disinfectants</style></keyword><keyword><style face="normal" font="default" size="100%">Guidelines as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Health Facilities</style></keyword><keyword><style face="normal" font="default" size="100%">Housekeeping, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Interviews as Topic</style></keyword><keyword><style face="normal" font="default" size="100%">Surface Properties</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><publisher><style face="normal" font="default" size="100%">W.B. Saunders Ltd</style></publisher><isbn><style face="normal" font="default" size="100%">01956701 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Recognized issues with poor hand hygiene compliance among healthcare workers and reports of recontamination of previously chemically disinfected surfaces through hand contact emphasize the need for novel hygiene methods in addition to those currently available. One such approach involves antimicrobial (nano) coatings (AMCs), whereby integrated active ingredients are responsible for elimination of micro-organisms that come into contact with treated surfaces. While widely studied under laboratory conditions with promising results, studies under real-life healthcare conditions are scarce. The views of 75 contributors from 30 European countries were collated regarding specialized cleaning associated with AMCs for reduction of healthcare-associated infection. There was unanimous agreement that generation of scientific guidelines for cleaning of AMCs, using traditional or new processes, is needed. Specific topics included: understanding mechanisms of action of cleaning materials and their physical interactions with conventional coatings and AMCs; that assessments mimic the life cycle of coatings to determine the impact of repetitive cleaning and other aspects of ageing (e.g. exposure to sunlight); determining concentrations of AMC-derived biocides in effluents; and development of effective de-activation and sterilization treatments for cleaning effluents. Further, the consensus opinion was that, prior to widespread implementation of AMCs, there is a need for clarification of the varying responsibilities of involved clinical, healthcare management, cleaning services and environmental safety stakeholders. © 2018 The Author(s)</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :2&#xD;Export Date: 26 March 2020&#xD;CODEN: JHIND&#xD;Correspondence Address: Dunne, C.P.; Graduate Entry Medical School, University of LimerickIreland; email: colum.dunne@ul.ie</style></notes><work-type><style face="normal" font="default" size="100%">Note</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046692530&amp;doi=10.1016%2fj.jhin.2018.03.006&amp;partnerID=40&amp;md5=aa0169b912c6ab657ba877634551427e</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">29550388</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.jhin.2018.03.006</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>137</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">137</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Efstathiou, P. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Commander of National Health Operations Centre, Hellenic College of Orthopaedic Surgeons, Olympics Hellas, Artis 17, Maroussi, 15125, Greece</style></auth-address><titles><title><style face="normal" font="default" size="100%">Economics of using biocidal surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Use of Biocidal Surf. for Red. of Healthc. Acquired Infect.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">167-186</style></pages><volume><style face="normal" font="default" size="100%">9783319080574</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Copper alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Cost reduction</style></keyword><keyword><style face="normal" font="default" size="100%">Microorganisms</style></keyword><keyword><style face="normal" font="default" size="100%">Petroleum reservoir evaluation</style></keyword><keyword><style face="normal" font="default" size="100%">Physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Surveys</style></keyword><keyword><style face="normal" font="default" size="100%">Acute physiology and chronic health evaluations</style></keyword><keyword><style face="normal" font="default" size="100%">Antimicrobial drug</style></keyword><keyword><style face="normal" font="default" size="100%">Economic crisis</style></keyword><keyword><style face="normal" font="default" size="100%">Financial data</style></keyword><keyword><style face="normal" font="default" size="100%">Financial parameters</style></keyword><keyword><style face="normal" font="default" size="100%">Microbial flora</style></keyword><keyword><style face="normal" font="default" size="100%">Operation parameters</style></keyword><keyword><style face="normal" font="default" size="100%">Time-periods</style></keyword><keyword><style face="normal" font="default" size="100%">Intensive care units</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319080574 (ISBN); 3319080563 (ISBN); 9783319080567 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">Aim: Aim of this study was to evaluate the reduction on Intensive Care Unit (ICU) microbial flora after the antimicrobial copper alloy (Cu+) implementation as well as the effect on financial - epidemiological operation parameters. Methods: Medical, epidemiological and financial data into two time periods, before and after the implementation of copper (Cu 63 % - Zn 37 %, Low Lead) were recorded and analyzed in a General ICU. The evaluated parameters were: the importance of patients&apos; admission (Acute Physiology and Chronic Health Evaluation - APACHE II and Simplified Acute Physiology Score - SAPS), microbial flora&apos;s record in the ICU before and after the implementation of Cu+ as well as the impact on epidemiological and ICU&apos;s operation financial parameters. Results: During December 2010 and March 2011 and respectively during December 2011 and March 2012 comparative results showed statistically significant reduction on the microbial flora (CFU/ml) by 95 % and the use of antimicrobial medicine (per day per patient) by 30 % (p = 0.014) as well as patients hospitalization time and cost. Conclusions: The innovative implementation of antimicrobial copper in ICUs contributed to their microbial flora significant reduction and antimicrobial drugs use reduction with the apparent positive effect (decrease) in both patients&apos; hospitalization time and cost. Under the present circumstances of economic crisis, survey results are of highest importance and value. © 2014 Springer International Publishing Switzerland. All rights are reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Efstathiou, P.A.; Commander of National Health Operations Centre, Hellenic College of Orthopaedic Surgeons, Olympics Hellas, Artis 17, Greece</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930359218&amp;doi=10.1007%2f978-3-319-08057-4_8&amp;partnerID=40&amp;md5=38e21b61eac3f5039525dd41633172d0</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-08057-4_8</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>138</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">138</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Elguindi, J.</style></author><author><style face="normal" font="default" size="100%">Wagner, J.</style></author><author><style face="normal" font="default" size="100%">Rensing, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Soil, Water and Environmental Science, University of Arizona, Shantz Bld no. 38, Tucson, AZ 85721, United States&#xD;Department of Soil, Water and Environmental Science, University of Arizona, Tucson, AZ, United States&#xD;FB Chemie-Biofilm Centre, University of Duisburg-Essen, Duisburg, Germany</style></auth-address><titles><title><style face="normal" font="default" size="100%">Genes involved in copper resistance influence survival of pseudomonas aeruginosa on copper surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Applied Microbiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Appl. Microbiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Applied Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Appl. Microbiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Applied Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Appl. Microbiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">1448-1455</style></pages><volume><style face="normal" font="default" size="100%">106</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">Copper cast alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Copper toxicity</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">Survival assay</style></keyword><keyword><style face="normal" font="default" size="100%">alloy</style></keyword><keyword><style face="normal" font="default" size="100%">copper</style></keyword><keyword><style face="normal" font="default" size="100%">stainless steel</style></keyword><keyword><style face="normal" font="default" size="100%">gene</style></keyword><keyword><style face="normal" font="default" size="100%">infectious disease</style></keyword><keyword><style face="normal" font="default" size="100%">inoculation</style></keyword><keyword><style face="normal" font="default" size="100%">survival</style></keyword><keyword><style face="normal" font="default" size="100%">toxicity</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial gene</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial survival</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium culture</style></keyword><keyword><style face="normal" font="default" size="100%">cast application</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">surface property</style></keyword><keyword><style face="normal" font="default" size="100%">survival rate</style></keyword><keyword><style face="normal" font="default" size="100%">temperature</style></keyword><keyword><style face="normal" font="default" size="100%">Alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Resistance, Bacterial</style></keyword><keyword><style face="normal" font="default" size="100%">Gene Expression Regulation, Bacterial</style></keyword><keyword><style face="normal" font="default" size="100%">Genes, Bacterial</style></keyword><keyword><style face="normal" font="default" size="100%">Microbial Sensitivity Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Time Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year></dates><isbn><style face="normal" font="default" size="100%">13645072 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Aims: To evaluate the killing of Pseudomonas aeruginosa PAO1 on copper cast alloys and the influence of genes on survival on copper containing medium and surfaces. Methods and Results: Different strains of P. aeruginosa were inoculated on copper containing medium or different copper cast alloys and the survival rate determined. The survival rates were compared with rates on copper-free medium and stainless steel as control. In addition, the effect of temperature on survival was examined. Conclusions: Copper cast alloys had been previously shown to be bactericidal to various bacteria, but the mechanism of copper-mediated killing is still not known. In this report, we demonstrate that P. aeruginosa PAO1 is rapidly killed on different copper cast alloys and that genes involved in conferring copper resistance in copper-containing medium also influenced survival on copper cast alloys. We also show that the rate of killing is influenced by temperature. Significance and Impact of the Study: To use copper surfaces more widely as bactericidal agents in various settings, it is important to understand how genes influence survival on these surfaces. Here we show that genes shown to be involved in copper resistance in P. aeruginosa PAO1 can have an impact on the length of survival time on copper cast alloys under certain conditions. This is an important first step for evaluation of future use of copper surfaces as bactericidal agents. © 2009 The Society for Applied Microbiology.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :66&#xD;Export Date: 26 March 2020&#xD;CODEN: JAMIF&#xD;Correspondence Address: Rensing, C.; Department of Soil, Water and Environmental Science, University of Arizona, Shantz Bld no. 38, Tucson, AZ 85721, United States; email: rensingc@ag.arizona.edu</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-64149100329&amp;doi=10.1111%2fj.1365-2672.2009.04148.x&amp;partnerID=40&amp;md5=a598a77860b018a0777968f99e9564c3</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">19239551</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/j.1365-2672.2009.04148.x</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>139</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">139</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Espírito Santo, C.</style></author><author><style face="normal" font="default" size="100%">German, N.</style></author><author><style face="normal" font="default" size="100%">Elguindi, J.</style></author><author><style face="normal" font="default" size="100%">Grass, G.</style></author><author><style face="normal" font="default" size="100%">Rensing, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">IMAR - Instituto Do Mar, Universidade de Coimbra, Coimbra, 3000, Portugal&#xD;Research Triangle Institute, Research Triangle Park, NC 27709, United States&#xD;Department of Soil Water and Environmental Sciences, University of Arizona, Tucson, AZ 85712, United States&#xD;Bundeswehr Institute of Microbiology, Munich, Germany&#xD;Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, Frederiksberg C, 1871, Denmark</style></auth-address><titles><title><style face="normal" font="default" size="100%">Biocidal mechanisms of metallic copper surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Use of Biocidal Surf. for Red. of Healthc. Acquired Infect.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">103-136</style></pages><volume><style face="normal" font="default" size="100%">9783319080574</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Antimicrobial</style></keyword><keyword><style face="normal" font="default" size="100%">Biocidal</style></keyword><keyword><style face="normal" font="default" size="100%">Genotoxicity</style></keyword><keyword><style face="normal" font="default" size="100%">Killing mechanism</style></keyword><keyword><style face="normal" font="default" size="100%">Membrane damage</style></keyword><keyword><style face="normal" font="default" size="100%">Metallic copper surface</style></keyword><keyword><style face="normal" font="default" size="100%">Toxicity</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Cell culture</style></keyword><keyword><style face="normal" font="default" size="100%">Cells</style></keyword><keyword><style face="normal" font="default" size="100%">Copper corrosion</style></keyword><keyword><style face="normal" font="default" size="100%">Copper metallurgy</style></keyword><keyword><style face="normal" font="default" size="100%">Disease control</style></keyword><keyword><style face="normal" font="default" size="100%">Health care</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals</style></keyword><keyword><style face="normal" font="default" size="100%">Metals</style></keyword><keyword><style face="normal" font="default" size="100%">Molecular oxygen</style></keyword><keyword><style face="normal" font="default" size="100%">Genotoxicities</style></keyword><keyword><style face="normal" font="default" size="100%">Metallic copper</style></keyword><keyword><style face="normal" font="default" size="100%">Copper alloys</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319080574 (ISBN); 3319080563 (ISBN); 9783319080567 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">Hospital acquired infections (HAI), also known as nosocomial infections, have a vast impact on patient and staff health and affect survival chances of patients with compromised immune system, elderly, and young children. Moreover, hospital environments are favoring the development of drug-resistant strains of bacteria, making treatment of such HAI more challenging. The Center of Disease Control estimates that one of the deadliest types of antibiotic-resistant bacteria, MRSA (methicillin-resistant Staphylococcus aureus), causes 19,000 death cases per year, whereas another superbug, Clostridium difficile, causes 500,000 incidents per year. The natural medicinal and sanitizing properties of copper and its minerals were used throughout the ages by many civilizations. However, only recently have we started understanding the mechanisms of such bactericidal effects of copper. One of the latest research developments in this area is concerned with showing that metallic copper surfaces strongly reduce microbial surface-burden, both in laboratory settings and healthcare environments. Microbiologists and hygiene specialists are increasingly recognizing this unique antimicrobial property of metallic copper as a very promising novel tool for reducing HAI, which are known to spread through touching contaminated surfaces. Copper surfaces have universal microbe-inactivating properties against a wide variety of Gram-positive and Gram-negative microbes under moist (droplets of cell suspensions, mimicking splash-contamination) or dry (direct contact between cells and surfaces, mimicking touch surfaces) conditions. This chapter reviews the molecular mechanisms underlying bactericidal properties of solid copper surfaces and factors that influence such processes: copper surface oxidation and corrosion, copper cell accumulation, copper alloy content and roughness, temperature, moisture, presence of chelators, osmotic stress, reactive oxygen species, cellular characteristics, cell wall structure, spores, genetic traits for copper resistance systems, anaerobiosis, viable but not culturable state (VBNC). Additionally, primary targets for metallic copper toxicity, DNA and lipids, are also included in discussion in this chapter. Our understanding of the antimicrobial properties of metallic copper surfaces have made great strides in the last 5 years both under laboratories and healthcare conditions, highlighting safe, economical and sustainable application of metallic copper surfaces in hospital or any public settings for prevention of HAI. © 2014 Springer International Publishing Switzerland. All rights are reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Rensing, C.; Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, Denmark</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930341896&amp;doi=10.1007%2f978-3-319-08057-4_6&amp;partnerID=40&amp;md5=6e3bf194615121bf02c6d50dd52365c7</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-08057-4_6</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>140</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">140</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Evans, G.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Cleaning, disinfecting hospital environment becoming a top priority in infection prevention</style></title><secondary-title><style face="normal" font="default" size="100%">Hospital Infection Control and Prevention</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Hosp. Infect. Control. Prev.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Hospital Infection Control and Prevention</style></full-title><abbr-1><style face="normal" font="default" size="100%">Hosp. Infect. Control. Prev.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Hospital Infection Control and Prevention</style></full-title><abbr-1><style face="normal" font="default" size="100%">Hosp. Infect. Control. Prev.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">61-64</style></pages><volume><style face="normal" font="default" size="100%">40</style></volume><number><style face="normal" font="default" size="100%">6</style></number><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><isbn><style face="normal" font="default" size="100%">0098180X (ISSN)</style></isbn><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Evans, G.</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879986239&amp;partnerID=40&amp;md5=c8d24464c477f07853d6ea122df28f0f</style></url></related-urls></urls><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>141</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">141</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Exline, M. C.</style></author><author><style face="normal" font="default" size="100%">Masood, S.</style></author><author><style face="normal" font="default" size="100%">Sopirala, M. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Internal Medicine, Ohio State University Wexner Medical Center, Columbus, OH, United States&#xD;Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati, Cincinnati, OH, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">A quality improvement imperative: Achieving command over hospital acquired infections in intensive care units</style></title><secondary-title><style face="normal" font="default" size="100%">Advances in Medicine and Biology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Adv. in Med. and Biol.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">1-20</style></pages><volume><style face="normal" font="default" size="100%">76</style></volume><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><publisher><style face="normal" font="default" size="100%">Nova Science Publishers, Inc.</style></publisher><isbn><style face="normal" font="default" size="100%">9781631171451 (ISBN); 9781631171444 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">Device related infections in the form of catheter-related blood stream infections, ventilator-associated pneumonias and catheter-associated urinary tract infections cause significant morbidity and mortality in intensive care units (ICUs). In addition, they impart heavy economic burden on healthcare. These infections can be detrimental to patients especially when they are caused by multidrug resistant organisms (MDRO) such as carbapenemase resistant Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter baumannii which have very limited to no options for treatment. MDRO have been a long standing problem for ICUs. Interaction between community and the healthcare environment has been an important factor in controlling the development and spread of these MDRO. More recently several studies have addressed different factors that play a role in the occurrence of infections including patient risk factors, bioburden on the patient and the environment and processes that involve healthcare personnel and systematic issues. Lately, there has been heightened awareness among clinicians and administrators that curtailing these infections is important to ensure superior quality care in an ICU and to avoid potential financial penalties. Whether achieving a &quot;zero&quot; infection rate is possible, striving towards &quot;zero&quot; with a goal towards achieving a &quot;near zero&quot; rate is essential. To this end, we will review the national trends and the impact of device related infections and MDRO on ICUs and focus on the evidence behind various techniques of infection prevention that include incorporation of evidence-based process improvement initiatives that require multidisciplinary involvement such as aseptic insertion of devices, prompt removal of devices when no longer indicated and their optimal maintenance. We will review the science of process improvement that focused on decreasing bioburden on patient and ICU environment via universal and targeted decolonization by comparing and contrasting the two modalities, utility of active surveillance for MDRO and ways to limit transmission within ICUs and wider medical community. Finally, we will review the management of device related infections and the treatment options for MDRO that are available and in development including those in pipeline. To our knowledge, such a comprehensive review has not been performed and this manuscript will provide a great depth of insight into the issue at hand and provide guidance in tackling the problem. © 2014 by Nova Science Publishers, Inc. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Sopirala, M.M.; Division of Infectious Diseases/Internal Medicine, University of Cincinnati College of MedicineUnited States</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84956978029&amp;partnerID=40&amp;md5=1504c54e012e48e82c5d0c64949dcda2</style></url></related-urls></urls><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>142</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">142</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fage, S. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Dermato-Venereology, Aarhus University Hospital, Aarhus, Denmark</style></auth-address><titles><title><style face="normal" font="default" size="100%">Metal allergy: Copper</style></title><secondary-title><style face="normal" font="default" size="100%">Metal Allergy: From Dermatitis to Implant and Device Failure</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Metal Allergy: From Dermatitis to Implant and Device Fail.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">373-386</style></pages><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319585031 (ISBN); 9783319585024 (ISBN)</style></isbn><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Fage, S.W.; Department of Dermato-Venereology, Aarhus University HospitalDenmark; email: simon.w.fage@gmail.com</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053966301&amp;doi=10.1007%2f978-3-319-58503-1_29&amp;partnerID=40&amp;md5=10f479bf3fccf2dffbb329cce95df87f</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-58503-1_29</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>143</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">143</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Febré, N.</style></author><author><style face="normal" font="default" size="100%">Silva, V.</style></author><author><style face="normal" font="default" size="100%">Báez, A.</style></author><author><style face="normal" font="default" size="100%">Palza, H.</style></author><author><style face="normal" font="default" size="100%">Delgado, K.</style></author><author><style face="normal" font="default" size="100%">Aburto, I.</style></author><author><style face="normal" font="default" size="100%">Silva, V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Universidad Mayor, Escuela de Enfermería, Facultad de Ciencias, Directora proyecto FONDEF, Chile&#xD;Universidad Mayor, Escuela de Tecnología Médica, Facultad de Ciencias, Santiago, Chile&#xD;Universidad Austral de Chile, Valdivia, Chile&#xD;Universidad de Chile, Departamento de Ingenieria Química y Biotecnología, Facultad de Ciencias Físicas y Matemáticas, Universidad de Chile, Santiago, Chile&#xD;Fundación Instituto Nacional de Heridas, Santiago, Chile&#xD;Universidad Mayor, Escuela de Tecnologia Médica, Facultad de Ciencias, Chile</style></auth-address><titles><title><style face="normal" font="default" size="100%">Antibacterial activity of copper salts against microorganisms isolated from chronic infected wounds</style></title><secondary-title><style face="normal" font="default" size="100%">Revista Medica de Chile</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Rev. Med. Chile</style></alt-title><short-title><style face="normal" font="default" size="100%">Comportamiento antibacteriano de partículas de cobre frente a microorganismos obtenidos de úlceras crónicas infectadas y su relación con la resistencia a antimicrobianos de uso común</style></short-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Revista Medica de Chile</style></full-title><abbr-1><style face="normal" font="default" size="100%">Rev. Med. Chile</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Revista Medica de Chile</style></full-title><abbr-1><style face="normal" font="default" size="100%">Rev. Med. Chile</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">1523-1530</style></pages><volume><style face="normal" font="default" size="100%">144</style></volume><number><style face="normal" font="default" size="100%">12</style></number><keywords><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Infective Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Microbial</style></keyword><keyword><style face="normal" font="default" size="100%">Skin Ulcer</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">inorganic salt</style></keyword><keyword><style face="normal" font="default" size="100%">chronic disease</style></keyword><keyword><style face="normal" font="default" size="100%">disk diffusion</style></keyword><keyword><style face="normal" font="default" size="100%">drug effects</style></keyword><keyword><style face="normal" font="default" size="100%">Gram negative bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">Gram positive bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">isolation and purification</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">prospective study</style></keyword><keyword><style face="normal" font="default" size="100%">time factor</style></keyword><keyword><style face="normal" font="default" size="100%">wound infection</style></keyword><keyword><style face="normal" font="default" size="100%">Disk Diffusion Antimicrobial Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Gram-Negative Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Gram-Positive Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Prospective Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Salts</style></keyword><keyword><style face="normal" font="default" size="100%">Time Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year></dates><publisher><style face="normal" font="default" size="100%">Sociedad Medica de Santiago</style></publisher><isbn><style face="normal" font="default" size="100%">00349887 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background: The antimicrobial activity of copper (Cu+2) is recognized and used as an antimicrobial agent. Aim: To evaluate the antimicrobial activity of copper against microorganisms obtained from chronic cutaneous wound infections. Material and Methods: Five chemical products that contained copper particles in their composition were tested (zeolite, silica, acetate, nitrate and nanoparticle of copper). The antimicrobial activity against antibiotic resistant strains usually isolated from chronic cutaneous wound infections was determined for two of the products with better performance in copper release. Results: The minimal inhibitory and minimal bactericidal concentrations of copper acetate and nitrate were similar, fluctuating between 400-2,000 μg/ml. Conclusions: The studied copper salts show great potential to be used to control both gram positive and gram negative, antibiotic resistant bacteria isolated from wound infections. © 2016, Sociedad Medica de Santiago. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :3&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Febré, N.; Facultad de Enfermería, Universidad Andrés Bello, Sazié 2212, 6° piso, Chile</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85015805077&amp;doi=10.4067%2fS0034-98872016001200003&amp;partnerID=40&amp;md5=7ed15cc114096396737e388cb70d3b02</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">28393986</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.4067/S0034-98872016001200003</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">Spanish</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>144</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">144</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Fijan, S.</style></author><author><style face="normal" font="default" size="100%">Turk, S. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Faculty of Health Sciences, University of Maribor, Žitna ulica 15, 2000 Maribor, Slovenia&#xD;Faculty of Mechanical Engineering, Centre for Textile Care, University of Maribor, Smetanova ulica 17, 2000 Maribor, Slovenia</style></auth-address><titles><title><style face="normal" font="default" size="100%">Hospital textiles, are they a possible vehicle for healthcare-associated infections?</style></title><secondary-title><style face="normal" font="default" size="100%">International Journal of Environmental Research and Public Health</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Int. J. Environ. Res. Public Health</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">International Journal of Environmental Research and Public Health</style></full-title><abbr-1><style face="normal" font="default" size="100%">Int. J. Environ. Res. Public Health</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">International Journal of Environmental Research and Public Health</style></full-title><abbr-1><style face="normal" font="default" size="100%">Int. J. Environ. Res. Public Health</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">3330-3343</style></pages><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">9</style></number><keywords><keyword><style face="normal" font="default" size="100%">Disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital-acquired infections</style></keyword><keyword><style face="normal" font="default" size="100%">Inanimate surfaces</style></keyword><keyword><style face="normal" font="default" size="100%">Infection transmission vehicles</style></keyword><keyword><style face="normal" font="default" size="100%">Textile hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">disease spread</style></keyword><keyword><style face="normal" font="default" size="100%">health impact</style></keyword><keyword><style face="normal" font="default" size="100%">hospital sector</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">pathogen</style></keyword><keyword><style face="normal" font="default" size="100%">Bacillus cereus</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">coagulase negative Staphylococcus</style></keyword><keyword><style face="normal" font="default" size="100%">coliform bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">Corynebacterium</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">Enterobacter aerogenes</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus faecalis</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus faecium</style></keyword><keyword><style face="normal" font="default" size="100%">epidemic</style></keyword><keyword><style face="normal" font="default" size="100%">fomite</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis A virus</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">hospital personnel</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">infection prevention</style></keyword><keyword><style face="normal" font="default" size="100%">infection rate</style></keyword><keyword><style face="normal" font="default" size="100%">infection risk</style></keyword><keyword><style face="normal" font="default" size="100%">Klebsiella pneumoniae</style></keyword><keyword><style face="normal" font="default" size="100%">laundry</style></keyword><keyword><style face="normal" font="default" size="100%">microbial contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Microsporum canis</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">Parainfluenza virus</style></keyword><keyword><style face="normal" font="default" size="100%">personal hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">review</style></keyword><keyword><style face="normal" font="default" size="100%">risk assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Rotavirus</style></keyword><keyword><style face="normal" font="default" size="100%">Salmonella typhimurium</style></keyword><keyword><style face="normal" font="default" size="100%">Sarcoptes scabiei</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">survival rate</style></keyword><keyword><style face="normal" font="default" size="100%">textile</style></keyword><keyword><style face="normal" font="default" size="100%">Trichophyton mentagrophytes</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin resistant Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Bedding and Linens</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Fungi</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Laundry Service, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Mycoses</style></keyword><keyword><style face="normal" font="default" size="100%">Patients</style></keyword><keyword><style face="normal" font="default" size="100%">Personnel, Hospital</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year></dates><isbn><style face="normal" font="default" size="100%">16617827 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Textiles are a common material in healthcare facilities; therefore it is important that they do not pose as a vehicle for the transfer of pathogens to patients or hospital workers. During the course of use hospital textiles become contaminated and laundering is necessary. Laundering of healthcare textiles is most commonly adequate, but in some instances, due to inappropriate disinfection or subsequent recontamination, the textiles may become a contaminated inanimate surface with the possibility to transfer pathogens. In this review we searched the published literature in order to answer four review questions: (1) Are there any reports on the survival of microorganisms on hospital textiles after laundering? (2) Are there any reports that indicate the presence of microorganisms on hospital textiles during use? (3) Are there any reports that microorganisms on textiles are a possible source infection of patients? (4) Are there any reports that microorganisms on textiles are a possible source infection for healthcare workers? © 2012 by the authors; licensee MDPI, Basel, Switzerland.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :56&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Fijan, S.; Faculty of Health Sciences, University of Maribor, Žitna ulica 15, 2000 Maribor, Slovenia; email: sabina.fijan@um.si</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84866939118&amp;doi=10.3390%2fijerph9093330&amp;partnerID=40&amp;md5=2818218e92cfb4b11edafb8f5b5d33f5</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">23202690</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.3390/ijerph9093330</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>145</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">145</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gabbay, J.</style></author><author><style face="normal" font="default" size="100%">Borkow, G.</style></author><author><style face="normal" font="default" size="100%">Mishal, J.</style></author><author><style face="normal" font="default" size="100%">Magen, E.</style></author><author><style face="normal" font="default" size="100%">Zatcoff, R.</style></author><author><style face="normal" font="default" size="100%">Shemer-Avni, Y.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Cupron Inc., POB 10973, Greensboro, NC 27404, United States&#xD;Medicine B and Infectious Diseases Unit, Barzilai Medical Center, Ben Gurion University, Ashkelon 78306, Israel&#xD;Upstate Podiatry, 727 SE Main Street, Simpsonville, SC 29681, United States&#xD;Department of Virology, Faculty of Health Sciences, Ben Gurion University, Beer-Sheva 84105, Israel</style></auth-address><titles><title><style face="normal" font="default" size="100%">Copper oxide impregnated textiles with potent biocidal activities</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Industrial Textiles</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Ind. Text.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Industrial Textiles</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Ind. Text.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Industrial Textiles</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Ind. Text.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">323-335</style></pages><volume><style face="normal" font="default" size="100%">35</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antibacterial</style></keyword><keyword><style face="normal" font="default" size="100%">Athlete&apos;s foot</style></keyword><keyword><style face="normal" font="default" size="100%">Biocidal</style></keyword><keyword><style face="normal" font="default" size="100%">Copper oxide</style></keyword><keyword><style face="normal" font="default" size="100%">Nosocomial infections</style></keyword><keyword><style face="normal" font="default" size="100%">Copper oxides</style></keyword><keyword><style face="normal" font="default" size="100%">Cotton</style></keyword><keyword><style face="normal" font="default" size="100%">Fabrics</style></keyword><keyword><style face="normal" font="default" size="100%">Impregnation</style></keyword><keyword><style face="normal" font="default" size="100%">Polyesters</style></keyword><keyword><style face="normal" font="default" size="100%">Biocidal activities</style></keyword><keyword><style face="normal" font="default" size="100%">Copper oxide impregnated textiles</style></keyword><keyword><style face="normal" font="default" size="100%">Textile processing</style></keyword><keyword><style face="normal" font="default" size="100%">antifungal property</style></keyword><keyword><style face="normal" font="default" size="100%">antimicrobial property</style></keyword><keyword><style face="normal" font="default" size="100%">cotton fiber</style></keyword><keyword><style face="normal" font="default" size="100%">fabric property</style></keyword><keyword><style face="normal" font="default" size="100%">fiber preparation</style></keyword><keyword><style face="normal" font="default" size="100%">impregnating</style></keyword><keyword><style face="normal" font="default" size="100%">polyester fiber</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2006</style></year></dates><isbn><style face="normal" font="default" size="100%">15280837 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Impregnation or coating of cotton and polyester fibers with cationic copper endows them with potent broad-spectrum antibacterial, antiviral, antifungal, and antimite properties (Borkow, G. and Gabbay, J. (2004). Putting Copper into Action: Copper-impregnated Products with Potent Biocidal Activities, FASEB Jounal, 18(14): 1728-1730). This durable platform technology enables the mass production of woven and non-woven fabrics, such as sheets, pillow covers, gowns, socks, air filters, mattress covers, carpets, etc. without the need of altering any industrial procedures or machinery, but only the introduction of copper oxide-treated fibers. The biocidal properties of fabrics containing 3-10% copper-impregnated fibers are permanent, are not affected by extreme washing conditions, and do not interfere with the manipulation of the final products (e.g., color, press, etc.). In this article, the authors describe data showing that (i) antifungal socks containing 10% w/ w (weight/weight) copper-impregnated fibers alleviate athlete&apos;s foot; (ii) antimicrobial fabrics (sheets) containing 10% (w/w) copper-impregnated fibers decrease bacterial colonization in a clinical setting; and (iii) these products do not have skin-sensitizing properties or any other adverse effects. Taken together, these results demonstrate the wide preventive and curative potential of copper oxide-impregnated apparel products. © 2006 Sage Publications.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :151&#xD;Export Date: 26 March 2020&#xD;CODEN: JINTF&#xD;Correspondence Address: Borkow, G.; Cupron Inc., POB 10973, Greensboro, NC 27404, United States; email: gadi@cupron.com</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646015068&amp;doi=10.1177%2f1528083706060785&amp;partnerID=40&amp;md5=fcd49969f5a0df6aff03e28ac8e13fc2</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1177/1528083706060785</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>146</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">146</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gastmeier, P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Charité - Universitätsmedizin Berlin, Institut für Hygiene und Umweltmedizin, Hindenburgdamm 27, 12203 Berlin, Germany</style></auth-address><titles><title><style face="normal" font="default" size="100%">Understanding scientific studies</style></title><secondary-title><style face="normal" font="default" size="100%">Hygiene + Medizin</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Hyg. Med.</style></alt-title><short-title><style face="normal" font="default" size="100%">Wissenschaftliche Studien richtig lesen</style></short-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Hygiene + Medizin</style></full-title><abbr-1><style face="normal" font="default" size="100%">Hyg. Med.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Hygiene + Medizin</style></full-title><abbr-1><style face="normal" font="default" size="100%">Hyg. Med.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">19-25</style></pages><volume><style face="normal" font="default" size="100%">39</style></volume><number><style face="normal" font="default" size="100%">1-2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Evidence</style></keyword><keyword><style face="normal" font="default" size="100%">Impregnation</style></keyword><keyword><style face="normal" font="default" size="100%">Nosocomial infection</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><isbn><style face="normal" font="default" size="100%">01723790 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Many colleagues are not familiar with the most important critical points which should be considered when interpreting clinical studies. A recently published intervention study was used to train the critical appraisal of the medical literature.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;CODEN: HYMED&#xD;Correspondence Address: Gastmeier, P.; Charité - Universitätsmedizin Berlin, Institut für Hygiene und Umweltmedizin, Hindenburgdamm 27, 12203 Berlin, Germany; email: petra.gastmeier@charite.de</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84894180771&amp;partnerID=40&amp;md5=5b461faf7fa2e8c95f336a88cecf6eab</style></url></related-urls></urls><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">German</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>147</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">147</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Gould, S. W. J.</style></author><author><style face="normal" font="default" size="100%">Fielder, M. D.</style></author><author><style face="normal" font="default" size="100%">Kelly, A. F.</style></author><author><style face="normal" font="default" size="100%">Morgan, M.</style></author><author><style face="normal" font="default" size="100%">Kenny, J.</style></author><author><style face="normal" font="default" size="100%">Naughton, D. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">School of Life Sciences, Kingston University, Kingston upon Thames, London KT1 2EE, United Kingdom&#xD;Royal Devon and Exeter Hospital, Exeter, EX2 5DW, United Kingdom&#xD;Royal Marsden Hospital, Sutton, Surrey, SM2 5PT, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">The antimicrobial properties of copper surfaces against a range of important nosocomial pathogens</style></title><secondary-title><style face="normal" font="default" size="100%">Annals of Microbiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Ann. Microbiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Annals of Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Ann. Microbiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Annals of Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Ann. Microbiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">151-156</style></pages><volume><style face="normal" font="default" size="100%">59</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antimicrobial</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Nosocomial pathogens</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria (microorganisms)</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2009</style></year></dates><isbn><style face="normal" font="default" size="100%">15904261 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Hospital acquired infections (HAI) are a major problem worldwide and controlling the spread of these infections within a hospital is a constant challenge. Recent studies have highlighted the antimicrobial properties of copper and its alloys against a range of different bacteria. The objective of this study was to evaluate the antimicrobial properties of copper compared to stainless steel against a range of clinically important pathogens. These pathogens consisted of five isolates of each of the following organisms; meticillin resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, Escherichia coli, vancomycin-resistant Enterococci (VRE) and Panton-Valentine Leukocidin positive community acquired-MSSA (PVL positive CA-MSSA). MRSA, P. aeruginosa, E. coli, and CA-MSSA isolates were not detectable after a median time of 60 minutes. No detectable levels for all VRE isolates were determined after a median time of 40 minutes. However, for all isolates tested the stainless steel had no effect on the survival of the bacteria and levels remained similar to the time zero count. The results of this study demonstrate that copper has a strong antimicrobial effect against a range of clinically important pathogens compared to stainless steel and potentially could be employed to aid the control HAI.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :42&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Gould, S. W. J.; School of Life Sciences, Kingston University, Kingston upon Thames, London KT1 2EE, United Kingdom; email: S.Gould@kingston.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-69549122781&amp;doi=10.1007%2fBF03175613&amp;partnerID=40&amp;md5=2040a7d65755c24c6ca7dd8679ec8f1e</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/BF03175613</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>148</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">148</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Grass, G.</style></author><author><style face="normal" font="default" size="100%">Hans, M.</style></author><author><style face="normal" font="default" size="100%">Mücklich, F.</style></author><author><style face="normal" font="default" size="100%">Solioz, M.</style></author><author><style face="normal" font="default" size="100%">Rensing, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institut Für Mikrobiologie Der Bundeswehr, DZIF - Deutsches Zentrum für Infektionsforschung, Neuherbergstrasse 11, München, 80937, Germany&#xD;Lehrstuhl Funktionswerkstoffe, Materialwissenschaft und Werkstofftechnik, Universität des Saarlandes, Saarbrücken, 66123, Germany&#xD;Department of Plant Physiology and Biotechnology, Tomsk State University, Tomsk, Russian Federation&#xD;Faculty of Science, Department of Plant and Environmental Sciences, University of Kopenhagen, Thorvaldsensvej 40, Frederiksberg C, 1871, Denmark</style></auth-address><titles><title><style face="normal" font="default" size="100%">Bulk copper materials for hygiene and infection prevention</style></title><secondary-title><style face="normal" font="default" size="100%">Hygiene + Medizin</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Hyg. Med.</style></alt-title><short-title><style face="normal" font="default" size="100%">Massive kupferwerkstoffe in der hygiene und infektionsprävention</style></short-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Hygiene + Medizin</style></full-title><abbr-1><style face="normal" font="default" size="100%">Hyg. Med.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Hygiene + Medizin</style></full-title><abbr-1><style face="normal" font="default" size="100%">Hyg. Med.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">458-463</style></pages><volume><style face="normal" font="default" size="100%">40</style></volume><number><style face="normal" font="default" size="100%">11</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antimicrobial copper</style></keyword><keyword><style face="normal" font="default" size="100%">Contact killing</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">Nosocomial infections</style></keyword><keyword><style face="normal" font="default" size="100%">Surface contamination</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><publisher><style face="normal" font="default" size="100%">mhp-Verlag GmbH</style></publisher><isbn><style face="normal" font="default" size="100%">01723790 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Strict adherence to protocols for the decontamination of surfaces and hands are a pivotal to functioning hospital hygiene. However, when standard hygiene measures fail inadvertently, additional contamination barriers could provide added protection of patients. Many recent studies have documented that metallic copper possesses antimicrobial properties. Copper-based materials could thus be employed as an added means of a infection prevention multi-barrier strategy. Based on the interdisciplinarity of the topic - microbiologists as well as material scientists contribute to the field - it is of special importance to summarize and put into perspective the various findings. It is the goal of this contribution to provide an interdisciplinary account of the state of basic research as well as fieldstudies on antimicrobial copper. Progress in the elucidation of the mechanism by which metallic copper inactivates germs, the so called &apos;contact killing&apos; process, will be discussed. Also considered will be aspects of material properties and engineering. In addition, the results of recent studies with copper surfaces in hospitals in different countries will be presented and evaluated. The question will be discussed to what extent copper could contribute to hospital hygiene and eventually the prevention of hospital acquired infections.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;CODEN: HYMED&#xD;Correspondence Address: Rensing, C.; Faculty of Science, Department of Plant and Environmental Sciences, University of Kopenhagen, Thorvaldsensvej 40, Denmark; email: chres@plen.ku.dk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84958047086&amp;partnerID=40&amp;md5=e2e88925f78eaf1d8985d0064827ded3</style></url></related-urls></urls><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">German</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>149</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">149</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Grota, P. G.</style></author><author><style face="normal" font="default" size="100%">Grant, P. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Office of Faculty Affairs and Diversity, School of Nursing, 7703 Floyd Curl Drive, Mail code 7975, San Antonio, TX 78229, United States&#xD;Infection Prevention and Quality, Methodist Hospital for Surgery, Addison, TX, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Environmental Infection Prevention: Priorities of Patient Safety Collaboration</style></title><secondary-title><style face="normal" font="default" size="100%">Critical Care Nursing Quarterly</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Crit. Care Nurs. Q.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Critical Care Nursing Quarterly</style></full-title><abbr-1><style face="normal" font="default" size="100%">Crit. Care Nurs. Q.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Critical Care Nursing Quarterly</style></full-title><abbr-1><style face="normal" font="default" size="100%">Crit. Care Nurs. Q.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">38-46</style></pages><volume><style face="normal" font="default" size="100%">41</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">environmental cleanliness</style></keyword><keyword><style face="normal" font="default" size="100%">health care-associated infections</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care units</style></keyword><keyword><style face="normal" font="default" size="100%">role of ICU nurse</style></keyword><keyword><style face="normal" font="default" size="100%">Acinetobacter</style></keyword><keyword><style face="normal" font="default" size="100%">Acinetobacter infection</style></keyword><keyword><style face="normal" font="default" size="100%">Article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial transmission</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile infection</style></keyword><keyword><style face="normal" font="default" size="100%">disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">enterococcal infection</style></keyword><keyword><style face="normal" font="default" size="100%">environmental sanitation</style></keyword><keyword><style face="normal" font="default" size="100%">hand washing</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">healthcare associated infection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection prevention</style></keyword><keyword><style face="normal" font="default" size="100%">infection risk</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care unit</style></keyword><keyword><style face="normal" font="default" size="100%">medical device contamination</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus infection</style></keyword><keyword><style face="normal" font="default" size="100%">microbial contamination</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">nurse attitude</style></keyword><keyword><style face="normal" font="default" size="100%">patient care</style></keyword><keyword><style face="normal" font="default" size="100%">patient safety</style></keyword><keyword><style face="normal" font="default" size="100%">Peptoclostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin resistant Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">hospital design</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care nursing</style></keyword><keyword><style face="normal" font="default" size="100%">isolation and purification</style></keyword><keyword><style face="normal" font="default" size="100%">multidrug resistance</style></keyword><keyword><style face="normal" font="default" size="100%">procedures</style></keyword><keyword><style face="normal" font="default" size="100%">standards</style></keyword><keyword><style face="normal" font="default" size="100%">transmission</style></keyword><keyword><style face="normal" font="default" size="100%">Critical Care Nursing</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Resistance, Multiple</style></keyword><keyword><style face="normal" font="default" size="100%">Health Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital Design and Construction</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin-Resistant Staphylococcus aureus</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><publisher><style face="normal" font="default" size="100%">Lippincott Williams and Wilkins</style></publisher><isbn><style face="normal" font="default" size="100%">08879303 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Although progress has been made in decreasing health care-associated infections (HAI) in intensive care unit (ICU) patients, there has been an increase in HAI caused by drug-resistant pathogens, particularly those that contaminate the environment such as methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, Pseudomonas spp, Acinetobacter spp, and Clostridium difficile. The ICU environment including sinks and medical equipment has been identified as being at risk for contamination and associated with cross-transmission of pathogens between the health care provider, the environment, and the patient. This article addresses the role of the ICU nurse as a team facilitator collaborating with environmental services, infection preventionists, and others to influence ICU design during preconstruction planning and unit environmental hygiene after construction to promote patient safety and prevent HAI associated with contaminated environments and equipment. © 2018 Wolters Kluwer Health, Inc. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :1&#xD;Export Date: 26 March 2020&#xD;CODEN: CCNQE&#xD;Correspondence Address: Grota, P.G.; Office of Faculty Affairs and Diversity, School of Nursing, 7703 Floyd Curl Drive, Mail code 7975, United States; email: grota@uthscsa.edu</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85037730406&amp;doi=10.1097%2fCNQ.0000000000000184&amp;partnerID=40&amp;md5=6b81d6f13bf70a555254fee44c6c411a</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">29210765</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1097/CNQ.0000000000000184</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>150</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">150</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Guan, B.</style></author><author><style face="normal" font="default" size="100%">Hong, S. H.</style></author><author><style face="normal" font="default" size="100%">Schulz, C.</style></author><author><style face="normal" font="default" size="100%">Stanford, N.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Future Industries Institute, University of South Australia, Mawson Lakes, SA 5095, Australia&#xD;Department of Physics, The Australian National University, Canberra, ACT 2601, Australia</style></auth-address><titles><title><style face="normal" font="default" size="100%">The Microstructure, Antimicrobial Properties, and Corrosion Resistance of Cu-Bearing Strip Cast Steel</style></title><secondary-title><style face="normal" font="default" size="100%">Advanced Engineering Materials</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Adv. Eng. Mater.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Advanced Engineering Materials</style></full-title><abbr-1><style face="normal" font="default" size="100%">Adv. Eng. Mater.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Advanced Engineering Materials</style></full-title><abbr-1><style face="normal" font="default" size="100%">Adv. Eng. Mater.</style></abbr-1></alt-periodical><keywords><keyword><style face="normal" font="default" size="100%">antimicrobial</style></keyword><keyword><style face="normal" font="default" size="100%">corrosion</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">stainless steel</style></keyword><keyword><style face="normal" font="default" size="100%">strip casting</style></keyword><keyword><style face="normal" font="default" size="100%">Copper alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Copper corrosion</style></keyword><keyword><style face="normal" font="default" size="100%">Copper oxides</style></keyword><keyword><style face="normal" font="default" size="100%">Corrosion resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Corrosive effects</style></keyword><keyword><style face="normal" font="default" size="100%">Dealloying</style></keyword><keyword><style face="normal" font="default" size="100%">Heavy ions</style></keyword><keyword><style face="normal" font="default" size="100%">Microstructure</style></keyword><keyword><style face="normal" font="default" size="100%">Pitting</style></keyword><keyword><style face="normal" font="default" size="100%">Solid solutions</style></keyword><keyword><style face="normal" font="default" size="100%">Steel castings</style></keyword><keyword><style face="normal" font="default" size="100%">Strip metal</style></keyword><keyword><style face="normal" font="default" size="100%">Surface analysis</style></keyword><keyword><style face="normal" font="default" size="100%">X ray photoelectron spectroscopy</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-microbial properties</style></keyword><keyword><style face="normal" font="default" size="100%">Anticorrosion performance</style></keyword><keyword><style face="normal" font="default" size="100%">Corrosion mechanisms</style></keyword><keyword><style face="normal" font="default" size="100%">Cu-rich precipitates</style></keyword><keyword><style face="normal" font="default" size="100%">Selective corrosion</style></keyword><keyword><style face="normal" font="default" size="100%">Two-phase structures</style></keyword><keyword><style face="normal" font="default" size="100%">Steel corrosion</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year></dates><publisher><style face="normal" font="default" size="100%">Wiley-VCH Verlag</style></publisher><isbn><style face="normal" font="default" size="100%">14381656 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">The antimicrobial and corrosion properties of Cu-bearing steels fabricated via simulated strip casting are examined. Two distinct microstructures are observed: those alloys with Cu concentrations below 5 wt% retain the Cu in solid solution, and those alloys with high Cu concentrations form a two-phase structure containing an austenite matrix and large Cu-rich precipitates. The alloys display antimicrobial properties against Escherichia coli, causing up to 65% of bacteria death upon direct contact for 24 h. Surface analysis by X-ray photoelectron spectroscopy indicates that after exposure to bacteria, the surface passive film remains enriched in Cu and its oxides, and immersion studies confirm gradual release of Cu ions from the passive film in a wet environment. Corrosion testing of the Cu alloys demonstrates that when the copper is retained in solid solution, the corrosion behavior is not markedly different from the copper-free reference alloy. However, in those higher-concentration alloys that contain Cu-rich precipitates, the anticorrosion performance of the steel is greatly deteriorated, with the corrosion mechanism changing from pitting corrosion to selective corrosion. © 2020 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Guan, B.; Future Industries Institute, University of South AustraliaAustralia; email: bin.guan@unisa.edu.au</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85079698372&amp;doi=10.1002%2fadem.201901265&amp;partnerID=40&amp;md5=5f0feec10b3f7262cf309c23a2638a1d</style></url></related-urls></urls><custom7><style face="normal" font="default" size="100%">1901265</style></custom7><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/adem.201901265</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>151</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">151</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hampson, B.</style></author><author><style face="normal" font="default" size="100%">Wilson, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Sunshine Coast Podiatry Services, Valdora, Q., Australia&#xD;John Wislon Farriery Service, Doonan, Q., Australia</style></auth-address><titles><title><style face="normal" font="default" size="100%">A Comparative Study on the Effects of Copper and Steel Nails on the Health of Horseshoe Nail Holes</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Equine Veterinary Science</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Equine Vet. Sci.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Equine Veterinary Science</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Equine Vet. Sci.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Equine Veterinary Science</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Equine Vet. Sci.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">29-33</style></pages><volume><style face="normal" font="default" size="100%">69</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Antibacterial</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Equine</style></keyword><keyword><style face="normal" font="default" size="100%">Hoof</style></keyword><keyword><style face="normal" font="default" size="100%">steel</style></keyword><keyword><style face="normal" font="default" size="100%">Article</style></keyword><keyword><style face="normal" font="default" size="100%">cohort analysis</style></keyword><keyword><style face="normal" font="default" size="100%">comparative effectiveness</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">foot care</style></keyword><keyword><style face="normal" font="default" size="100%">forefoot</style></keyword><keyword><style face="normal" font="default" size="100%">leaching</style></keyword><keyword><style face="normal" font="default" size="100%">nail</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">pathogen load</style></keyword><keyword><style face="normal" font="default" size="100%">photography</style></keyword><keyword><style face="normal" font="default" size="100%">surface property</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><publisher><style face="normal" font="default" size="100%">W.B. Saunders</style></publisher><isbn><style face="normal" font="default" size="100%">07370806 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Copper-coated steel nails are being increasingly used during shoeing due to their proposed ability to reduce bacterial invasion, despite limited evidence for their effectiveness in this application. The aim of the present study was to determine whether copper-coated horseshoe nails would have a beneficial effect on nail hole health compared to traditional steel nails. All horses were shod by the same farrier at 5- to 6-week intervals. In phase one of the study, a cohort of 11 sport horses was shod for two shoeing cycles using copper-coated nails in the left forefoot (LF) and steel nails in the right forefoot (RF). To eliminate bias related to the use of the same foot in all animals, a second phase of the study was carried out where a subset (n = 6) of the horses were then reshod for two shoeing cycles using a cross-over design. In phase two, the copper-coated nails were used in the RF and steel nails in the LF after a washout period. At the completion of each phase, the horseshoes were removed and the feet trimmed for reshoeing. Before reshoeing, a photograph was taken of the solear surface of each foot and a 10-point pathology score scale was used to assess nail hole health. Overall, the mean ± standard error nail hole pathology score was significantly (P &lt;.01) higher (less healthy) for the steel nails (6.1 ± 0.31), compared with the copper-coated nails (4.4 ± 0.27). Following the cross-over period, the mean ± standard error nail hole pathology score was found to be similar for the LF and RF for each type of nail. Consistent with phase one of the study, there was a significant difference between the pathology scores when copper-coated nails were used in the RF, compared to the steel nails. It appears that the well-known antimicrobial effects of copper may apply to the application of copper coating of horseshoe nails in reducing the microbial damage to the horses&apos; hoof frequently associated with horseshoe nail insertion. © 2018 Elsevier Inc.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;CODEN: JEVSC&#xD;Correspondence Address: Hampson, B.; Sunshine Coast Podiatry Services, 18 Aurora Place, Australia; email: b.hamp@bigpond.com</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85049344049&amp;doi=10.1016%2fj.jevs.2018.06.005&amp;partnerID=40&amp;md5=daf833e34a62192eb0dd2b250951824d</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.jevs.2018.06.005</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>152</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">152</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hayden, M. K.</style></author><author><style face="normal" font="default" size="100%">Bonten, M. J. M.</style></author><author><style face="normal" font="default" size="100%">Blom, D. W.</style></author><author><style face="normal" font="default" size="100%">Lyle, E. A.</style></author><author><style face="normal" font="default" size="100%">Van De Vijver, D. A. M. C.</style></author><author><style face="normal" font="default" size="100%">Weinstein, R. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Rush University Medical Center, Chicago, IL, United States&#xD;Stroger (Cook County) Hospital, Chicago, IL, United States&#xD;University Medical Center Utrecht, Utrecht, Netherlands&#xD;Dept. of Medicine and Pathology, Rush University Medical Center, 1653 W. Congress Pkwy., Chicago, IL 60612, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Reduction in acquisition of vancomycin-resistant enterococcus after enforcement of routine environmental cleaning measures</style></title><secondary-title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Clin. Infect. Dis.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Clin. Infect. Dis.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Clin. Infect. Dis.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">1552-1560</style></pages><volume><style face="normal" font="default" size="100%">42</style></volume><number><style face="normal" font="default" size="100%">11</style></number><keywords><keyword><style face="normal" font="default" size="100%">cephalosporin</style></keyword><keyword><style face="normal" font="default" size="100%">clindamycin</style></keyword><keyword><style face="normal" font="default" size="100%">imipenem</style></keyword><keyword><style face="normal" font="default" size="100%">meropenem</style></keyword><keyword><style face="normal" font="default" size="100%">penicillin G</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">contamination</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">enterococcal infection</style></keyword><keyword><style face="normal" font="default" size="100%">environmental factor</style></keyword><keyword><style face="normal" font="default" size="100%">hospital admission</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">personal hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">rectum</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin resistant Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">Gram-Positive Bacterial Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Handwashing</style></keyword><keyword><style face="normal" font="default" size="100%">Housekeeping, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infection Control</style></keyword><keyword><style face="normal" font="default" size="100%">Intensive Care Units</style></keyword><keyword><style face="normal" font="default" size="100%">Multivariate Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Practice Guidelines</style></keyword><keyword><style face="normal" font="default" size="100%">Vancomycin Resistance</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2006</style></year></dates><isbn><style face="normal" font="default" size="100%">10584838 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background. The role of environmental contamination in nosocomial cross-transmission of antibiotic-resistant bacteria has been unresolved. Using vancomycin-resistant enterococci (VRE) as a marker organism, we investigated the effects of improved environmental cleaning with and without promotion of hand hygiene adherence on the spread of VRE in a medical intensive care unit. Methods. The study comprised a baseline period (period 1), a period of educational intervention to improve environmental cleaning (period 2), a &quot;washout&quot; period without any specific intervention (period 3), and a period of multimodal hand hygiene intervention (period 4). We performed cultures for VRE of rectal swab samples obtained from patients at admission to the intensive care unit and daily thereafter, and we performed cultures of environmental samples and samples from the hands of health care workers twice weekly. We measured patient clinical and demographic variables and monitored intervention adherence frequently. Results. Our study included 748 admissions to the intensive care unit over a 9-month period. VRE acquisition rates were 33.47 cases per 1000 patient-days at risk for period 1 and 16.84, 12.09, and 10.40 cases per 1000 patient-days at risk for periods 2, 3, and 4, respectively. The mean (±SD) weekly rate of environmental sites cleaned increased from 0.48 ± 0.08 at baseline to 0.87 ± 0.08 in period 2; similarly high cleaning rates persisted in periods 3 and 4. Mean (±SD) weekly hand hygiene adherence rate was 0.40 ± 0.01 at baseline and increased to 0.57 ± 0.11 in period 2, without a specific intervention to improve adherence, but decreased to 0.29 ± 0.26 in period 3 and 0.43 ± 0.1 in period 4. Mean proportions of positive results of cultures of environmental and hand samples decreased in period 2 and remained low thereafter. In a Cox proportional hazards model, the hazard ratio for acquiring VRE during periods 2-4 was 0.36 (95% confidence interval, 0.19-0.68); the only determinant explaining the difference in VRE acquisition was admission to the intensive care unit during period 1. Conclusions. Decreasing environmental contamination may help to control the spread of some antibiotic-resistant bacteria in hospitals. © 2006 by the Infectious Diseases Society of America. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :271&#xD;Export Date: 26 March 2020&#xD;CODEN: CIDIE&#xD;Correspondence Address: Hayden, M.K.; Dept. of Medicine and Pathology, Rush University Medical Center, 1653 W. Congress Pkwy., Chicago, IL 60612, United States; email: mhayden@rush.edu</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-33646751714&amp;doi=10.1086%2f503845&amp;partnerID=40&amp;md5=1b7d2688068162fc668c612d2695c198</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">16652312</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1086/503845</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>153</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">153</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Heppner, H. J.</style></author><author><style face="normal" font="default" size="100%">Cornel, S.</style></author><author><style face="normal" font="default" size="100%">Peter, W.</style></author><author><style face="normal" font="default" size="100%">Philipp, B.</style></author><author><style face="normal" font="default" size="100%">Katrin, S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Emergency and Intensive Care Medicine, Klinikum Nuremberg, Prof.-E.-Nathan-Str. 1, Nuremberg D-90419, Germany&#xD;Institute for Biomedicine of Aging, Friedrich-Alexander-University Erlangen-Nuremberg, Heimerichstr. 58, Nuremberg D-90419, Germany&#xD;Depatment of Intensive Care Medicine, Johanniter Hospital Bonn, Johanniterstr. 3-5, Bonn D-53113, Germany&#xD;Department of Acute Geriatric Medicine, Klinikum Nuremberg, Prof.-E.-Nathan-Str. 1, Nuremberg D-90419, Germany</style></auth-address><titles><title><style face="normal" font="default" size="100%">Infections in the Elderly</style></title><secondary-title><style face="normal" font="default" size="100%">Critical Care Clinics</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Crit. Care Clin.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Critical Care Clinics</style></full-title><abbr-1><style face="normal" font="default" size="100%">Crit. Care Clin.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Critical Care Clinics</style></full-title><abbr-1><style face="normal" font="default" size="100%">Crit. Care Clin.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">757-774</style></pages><volume><style face="normal" font="default" size="100%">29</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Elderly</style></keyword><keyword><style face="normal" font="default" size="100%">Functional decline</style></keyword><keyword><style face="normal" font="default" size="100%">Geriatric</style></keyword><keyword><style face="normal" font="default" size="100%">Immune senescence</style></keyword><keyword><style face="normal" font="default" size="100%">Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Pneumonia</style></keyword><keyword><style face="normal" font="default" size="100%">Sepsis</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">beta lactam antibiotic</style></keyword><keyword><style face="normal" font="default" size="100%">biological marker</style></keyword><keyword><style face="normal" font="default" size="100%">C reactive protein</style></keyword><keyword><style face="normal" font="default" size="100%">carbamazepine</style></keyword><keyword><style face="normal" font="default" size="100%">CD16 antigen</style></keyword><keyword><style face="normal" font="default" size="100%">cephalosporin derivative</style></keyword><keyword><style face="normal" font="default" size="100%">clindamycin</style></keyword><keyword><style face="normal" font="default" size="100%">digoxin</style></keyword><keyword><style face="normal" font="default" size="100%">fidaxomycin</style></keyword><keyword><style face="normal" font="default" size="100%">hydroxymethylglutaryl coenzyme A reductase inhibitor</style></keyword><keyword><style face="normal" font="default" size="100%">interleukin 6</style></keyword><keyword><style face="normal" font="default" size="100%">macrolide</style></keyword><keyword><style face="normal" font="default" size="100%">metronidazole</style></keyword><keyword><style face="normal" font="default" size="100%">phenytoin</style></keyword><keyword><style face="normal" font="default" size="100%">procalcitonin</style></keyword><keyword><style face="normal" font="default" size="100%">quinoline derived antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">rifampicin</style></keyword><keyword><style face="normal" font="default" size="100%">unclassified drug</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin</style></keyword><keyword><style face="normal" font="default" size="100%">warfarin</style></keyword><keyword><style face="normal" font="default" size="100%">aging</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic therapy</style></keyword><keyword><style face="normal" font="default" size="100%">aspergillosis</style></keyword><keyword><style face="normal" font="default" size="100%">aspiration pneumonia</style></keyword><keyword><style face="normal" font="default" size="100%">Barthel index</style></keyword><keyword><style face="normal" font="default" size="100%">blood cell count</style></keyword><keyword><style face="normal" font="default" size="100%">bloodstream infection</style></keyword><keyword><style face="normal" font="default" size="100%">candidiasis</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile infection</style></keyword><keyword><style face="normal" font="default" size="100%">community acquired pneumonia</style></keyword><keyword><style face="normal" font="default" size="100%">comorbidity</style></keyword><keyword><style face="normal" font="default" size="100%">confusion</style></keyword><keyword><style face="normal" font="default" size="100%">daily life activity</style></keyword><keyword><style face="normal" font="default" size="100%">delirium</style></keyword><keyword><style face="normal" font="default" size="100%">diarrhea</style></keyword><keyword><style face="normal" font="default" size="100%">dizziness</style></keyword><keyword><style face="normal" font="default" size="100%">drug distribution</style></keyword><keyword><style face="normal" font="default" size="100%">drug elimination</style></keyword><keyword><style face="normal" font="default" size="100%">drug eruption</style></keyword><keyword><style face="normal" font="default" size="100%">frail elderly</style></keyword><keyword><style face="normal" font="default" size="100%">geriatric disorder</style></keyword><keyword><style face="normal" font="default" size="100%">hallucination</style></keyword><keyword><style face="normal" font="default" size="100%">health care system</style></keyword><keyword><style face="normal" font="default" size="100%">heart arrhythmia</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">immune system</style></keyword><keyword><style face="normal" font="default" size="100%">infection</style></keyword><keyword><style face="normal" font="default" size="100%">leukocyte count</style></keyword><keyword><style face="normal" font="default" size="100%">monotherapy</style></keyword><keyword><style face="normal" font="default" size="100%">mycosis</style></keyword><keyword><style face="normal" font="default" size="100%">nausea</style></keyword><keyword><style face="normal" font="default" size="100%">ototoxicity</style></keyword><keyword><style face="normal" font="default" size="100%">photosensitivity</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">prognosis</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas infection</style></keyword><keyword><style face="normal" font="default" size="100%">quality of life</style></keyword><keyword><style face="normal" font="default" size="100%">review</style></keyword><keyword><style face="normal" font="default" size="100%">sarcopenia</style></keyword><keyword><style face="normal" font="default" size="100%">seizure</style></keyword><keyword><style face="normal" font="default" size="100%">septic shock</style></keyword><keyword><style face="normal" font="default" size="100%">side effect</style></keyword><keyword><style face="normal" font="default" size="100%">somnolence</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus infection</style></keyword><keyword><style face="normal" font="default" size="100%">stress</style></keyword><keyword><style face="normal" font="default" size="100%">T lymphocyte</style></keyword><keyword><style face="normal" font="default" size="100%">thorax radiography</style></keyword><keyword><style face="normal" font="default" size="100%">urinary tract infection</style></keyword><keyword><style face="normal" font="default" size="100%">vomiting</style></keyword><keyword><style face="normal" font="default" size="100%">Activities of Daily Living</style></keyword><keyword><style face="normal" font="default" size="100%">Acute Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Aged, 80 and over</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Infective Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Case Management</style></keyword><keyword><style face="normal" font="default" size="100%">Chronic Disease</style></keyword><keyword><style face="normal" font="default" size="100%">Communicable Diseases</style></keyword><keyword><style face="normal" font="default" size="100%">Disease Progression</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Assessment</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><isbn><style face="normal" font="default" size="100%">07490704 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Infections have plagued humans since the beginning of recorded history. Huge segments of the human population were episodically wiped out by epidemic infectious diseases in past centuries. Infection was and is often the final cause of mortality in the debilitated elderly. Substantial ongoing research has been performed to investigate mechanisms, causes, pathogenesis, and therapy for infectious disease. Much of this work has involved the elderly because that group is uniquely predisposed to morbidity and mortality from infection. It is hoped that continued research will result in a decrease in infection morbidity and mortality in elderly. © 2013 Elsevier Inc.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :37&#xD;Export Date: 26 March 2020&#xD;CODEN: CCCLE&#xD;Correspondence Address: Heppner, H.J.; Department of Emergency and Intensive Care Medicine, Klinikum Nuremberg, Prof.-E.-Nathan-Str. 1, Nuremberg D-90419, Germany; email: heppner@klinikum-nuernberg.de</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880014614&amp;doi=10.1016%2fj.ccc.2013.03.016&amp;partnerID=40&amp;md5=d6557704c1e2910aebefb19a968351ae</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">23830661</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.ccc.2013.03.016</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>154</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">154</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hess, A. S.</style></author><author><style face="normal" font="default" size="100%">Shardell, M.</style></author><author><style face="normal" font="default" size="100%">Kristie Johnson, J.</style></author><author><style face="normal" font="default" size="100%">Thom, K. A.</style></author><author><style face="normal" font="default" size="100%">Roghmann, M. C.</style></author><author><style face="normal" font="default" size="100%">Netzer, G.</style></author><author><style face="normal" font="default" size="100%">Amr, S.</style></author><author><style face="normal" font="default" size="100%">Morgan, D. J.</style></author><author><style face="normal" font="default" size="100%">Harris, A. D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, United States&#xD;Department of Pathology, University of Maryland School of Medicine, Baltimore, MD, United States&#xD;Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">A randomized controlled trial of enhanced cleaning to reduce contamination of healthcare worker gowns and gloves with multidrug-resistant bacteria</style></title><secondary-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">487-493</style></pages><volume><style face="normal" font="default" size="100%">34</style></volume><number><style face="normal" font="default" size="100%">5 SPL</style></number><keywords><keyword><style face="normal" font="default" size="100%">Acinetobacter baumannii</style></keyword><keyword><style face="normal" font="default" size="100%">Acinetobacter infection</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">clinical article</style></keyword><keyword><style face="normal" font="default" size="100%">contamination</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">follow up</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">hospital service</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care unit</style></keyword><keyword><style face="normal" font="default" size="100%">intervention study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">outcome assessment</style></keyword><keyword><style face="normal" font="default" size="100%">patient care</style></keyword><keyword><style face="normal" font="default" size="100%">randomized controlled trial</style></keyword><keyword><style face="normal" font="default" size="100%">sample size</style></keyword><keyword><style face="normal" font="default" size="100%">surgical glove</style></keyword><keyword><style face="normal" font="default" size="100%">surgical gown</style></keyword><keyword><style face="normal" font="default" size="100%">tertiary health care</style></keyword><keyword><style face="normal" font="default" size="100%">Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Resistance, Multiple, Bacterial</style></keyword><keyword><style face="normal" font="default" size="100%">Fluorescent Dyes</style></keyword><keyword><style face="normal" font="default" size="100%">Fomites</style></keyword><keyword><style face="normal" font="default" size="100%">Gloves, Protective</style></keyword><keyword><style face="normal" font="default" size="100%">Housekeeping, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Intensive Care Units</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin-Resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Middle Aged</style></keyword><keyword><style face="normal" font="default" size="100%">Patients&apos; Rooms</style></keyword><keyword><style face="normal" font="default" size="100%">Surgical Attire</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><isbn><style face="normal" font="default" size="100%">0899823X (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Objective. To determine whether enhanced daily cleaning would reduce contamination of healthcare worker (HCW) gowns and gloves with methicillin-resistant Staphylococcus aureus (MRSA) or multidrug-resistant Acinetobacter baumannii (MDRAB). design. A cluster-randomized controlled trial. setting. Four intensive care units (ICUs) in an urban tertiary care hospital. participants. ICU rooms occupied by patients colonized with MRSA or MDRAB. intervention. Extra enhanced daily cleaning of ICU room surfaces frequently touched by HCWs. results. A total of 4,444 cultures were collected from 132 rooms over 10 months. Using fiuorescent dot markers at 2,199 surfaces, we found that 26% of surfaces in control rooms were cleaned and that 100% of surfaces in experimental rooms were cleaned. The P &lt;.001 mean proportion of contaminated HCW gowns and gloves following routine care provision and before leaving the rooms of patients with MDRAB was 16% among control rooms and 12% among experimental rooms (relative risk, 0.77 [95% confidence interval, 0.28-2.11]; P=.23). For MRSA, the mean proportions were 22% and 19%, respectively (relative risk, 0.89 [95% confidence interval, 0.50-1.53]; P=.16). discussion. Intense enhanced daily cleaning of ICU rooms occupied by patients colonized with MRSA or MDRAB was associated with a nonsignificant reduction in contamination of HCW gowns and gloves after routine patient care activities. Further research is needed to determine whether intense environmental cleaning will lead to significant reductions and fewer infections. trial registration. ClinicalTrials.gov identifier: NCT01481935. © 2013 by The Society for Healthcare Epidemiology of America. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :23&#xD;Export Date: 26 March 2020&#xD;CODEN: ICEPE&#xD;Correspondence Address: Hess, A. S.; Department of Epidemiology and Public Health, University of Maryland School of Medicine, MSTF 362, 685 West Baltimore Street, Baltimore, MD 21201, United States; email: aaron.hess@som.umaryland.edu</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84876095717&amp;doi=10.1086%2f670205&amp;partnerID=40&amp;md5=247b80b28d05f0e4edbd27d48936b595</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">23571365</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1086/670205</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>155</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">155</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hota, B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Section of Infectious Diseases, Stroger Hospital of Cook County, Rush University Medical Center, Chicago, IL, United States&#xD;Section of Infectious Diseases, Stroger Hospital of Cook County, Rush University Medical Center, 637 S. Wood St., Chicago, IL 60612, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Contamination, disinfection, and cross-colonization: Are hospital surfaces reservoirs for nosocomial infection?</style></title><secondary-title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Clin. Infect. Dis.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Clin. Infect. Dis.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Clinical Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Clin. Infect. Dis.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">1182-1189</style></pages><volume><style face="normal" font="default" size="100%">39</style></volume><number><style face="normal" font="default" size="100%">8</style></number><keywords><keyword><style face="normal" font="default" size="100%">detergent</style></keyword><keyword><style face="normal" font="default" size="100%">disinfectant agent</style></keyword><keyword><style face="normal" font="default" size="100%">Acinetobacter baumannii</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial colonization</style></keyword><keyword><style face="normal" font="default" size="100%">Candida</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Coronavirus</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">environmental sanitation</style></keyword><keyword><style face="normal" font="default" size="100%">Gram negative bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">Gram positive bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">Hepatitis B virus</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">Influenza virus</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">Norovirus</style></keyword><keyword><style face="normal" font="default" size="100%">Parainfluenza virus</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">review</style></keyword><keyword><style face="normal" font="default" size="100%">severe acute respiratory syndrome</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin resistant Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Fomites</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Mycoses</style></keyword><keyword><style face="normal" font="default" size="100%">Virus Diseases</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2004</style></year></dates><isbn><style face="normal" font="default" size="100%">10584838 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Despite documentation that the inanimate hospital environment (e.g., surfaces and medical equipment) becomes contaminated with nosocomial pathogens, the data that suggest that contaminated fomites lead to nosocomial infections do so indirectly. Pathogens for which there is more-compelling evidence of survival in environmental reservoirs include Clostridium difficile, vancomycin-resistant enterococci, and methicillin-resistant Staphylococcus aureus, and pathogens for which there is evidence of probable survival in environmental reservoirs include norovirus, influenza virus, severe acute respiratory syndrome-associated coronavirus, and Candida species. Strategies to reduce the rates of nosocomial infection with these pathogens should conform to established guidelines, with an emphasis on thorough environmental cleaning and use of Environmental Protection Agency-approved detergent-disinfectants.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :413&#xD;Export Date: 26 March 2020&#xD;CODEN: CIDIE&#xD;Correspondence Address: Hota, B.; Section of Infectious Diseases, Stroger Hospital of Cook County, Rush University Medical Center, 637 S. Wood St., Chicago, IL 60612, United States; email: bhota@rush.edu</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-12844278645&amp;doi=10.1086%2f424667&amp;partnerID=40&amp;md5=1eb2e8d7627b98bacd23d8f378048394</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">15486843</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1086/424667</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>156</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">156</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Huslage, K.</style></author><author><style face="normal" font="default" size="100%">Rutala, W. A.</style></author><author><style face="normal" font="default" size="100%">Gergen, M. F.</style></author><author><style face="normal" font="default" size="100%">Sickbert-Bennett, E. E.</style></author><author><style face="normal" font="default" size="100%">Weber, D. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Infectious Diseases, University of North Carolina, Statewide Program for Infection Control and Epidemiology, CB 7030, 2156 Bioinformatics, 130 Mason Farm Road, Chapel Hill, NC 27599, United States&#xD;Department of Hospital Epidemiology, University of North Carolina Health Care, Chapel Hill, NC, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Microbial assessment of high-, medium-, and low-touch hospital room surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">211-212</style></pages><volume><style face="normal" font="default" size="100%">34</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">colony forming unit</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">follow up</style></keyword><keyword><style face="normal" font="default" size="100%">hand washing</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">hospital building</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">microbial contamination</style></keyword><keyword><style face="normal" font="default" size="100%">microbial identification</style></keyword><keyword><style face="normal" font="default" size="100%">pathogen load</style></keyword><keyword><style face="normal" font="default" size="100%">practice guideline</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">touch</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Load</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals</style></keyword><keyword><style face="normal" font="default" size="100%">Patients&apos; Rooms</style></keyword><keyword><style face="normal" font="default" size="100%">Personnel, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Management</style></keyword><keyword><style face="normal" font="default" size="100%">United States</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><isbn><style face="normal" font="default" size="100%">0899823X (ISSN)</style></isbn><notes><style face="normal" font="default" size="100%">Cited By :28&#xD;Export Date: 26 March 2020&#xD;CODEN: ICEPE&#xD;Correspondence Address: Huslage, K.; Division of Infectious Diseases, University of North Carolina, Statewide Program for Infection Control and Epidemiology, CB 7030, 2156 Bioinformatics, 130 Mason Farm Road, Chapel Hill, NC 27599, United States; email: kirk.huslage@unc.edu</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872200266&amp;doi=10.1086%2f669092&amp;partnerID=40&amp;md5=9aaa6eed9864d987c6010d3183563429</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">23295570</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1086/669092</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>157</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">157</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ibrahim, M. S.</style></author><author><style face="normal" font="default" size="100%">Ibrahim, A. S.</style></author><author><style face="normal" font="default" size="100%">Balhaddad, A. A.</style></author><author><style face="normal" font="default" size="100%">Weir, M. D.</style></author><author><style face="normal" font="default" size="100%">Lin, N. J.</style></author><author><style face="normal" font="default" size="100%">Tay, F. R.</style></author><author><style face="normal" font="default" size="100%">Oates, T. W.</style></author><author><style face="normal" font="default" size="100%">Xu, H. H. K.</style></author><author><style face="normal" font="default" size="100%">Melo, M. A. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">University of Maryland School of Dentistry, Cheras, Baltimore, MD 21201, United States&#xD;Department of Preventive Dental Sciences, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam, 34212, Saudi Arabia&#xD;Medical Microbiology Department, Health Monitoring Centers, Ministry of Health, Ampang, Jeddah, 21176, Saudi Arabia&#xD;Department of Restorative Dental Sciences, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam, 34212, Saudi Arabia&#xD;Department of Advanced Oral Sciences and Therapeutics, Division of Biomaterials and Tissue Engineering, University of Maryland School of Dentistry, Baltimore, MD 21201, United States&#xD;Biosystems and Biomaterials Division, National Institute of Standards and Technology, Gaithersburg, MD 20899, United States&#xD;Department of Endodontics, The Dental College of Georgia, Augusta University, Augusta, GA 30912, United States&#xD;Center for Stem Cell Biology and Regenerative Medicine, University of Maryland School of Medicine, Ampang, Baltimore, MD 21201, United States&#xD;University of Maryland Marlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, United States&#xD;Division of Operative Dentistry, Department of General Dentistry, University of Maryland School of Dentistry, Baltimore, MD 21201, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">A novel dental sealant containing dimethylaminohexadecyl methacrylate suppresses the cariogenic pathogenicity of streptococcus mutans biofilms</style></title><secondary-title><style face="normal" font="default" size="100%">International Journal of Molecular Sciences</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Int. J. Mol. Sci.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">International Journal of Molecular Sciences</style></full-title><abbr-1><style face="normal" font="default" size="100%">Int. J. Mol. Sci.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">International Journal of Molecular Sciences</style></full-title><abbr-1><style face="normal" font="default" size="100%">Int. J. Mol. Sci.</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">20</style></volume><number><style face="normal" font="default" size="100%">14</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antibacterial agents</style></keyword><keyword><style face="normal" font="default" size="100%">Biofilm</style></keyword><keyword><style face="normal" font="default" size="100%">Edental cariesMT</style></keyword><keyword><style face="normal" font="default" size="100%">Quaternary ammonium compounds</style></keyword><keyword><style face="normal" font="default" size="100%">Sealant</style></keyword><keyword><style face="normal" font="default" size="100%">Streptococcus mutans</style></keyword><keyword><style face="normal" font="default" size="100%">acid</style></keyword><keyword><style face="normal" font="default" size="100%">calcium phosphate</style></keyword><keyword><style face="normal" font="default" size="100%">dental material</style></keyword><keyword><style face="normal" font="default" size="100%">dimethylaminohexadecyl methacrylate</style></keyword><keyword><style face="normal" font="default" size="100%">exopolysaccharide</style></keyword><keyword><style face="normal" font="default" size="100%">fissure sealant</style></keyword><keyword><style face="normal" font="default" size="100%">green fluorescent protein</style></keyword><keyword><style face="normal" font="default" size="100%">lactic acid</style></keyword><keyword><style face="normal" font="default" size="100%">nanoparticle</style></keyword><keyword><style face="normal" font="default" size="100%">unclassified drug</style></keyword><keyword><style face="normal" font="default" size="100%">virulence factor</style></keyword><keyword><style face="normal" font="default" size="100%">amorphous calcium phosphate</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">hydrogen peroxide</style></keyword><keyword><style face="normal" font="default" size="100%">methacrylic acid</style></keyword><keyword><style face="normal" font="default" size="100%">tooth cement</style></keyword><keyword><style face="normal" font="default" size="100%">acidity</style></keyword><keyword><style face="normal" font="default" size="100%">Article</style></keyword><keyword><style face="normal" font="default" size="100%">assay</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial virulence</style></keyword><keyword><style face="normal" font="default" size="100%">cariogenic pathogenicity</style></keyword><keyword><style face="normal" font="default" size="100%">clinical practice</style></keyword><keyword><style face="normal" font="default" size="100%">colony forming unit</style></keyword><keyword><style face="normal" font="default" size="100%">confocal laser scanning microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">dental caries</style></keyword><keyword><style face="normal" font="default" size="100%">fluorescence</style></keyword><keyword><style face="normal" font="default" size="100%">hydrogen peroxide killing assay</style></keyword><keyword><style face="normal" font="default" size="100%">metabolic activity assay</style></keyword><keyword><style face="normal" font="default" size="100%">MTT assay</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">oxidative stress</style></keyword><keyword><style face="normal" font="default" size="100%">oxygen stress tolerance</style></keyword><keyword><style face="normal" font="default" size="100%">pathogenicity</style></keyword><keyword><style face="normal" font="default" size="100%">pH</style></keyword><keyword><style face="normal" font="default" size="100%">physical sensitivity and tolerance</style></keyword><keyword><style face="normal" font="default" size="100%">protein expression</style></keyword><keyword><style face="normal" font="default" size="100%">spectrophotometry</style></keyword><keyword><style face="normal" font="default" size="100%">chemistry</style></keyword><keyword><style face="normal" font="default" size="100%">drug effect</style></keyword><keyword><style face="normal" font="default" size="100%">physiology</style></keyword><keyword><style face="normal" font="default" size="100%">Acids</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Biofilms</style></keyword><keyword><style face="normal" font="default" size="100%">Calcium Phosphates</style></keyword><keyword><style face="normal" font="default" size="100%">Dental Cements</style></keyword><keyword><style face="normal" font="default" size="100%">Methacrylates</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><publisher><style face="normal" font="default" size="100%">MDPI AG</style></publisher><isbn><style face="normal" font="default" size="100%">16616596 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Cariogenic oral biofilms are strongly linked to dental caries around dental sealants. Quaternary ammonium monomers copolymerized with dental resin systems have been increasingly explored formodulation of biofilmgrowth. Here,we investigated the effect of dimethylaminohexadecyl methacrylate (DMAHDM) on the cariogenic pathogenicity of Streptococcus mutans (S. mutans) biofilms. DMAHDM at 5 mass% was incorporated into a parental formulation containing 20 mass% nanoparticles of amorphous calcium phosphate (NACP). S. mutans biofilms were grown on the formulations, and biofilm inhibition and virulence properties were assessed. The tolerances to acid stress and hydrogen peroxide stress were also evaluated. Our findings suggest that incorporating 5% DMAHDMinto 20% NACP-containing sealants (1) imparts a detrimental biological effect on S. mutans by reducing colony-forming unit counts, metabolic activity and exopolysaccharide synthesis; and (2) reduces overall acid production and tolerance to oxygen stress, two major virulence factors of this microorganism. These results provide a perspective on the value of integrating bioactive restorative materials with traditional caries management approaches in clinical practice. Contact-killing strategies via dental materials aiming to prevent or at least reduce high numbers of cariogenic bacteria may be a promising approach to decrease caries in patients at high risk. © 2019 by the authors. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :1&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Melo, M.A.S.; University of Maryland School of Dentistry, Cheras, United States; email: mmelo@umaryland.edu</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85070074318&amp;doi=10.3390%2fijms20143491&amp;partnerID=40&amp;md5=b2d83d3c1392088abd3af53b2b265e3c</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">31315225</style></custom2><custom7><style face="normal" font="default" size="100%">3491</style></custom7><electronic-resource-num><style face="normal" font="default" size="100%">10.3390/ijms20143491</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>158</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">158</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jarvis, W. R.</style></author><author><style face="normal" font="default" size="100%">Martone, W. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Centers for Disease Control, Atlanta, GA, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Predominant pathogens in hospital infections</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Antimicrobial Chemotherapy</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Antimicrob. Chemother.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Antimicrobial Chemotherapy</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Antimicrob. Chemother.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Antimicrobial Chemotherapy</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Antimicrob. Chemother.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">19-24</style></pages><volume><style face="normal" font="default" size="100%">29</style></volume><keywords><keyword><style face="normal" font="default" size="100%">bacterium isolation</style></keyword><keyword><style face="normal" font="default" size="100%">blood</style></keyword><keyword><style face="normal" font="default" size="100%">candida</style></keyword><keyword><style face="normal" font="default" size="100%">candida albicans</style></keyword><keyword><style face="normal" font="default" size="100%">coagulase negative staphylococcus</style></keyword><keyword><style face="normal" font="default" size="100%">conference paper</style></keyword><keyword><style face="normal" font="default" size="100%">enterobacter</style></keyword><keyword><style face="normal" font="default" size="100%">enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care unit</style></keyword><keyword><style face="normal" font="default" size="100%">lower respiratory tract</style></keyword><keyword><style face="normal" font="default" size="100%">lower respiratory tract infection</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">surgical wound</style></keyword><keyword><style face="normal" font="default" size="100%">united states</style></keyword><keyword><style face="normal" font="default" size="100%">urinary tract</style></keyword><keyword><style face="normal" font="default" size="100%">urinary tract infection</style></keyword><keyword><style face="normal" font="default" size="100%">wound infection</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Candidiasis</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Coagulase</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Enterobacteriaceae Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Human</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcal Infections</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1992</style></year></dates><isbn><style face="normal" font="default" size="100%">03057453 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">To determine the distribution of pathogens causing nosocomial infections in United States hospitals, we analysed data from the National Nosocomial Infections Surveillance (NNIS) System. From October 1986 to December 1990, amongst hospitals conducting hospital-wide surveillance, the five most commonly reported pathogens were Escherichia coli (13·7%), Staphylococcus aureus (11·2%), enterococci (10·7%), Pseudomonas aeruginosa (10·1%), and coagulase-negative staphylococci (9·7%). The commonest pathogens reported by site included, bloodstream: coagulase-negative staphylococci, S. aureus, enterococci, E. coli, and Candida spp.; lower respiratory tract infection: S. aureus, P. aeruginosa and Enterobacter spp.; surgical wound infection: S. aureus, enterococci and coagulase-negative staphylococci; and urinary tract infection: E. coli, enterococci, and P. aeruginosa. Among hospitals conducting intensive care unit (ICU) surveillance, the commonest pathogens were P. aeruginosa (12·4%), S. aureus (12·3%), coagulase-negative staphylococci (10·2%), Candida spp. (10·1%), Enterobacter spp. and enterococci (8·6% each). In the ICUs, the commonest pathogens found in the bloodstream were coagulase-negative staphylococci, S. aureus, and enterococci; in lower respiratory tract infections P. aeruginosa, S. aureus, and enterococci; in surgical wound infections enterococci, coagulase-negative staphylococci, and Enterobacter spp. and in urinary tract infections Candida spp., E. coli, enterococci, P. aeruginosa, and Enterobacter spp. These data show that S. aureus, E. coli and P. aeruginosa remain important nosocomial pathogens, that coagulase-negative staphylococci, enterococci and C. albicans are pathogens of increasing importance, and that the distribution of pathogens differs by site and hospital location. © 1992 Oxford University Press.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :464&#xD;Export Date: 26 March 2020</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0026579896&amp;doi=10.1093%2fjac%2f29.suppl_A.19&amp;partnerID=40&amp;md5=726ed3463850d5a87b2a38ab8f88c7b1</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">1601752</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1093/jac/29.suppl_A.19</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>159</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">159</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Joshi, S. C.</style></author><author><style face="normal" font="default" size="100%">Diwan, V.</style></author><author><style face="normal" font="default" size="100%">Joshi, R.</style></author><author><style face="normal" font="default" size="100%">Sharma, M.</style></author><author><style face="normal" font="default" size="100%">Pathak, A.</style></author><author><style face="normal" font="default" size="100%">Shah, H.</style></author><author><style face="normal" font="default" size="100%">Tamhankar, A. J.</style></author><author><style face="normal" font="default" size="100%">Stålsby Lundborg, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Community Medicine, R.D. Gardi Medical College, Ujjain, 456006, India&#xD;Department of Public Health and Environment, R.D. Gardi Medical College, Ujjain, 456006, India&#xD;International Centre for Health Research, Ujjain Charitable Trust Hospital and Research Centre, Ujjain, 456001, India&#xD;Department of Public Health Sciences, Global Health, Health Systems and Policy (HSP): Medicines Focusing Antibiotics, Karolinska Institutet, 17177, Stockholm, Sweden&#xD;Department of Microbiology, R.D. Gardi Medical College, Ujjain, 456006, India&#xD;Department of Pharmacology, R.D. Gardi Medical College, Ujjain, 456006, India&#xD;Department of Pediatrics, R.D. Gardi Medical College, Ujjain, 456006, India&#xD;Department of Women and Children’s Health, International Maternal and Child Health Unit, Uppsala University, Uppsala, 75185, Sweden&#xD;Indian Initiative for Management of Antibiotic Resistance, Department of Environmental Medicine, R.D. Gardi Medical College, Ujjain, 456006, India</style></auth-address><titles><title><style face="normal" font="default" size="100%">“How can the patients remain safe, if we are not safe and protected from the infections”? A qualitative exploration among health-care workers about challenges of maintaining hospital cleanliness in a resource limited tertiary setting in rural india</style></title><secondary-title><style face="normal" font="default" size="100%">International Journal of Environmental Research and Public Health</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Int. J. Environ. Res. Public Health</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">International Journal of Environmental Research and Public Health</style></full-title><abbr-1><style face="normal" font="default" size="100%">Int. J. Environ. Res. Public Health</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">International Journal of Environmental Research and Public Health</style></full-title><abbr-1><style face="normal" font="default" size="100%">Int. J. Environ. Res. Public Health</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">15</style></volume><number><style face="normal" font="default" size="100%">9</style></number><keywords><keyword><style face="normal" font="default" size="100%">Health care-associated infection</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital environmental hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital personnel</style></keyword><keyword><style face="normal" font="default" size="100%">India</style></keyword><keyword><style face="normal" font="default" size="100%">Infection control</style></keyword><keyword><style face="normal" font="default" size="100%">Patient safety</style></keyword><keyword><style face="normal" font="default" size="100%">Qualitative research</style></keyword><keyword><style face="normal" font="default" size="100%">disease control</style></keyword><keyword><style face="normal" font="default" size="100%">environmental factor</style></keyword><keyword><style face="normal" font="default" size="100%">health care</style></keyword><keyword><style face="normal" font="default" size="100%">hospital sector</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">infectious disease</style></keyword><keyword><style face="normal" font="default" size="100%">morbidity</style></keyword><keyword><style face="normal" font="default" size="100%">mortality</style></keyword><keyword><style face="normal" font="default" size="100%">qualitative analysis</style></keyword><keyword><style face="normal" font="default" size="100%">research work</style></keyword><keyword><style face="normal" font="default" size="100%">rural area</style></keyword><keyword><style face="normal" font="default" size="100%">sanitation</style></keyword><keyword><style face="normal" font="default" size="100%">stakeholder</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">aged</style></keyword><keyword><style face="normal" font="default" size="100%">Article</style></keyword><keyword><style face="normal" font="default" size="100%">environmental cleaning staff</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">healthcare associated infection</style></keyword><keyword><style face="normal" font="default" size="100%">hospital administrator</style></keyword><keyword><style face="normal" font="default" size="100%">hospital cleanliness</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection prevention</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">medical student</style></keyword><keyword><style face="normal" font="default" size="100%">nurse</style></keyword><keyword><style face="normal" font="default" size="100%">perception</style></keyword><keyword><style face="normal" font="default" size="100%">physician</style></keyword><keyword><style face="normal" font="default" size="100%">staff</style></keyword><keyword><style face="normal" font="default" size="100%">teaching hospital</style></keyword><keyword><style face="normal" font="default" size="100%">tertiary care center</style></keyword><keyword><style face="normal" font="default" size="100%">young adult</style></keyword><keyword><style face="normal" font="default" size="100%">adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">developing country</style></keyword><keyword><style face="normal" font="default" size="100%">health care delivery</style></keyword><keyword><style face="normal" font="default" size="100%">health care planning</style></keyword><keyword><style face="normal" font="default" size="100%">information processing</style></keyword><keyword><style face="normal" font="default" size="100%">middle aged</style></keyword><keyword><style face="normal" font="default" size="100%">psychology</style></keyword><keyword><style face="normal" font="default" size="100%">rural population</style></keyword><keyword><style face="normal" font="default" size="100%">standards</style></keyword><keyword><style face="normal" font="default" size="100%">Delivery of Health Care</style></keyword><keyword><style face="normal" font="default" size="100%">Developing Countries</style></keyword><keyword><style face="normal" font="default" size="100%">Focus Groups</style></keyword><keyword><style face="normal" font="default" size="100%">Health Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Health Resources</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, Teaching</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Tertiary Care Centers</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><publisher><style face="normal" font="default" size="100%">MDPI AG</style></publisher><isbn><style face="normal" font="default" size="100%">16617827 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Health care-associated infections (HAIs) result in treatment delays as well as failures and financial losses not only to patients but also to the treating hospital and overall health-care delivery system. Due to hospital-acquired infections, there are problems of increase in morbidity and mortality, additional diagnostic and therapeutic interventions and ultimately antimicrobial resistance. Proper understanding among health-care workers about the ill effects of HAIs is very important to address this issue. The present study is a qualitative exploration aimed at understanding various aspects of hospital environmental hygiene and Infection prevention control program, by exploring the staff perception regarding the challenges, facilitators and barriers as well as feasible measures towards improvement in a rural tertiary teaching hospital in central India. Method: A qualitative study was conducted using 10 focus group discussions (FGDs) among five different professional groups, which included hospital administrators, doctors, nurses, environmental cleaning staff, and undergraduate medical students. The FGD guide included the following topics: (1) opinion about the status of cleanliness, (2) concepts and actual practices prevailing of hospital environmental hygiene, (3) Barriers, constraints, and problems in maintaining hospital environmental hygiene, (4) Suggestions for improvements. The data were analyzed manually using the content (thematic) analysis method. Results: Two themes were identified: Theme 1: “Prevailing practices and problems related to hospital surface/object contamination and hospital infection control”. Theme 2: “Measures suggested for improving hospital cleanliness within the existing constraints”. The participants emphasized the influence of resource constraints and needed inputs. They brought up the consequentprevailing practices and problems related, on one hand, to various stakeholders (service consumers, hospital personnel including the management), on the other, to specific infection prevention and control processes. They also suggested various measures for improvement. Conclusions: The study has revealed prevailing practices, problems, and suggested measures related to hospital environmental hygiene, particularly hospital cleanliness and HAI prevention and control processes. These insights and assertions are important for developing future behavioral and structural interventions in resource-limited settings. This study recommends a nationwide reliable HAI surveillance system and a robust infection prevention and control program in each health-care institution. © 2018 by the authors. Licensee MDPI, Basel, Switzerland.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :4&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Diwan, V.; Department of Public Health and Environment, R.D. Gardi Medical CollegeIndia; email: vishal.diwan@ki.se</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85053286962&amp;doi=10.3390%2fijerph15091942&amp;partnerID=40&amp;md5=dc647e7be2479adf84cf88ae4b1bb6bc</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">30200603</style></custom2><custom7><style face="normal" font="default" size="100%">1942</style></custom7><electronic-resource-num><style face="normal" font="default" size="100%">10.3390/ijerph15091942</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>160</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">160</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Jou, J.</style></author><author><style face="normal" font="default" size="100%">Ebrahim, J.</style></author><author><style face="normal" font="default" size="100%">Shofer, F. S.</style></author><author><style face="normal" font="default" size="100%">Hamilton, K. W.</style></author><author><style face="normal" font="default" size="100%">Stern, J.</style></author><author><style face="normal" font="default" size="100%">Han, J. H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Center for Public Health Initiatives, University of Pennsylvania, Philadelphia, PA, United States&#xD;Department of Emergency Medicine, University of Pennsylvania, Philadelphia, PA, United States&#xD;Division of Infectious Diseases, Department of Medicine, University of Pennsylvania, 423 Guardian Drive, Philadelphia, PA 19104, United States&#xD;Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, United States&#xD;Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States&#xD;Department of Medicine, New York University, New York, NY, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Environmental Transmission of Clostridium difficile: Association between Hospital Room Size and C. difficile Infection</style></title><secondary-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">564-568</style></pages><volume><style face="normal" font="default" size="100%">36</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">cefepime</style></keyword><keyword><style face="normal" font="default" size="100%">clindamycin</style></keyword><keyword><style face="normal" font="default" size="100%">corticosteroid</style></keyword><keyword><style face="normal" font="default" size="100%">immunosuppressive agent</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">aged</style></keyword><keyword><style face="normal" font="default" size="100%">Article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial transmission</style></keyword><keyword><style face="normal" font="default" size="100%">case control study</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile infection</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">hospital patient</style></keyword><keyword><style face="normal" font="default" size="100%">hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection risk</style></keyword><keyword><style face="normal" font="default" size="100%">length of stay</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">obesity</style></keyword><keyword><style face="normal" font="default" size="100%">Peptoclostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">university hospital</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">Enterocolitis, Pseudomembranous</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">hospital design</style></keyword><keyword><style face="normal" font="default" size="100%">middle aged</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">statistical model</style></keyword><keyword><style face="normal" font="default" size="100%">statistics and numerical data</style></keyword><keyword><style face="normal" font="default" size="100%">transmission</style></keyword><keyword><style face="normal" font="default" size="100%">Case-Control Studies</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital Design and Construction</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, University</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">Patients&apos; Rooms</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><publisher><style face="normal" font="default" size="100%">Cambridge University Press</style></publisher><isbn><style face="normal" font="default" size="100%">0899823X (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVE To evaluate the association between hospital room square footage and acquisition of nosocomial Clostridium difficile infection (CDI). METHODS A case-control study was conducted at a university hospital during the calendar year of 2011. Case patients were adult inpatients with nosocomial CDI. Control patients were hospitalized patients without CDI and were randomly selected and matched to cases in a 2:1 ratio on the basis of hospital length of stay in 3-day strata. A multivariate model was developed using conditional logistic regression to evaluate risk factors for nosocomial CDI. RESULTS A total of 75 case patients and 150 control patients were included. On multivariate analyses, greater square footage of the hospital room was associated with a significantly increased risk of acquiring CDI (odds ratio for every 50 ft2 increase, 3.00; 95% CI, 1.75-5.16; P&amp;lt;.001). Other factors associated with an increased risk of CDI were location in a single room (odds ratio, 3.43; 95% CI, 1.31-9.05; P=.01), malignant tumor (4.56; 1.82-11.4; P=.001), and receipt of cefepime (2.48; 1.06-5.82; P=.04) or immunosuppressants (6.90; 2.07-23.0; P=.002) within the previous 30 days. CONCLUSIONS Greater room square footage increased the risk of acquisition of CDI in the hospital setting, likely owing to increased environmental contamination and/or difficulty in effective disinfection. Future studies are needed to determine feasible and effective cleaning protocols based on patient and room characteristics. © 2015 by The Society for Healthcare Epidemiology of America. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :8&#xD;Export Date: 26 March 2020&#xD;CODEN: ICEPE&#xD;Correspondence Address: Han, J.H.; Division of Infectious Diseases, Department of Medicine, University of Pennsylvania, 423 Guardian Drive, United States; email: jennifer.han@uphs.upenn.edu</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994235464&amp;doi=10.1017%2fice.2015.18&amp;partnerID=40&amp;md5=45411955eda4e0d0af0e029ef9bf4312</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">25652311</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1017/ice.2015.18</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>161</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">161</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kramer, A.</style></author><author><style face="normal" font="default" size="100%">Assadian, O.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute of Hygiene and Environmental Medicine, Universitätsmedizin Greifswald, Ernst-Moritz-Arndt University Greifswald, Walther-Rathenau-Str. 49A, Greifswald, 17485, Germany&#xD;Department for Hospital Hygiene and Infection Control, Medical University of Vienna, Währinger Guertel 18-20, Vienna, 1090, Austria</style></auth-address><titles><title><style face="normal" font="default" size="100%">Survival of microorganisms on inanimate surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Use of Biocidal Surf. for Red. of Healthc. Acquired Infect.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">7-26</style></pages><volume><style face="normal" font="default" size="100%">9783319080574</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Fungi</style></keyword><keyword><style face="normal" font="default" size="100%">Persistence</style></keyword><keyword><style face="normal" font="default" size="100%">Protozoa transmission mechanisms</style></keyword><keyword><style face="normal" font="default" size="100%">Surface disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">Viruses</style></keyword><keyword><style face="normal" font="default" size="100%">Computer viruses</style></keyword><keyword><style face="normal" font="default" size="100%">Contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">Food safety</style></keyword><keyword><style face="normal" font="default" size="100%">Health care</style></keyword><keyword><style face="normal" font="default" size="100%">Pathogens</style></keyword><keyword><style face="normal" font="default" size="100%">Protozoa</style></keyword><keyword><style face="normal" font="default" size="100%">Risk assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Biomedical laboratories</style></keyword><keyword><style face="normal" font="default" size="100%">Contaminated surfaces</style></keyword><keyword><style face="normal" font="default" size="100%">Nosocomial pathogens</style></keyword><keyword><style face="normal" font="default" size="100%">Survival of bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Terminal disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">Transmission mechanisms</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319080574 (ISBN); 3319080563 (ISBN); 9783319080567 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">In healthcare settings microbial contaminated surfaces play an important role in indirect transmission of infection. Especially surfaces close to the patients&apos; environment may be touched at high frequencies, allowing transmission from animated sources to others via contaminated inanimate surfaces. Therefore, the knowledge on the survival of bacteria, fungi, viruses and protozoa on surfaces, and hence, in a broader sense, in the human environment, is important for implementing tactics for prevention of Healthcare-acquired Infections (HAI). This chapter will elaborate the role of surfaces in the transmission of pathogens. Particular emphasis is laid on the current knowledge of the survival time and conditions favouring survival of the pathogens. Finally, mechanisms of transmission from inanimate surfaces to patients are highlighted. Within the multi-barrier strategy of the prevention of HAI, environmental disinfection policies should be based on risk assessments for surfaces with different risks for cross contamination such as high- and low-touched surfaces with appropriate standards for adequate disinfection measures under consideration of the persistence and infectious dose of the pathogens. As a result, surface disinfection is indicated in the following situations: Frequently touched surfaces adjacent to patients Surfaces with assumed or visible contamination Terminal disinfection in rooms or areas where infected or colonized patients with easily transferable nosocomial pathogens are cared for, and in outbreak situations. Furthermore, the knowledge of the persistence of pathogens will also support ensuring the biosafety in microbiological and biomedical laboratories, food-handling settings, and for hygienic behaviour in the everyday life to prevent transmission of infectious diseases. © 2014 Springer International Publishing Switzerland. All rights are reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :8&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Assadian, O.; Department for Hospital Hygiene and Infection Control, Medical University of Vienna, Währinger Guertel 18-20, Austria</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930319202&amp;doi=10.1007%2f978-3-319-08057-4_2&amp;partnerID=40&amp;md5=80359f5174a9a98e8c1f4dc6b51f133a</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-08057-4_2</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>162</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">162</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kuehnert, M. J.</style></author><author><style face="normal" font="default" size="100%">Hill, H. A.</style></author><author><style face="normal" font="default" size="100%">Kupronis, B. A.</style></author><author><style face="normal" font="default" size="100%">Tokars, J. I.</style></author><author><style face="normal" font="default" size="100%">Solomon, S. L.</style></author><author><style face="normal" font="default" size="100%">Jernigan, D. B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Centers for Disease Control and Prevention, Atlanta, GA, United States&#xD;National Center for Infectious Diseases, Centers for Disease Control and Prevention, United States&#xD;Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30333, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Methicillin-resistant-Staphylococcus aureus hospitalizations, United States</style></title><secondary-title><style face="normal" font="default" size="100%">Emerging Infectious Diseases</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Emerg. Infect. Dis.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Emerging Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Emerg. Infect. Dis.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Emerging Infectious Diseases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Emerg. Infect. Dis.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">868-872</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">meticillin</style></keyword><keyword><style face="normal" font="default" size="100%">adolescent</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">aged</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">community</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">pneumonia</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">septicemia</style></keyword><keyword><style face="normal" font="default" size="100%">skin infection</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus infection</style></keyword><keyword><style face="normal" font="default" size="100%">United States</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2005</style></year></dates><publisher><style face="normal" font="default" size="100%">Centers for Disease Control and Prevention (CDC)</style></publisher><isbn><style face="normal" font="default" size="100%">10806040 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Methicillin-resistant Staphylococcus aureus (MRSA) is increasingly a cause of nosocomial and community-onset infection with unknown national scope and magnitude. We used the National Hospital Discharge Survey to calculate the number of US hospital discharges listing S. aureus - specific diagnoses, defined as those having at least 1 International Classification of Diseases (ICD)-9 code specific for S. aureus infection. The number of hospital discharges listing S. aureus-specific diagnoses was multiplied by the proportion of methicillin resistance for each corresponding infection site to determine the number of MRSA infections. From 1999 to 2000, an estimated 125,969 hospitalizations with a diagnosis of MRSA infection occurred annually, including 31,440 for septicemia, 29,823 for pneumonia, and 64,706 for other infections, accounting for 3.95 per 1,000 hospital discharges. The method used in our analysis may provide a simple way to assess trends of the magnitude of MRSA infection nationally.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :219&#xD;Export Date: 26 March 2020&#xD;CODEN: EIDIF&#xD;Correspondence Address: Jernigan, D.B.; Division of Healthcare Quality Promotion, National Center for Infectious Diseases, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Atlanta, GA 30333, United States; email: djernigan@cdc.gov</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-19344372333&amp;doi=10.3201%2feid1106.040831&amp;partnerID=40&amp;md5=ca89cb0b4dfb7e518ffe151ce391aebc</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.3201/eid1106.040831</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>163</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">163</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lemire, J. A.</style></author><author><style face="normal" font="default" size="100%">Kalan, L.</style></author><author><style face="normal" font="default" size="100%">Gugala, N.</style></author><author><style face="normal" font="default" size="100%">Bradu, A.</style></author><author><style face="normal" font="default" size="100%">Turner, R. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">The Biofilm Research Group, Department of Biological Sciences, University of Calgary, Calgary, Canada&#xD;Exciton Technologies Inc., Edmonton, Canada</style></auth-address><titles><title><style face="normal" font="default" size="100%">Silver oxynitrate–an efficacious compound for the prevention and eradication of dual-species biofilms</style></title><secondary-title><style face="normal" font="default" size="100%">Biofouling</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Biofouling</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Biofouling</style></full-title><abbr-1><style face="normal" font="default" size="100%">Biofouling</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Biofouling</style></full-title><abbr-1><style face="normal" font="default" size="100%">Biofouling</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">460-469</style></pages><volume><style face="normal" font="default" size="100%">33</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">anti-biofilm</style></keyword><keyword><style face="normal" font="default" size="100%">antimicrobial</style></keyword><keyword><style face="normal" font="default" size="100%">biofilm</style></keyword><keyword><style face="normal" font="default" size="100%">multispecies bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Silver</style></keyword><keyword><style face="normal" font="default" size="100%">antimicrobial activity</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">bioassay</style></keyword><keyword><style face="normal" font="default" size="100%">chemical compound</style></keyword><keyword><style face="normal" font="default" size="100%">concentration (composition)</style></keyword><keyword><style face="normal" font="default" size="100%">microbial community</style></keyword><keyword><style face="normal" font="default" size="100%">plankton</style></keyword><keyword><style face="normal" font="default" size="100%">testing method</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria (microorganisms)</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">nitric acid derivative</style></keyword><keyword><style face="normal" font="default" size="100%">silver derivative</style></keyword><keyword><style face="normal" font="default" size="100%">drug effects</style></keyword><keyword><style face="normal" font="default" size="100%">growth, development and aging</style></keyword><keyword><style face="normal" font="default" size="100%">microbial sensitivity test</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Infective Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Biofilms</style></keyword><keyword><style face="normal" font="default" size="100%">Microbial Sensitivity Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Nitrates</style></keyword><keyword><style face="normal" font="default" size="100%">Silver Compounds</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">Taylor and Francis Ltd.</style></publisher><isbn><style face="normal" font="default" size="100%">08927014 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Preventing and eradicating biofilms remains a challenge in clinical and industrial settings. Recently, the present authors demonstrated that silver oxynitrate (Ag7NO11) prevented and eradicated single-species planktonic and biofilm populations of numerous microbes at lower concentrations than other silver (Ag) compounds. Here, the antimicrobial and anti-biofilm efficacy of Ag7NO11 is elaborated by testing its in vitro activity against combinations of dual-species, planktonic and biofilm populations of Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa. As further evidence emerges that multispecies bacterial communities are more common in the environment than their single-species counterparts, this study reinforces the diverse applicability of the minimal biofilm eradication concentration (MBEC™) assay for testing antimicrobial compounds against biofilms. Furthermore, this study demonstrated that Ag7NO11 had enhanced antimicrobial and anti-biofilm activity compared to copper sulfate (CuSO4) and silver nitrate (AgNO3) against the tested bacterial species. © 2017 Informa UK Limited, trading as Taylor &amp; Francis Group.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :11&#xD;Export Date: 26 March 2020&#xD;CODEN: BFOUE&#xD;Correspondence Address: Turner, R.J.; The Biofilm Research Group, Department of Biological Sciences, University of CalgaryCanada; email: turnerr@ucalgary.ca</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019635624&amp;doi=10.1080%2f08927014.2017.1322586&amp;partnerID=40&amp;md5=9a61e56fe95764f32f67778bc89bb92d</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">28521545</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1080/08927014.2017.1322586</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>164</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">164</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lemire, J. A.</style></author><author><style face="normal" font="default" size="100%">Turner, R. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Biofilm Research Group, University of Calgary, Calgary, AB, Canada</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mechanisms Underlying the Antimicrobial Capacity of Metals</style></title><secondary-title><style face="normal" font="default" size="100%">Stress and Environmental Regulation of Gene Expression and Adaptation in Bacteria</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Stress and Environ. Regul. of Gene Expr. and Adapt. in Bact.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">215-224</style></pages><volume><style face="normal" font="default" size="100%">1</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Antimicrobial</style></keyword><keyword><style face="normal" font="default" size="100%">Metal toxicity</style></keyword><keyword><style face="normal" font="default" size="100%">Metals</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2016</style></year></dates><publisher><style face="normal" font="default" size="100%">Wiley Blackwell</style></publisher><isbn><style face="normal" font="default" size="100%">9781119004813 (ISBN); 9781119004882 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">The antimicrobial activity of metals - how metals poison the microbial cell - is based on the metal ions&apos; particular chemistries. As such, metals target specified biological functional groups within the bacterial cell. Moreover, metal toxicity can lead to the expression of select genetic determinants within the microbial cell that alter cellular physiology. For centuries, we&apos;ve known that certain metals, such as silver (Ag) and copper (Cu), have antimicrobial capacities. A modern environmental concern is how anthropogenic metal contaminants might toxify indigenous microbial communities (microbiomes) or affect bioremediation efforts. Furthermore, the emergence of antibiotic-resistant pathogens, combined with a slow pipeline of novel antibiotic therapies, has reinvigorated research into exploring the antimicrobial potential of metal and metal nanoparticles. Currently, the potential for Ag, Cu, and gallium (Ga) to complement the current armamentarium of antimicrobials is being rigorously explored in the lab and clinic. Still, many other metals have antimicrobial activities that require exploration. Here, we will describe what has been established regarding the antimicrobial activity of metals, as well as the current gaps in our knowledge. To that end, this chapter will aim to provide a guide for future research surrounding the antimicrobial capacity of metals. © 2016 John Wiley &amp; Sons, Inc. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :1&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Lemire, J.A.; Biofilm Research Group, University of CalgaryCanada</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85018797758&amp;doi=10.1002%2f9781119004813.ch18&amp;partnerID=40&amp;md5=0a3488174528ff363c9091be465e8f79</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1002/9781119004813.ch18</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>165</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">165</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lewis, T.</style></author><author><style face="normal" font="default" size="100%">Griffith, C.</style></author><author><style face="normal" font="default" size="100%">Gallo, M.</style></author><author><style face="normal" font="default" size="100%">Weinbren, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">University of Wales Institute, Cardiff, United Kingdom&#xD;University Hospitals Coventry, Warwickshire NHS Trust Hospital, Walsgrave, Coventry, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">A modified ATP benchmark for evaluating the cleaning of some hospital environmental surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">156-163</style></pages><volume><style face="normal" font="default" size="100%">69</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">ATP</style></keyword><keyword><style face="normal" font="default" size="100%">Benchmark</style></keyword><keyword><style face="normal" font="default" size="100%">Cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental surfaces</style></keyword><keyword><style face="normal" font="default" size="100%">adenosine triphosphate</style></keyword><keyword><style face="normal" font="default" size="100%">Acinetobacter baumannii</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial count</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium colony</style></keyword><keyword><style face="normal" font="default" size="100%">bioluminescence</style></keyword><keyword><style face="normal" font="default" size="100%">colony forming unit</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">Enterobacteriaceae</style></keyword><keyword><style face="normal" font="default" size="100%">hospital bed capacity</style></keyword><keyword><style face="normal" font="default" size="100%">hospital hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">Klebsiella pneumoniae</style></keyword><keyword><style face="normal" font="default" size="100%">microbiological examination</style></keyword><keyword><style face="normal" font="default" size="100%">national health service</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">teaching hospital</style></keyword><keyword><style face="normal" font="default" size="100%">water vapor</style></keyword><keyword><style face="normal" font="default" size="100%">Colony Count, Microbial</style></keyword><keyword><style face="normal" font="default" size="100%">Great Britain</style></keyword><keyword><style face="normal" font="default" size="100%">Health Services Research</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals, Teaching</style></keyword><keyword><style face="normal" font="default" size="100%">Housekeeping, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infection Control</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year></dates><isbn><style face="normal" font="default" size="100%">01956701 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Hospital cleaning continues to attract patient, media and political attention. In the UK it is still primarily assessed via visual inspection, which can be misleading. Calls have therefore been made for a more objective approach to assessing surface cleanliness. To improve the management of hospital cleaning the use of adenosine triphosphate (ATP) in combination with microbiological analysis has been proposed, with a general ATP benchmark value of 500 relative light units (RLU) for one combination of test and equipment. In this study, the same test combination was used to assess cleaning effectiveness in a 1300-bed teaching hospital after routine and modified cleaning protocols. Based upon the ATP results a revised stricter pass/fail benchmark of 250 RLU is proposed for the range of surfaces used in this study. This was routinely achieved using modified best practice cleaning procedures which also gave reduced surface counts with, for example, aerobic colony counts reduced from &amp;gt;100 to &amp;lt;2.5 cfu/cm2, and counts of Staphylococcus aureus reduced from up to 2.5 to &amp;lt;1 cfu/cm2 (95% of the time). Benchmarking is linked to incremental quality improvements and both the original suggestion of 500 RLU and the revised figure of 250 RLU can be used by hospitals as part of this process. They can also be used in the assessment of novel cleaning methods, such as steam cleaning and microfibre cloths, which have potential use in the National Health Service. © 2008 The Hospital Infection Society.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :124&#xD;Export Date: 26 March 2020&#xD;CODEN: JHIND&#xD;Correspondence Address: Griffith, C.; University of Wales Institute, Cardiff, United Kingdom; email: cgriffith@uwic.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-44149087791&amp;doi=10.1016%2fj.jhin.2008.03.013&amp;partnerID=40&amp;md5=834a396cca7642e1a82f4cbe58a289f4</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">18468725</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.jhin.2008.03.013</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>166</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">166</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Liao, C.</style></author><author><style face="normal" font="default" size="100%">Li, Y.</style></author><author><style face="normal" font="default" size="100%">Tjong, S. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Materials Science and Engineering, Southern University of Science and Technology, Shenzhen, 518055, China&#xD;Department of Materials Science and Engineering, Liaocheng University, Liaocheng, 252000, China&#xD;Department of Physics, City University of Hong Kong, Tat Chee Avenue, Kowloon999077, Hong Kong</style></auth-address><titles><title><style face="normal" font="default" size="100%">Antibacterial activities of aliphatic polyester nanocomposites with silver nanoparticles and/or graphene oxide sheets</style></title><secondary-title><style face="normal" font="default" size="100%">Nanomaterials</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Nanomaterials</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Nanomaterials</style></full-title><abbr-1><style face="normal" font="default" size="100%">Nanomaterials</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Nanomaterials</style></full-title><abbr-1><style face="normal" font="default" size="100%">Nanomaterials</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">9</style></volume><number><style face="normal" font="default" size="100%">8</style></number><keywords><keyword><style face="normal" font="default" size="100%">Aliphatic polyester</style></keyword><keyword><style face="normal" font="default" size="100%">Antibacterial activity</style></keyword><keyword><style face="normal" font="default" size="100%">Cellular viability</style></keyword><keyword><style face="normal" font="default" size="100%">Electrospinning</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">Graphene oxide</style></keyword><keyword><style face="normal" font="default" size="100%">Osteoblast</style></keyword><keyword><style face="normal" font="default" size="100%">Scaffold</style></keyword><keyword><style face="normal" font="default" size="100%">Silver nanoparticle</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><publisher><style face="normal" font="default" size="100%">MDPI AG</style></publisher><isbn><style face="normal" font="default" size="100%">20794991 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Aliphatic polyesters such as poly(lactic acid) (PLA), polycaprolactone (PCL) and poly(lactic-co-glycolic) acid (PLGA) copolymers have been widely used as biomaterials for tissue engineering applications including: bone fixation devices, bone scaffolds, and wound dressings in orthopedics. However, biodegradable aliphatic polyesters are prone to bacterial infections due to the lack of antibacterial moieties in their macromolecular chains. In this respect, silver nanoparticles (AgNPs), graphene oxide (GO) sheets and AgNPs-GO hybrids can be used as reinforcing nanofillers for aliphatic polyesters in forming antimicrobial nanocomposites. However, polymeric matrix materials immobilize nanofillers to a large extent so that they cannot penetrate bacterial membrane into cytoplasm as in the case of colloidal nanoparticles or nanosheets. Accordingly, loaded GO sheets of aliphatic polyester nanocomposites have lost their antibacterial functions such as nanoknife cutting, blanket wrapping and membrane phospholipid extraction. In contrast, AgNPs fillers of polyester nanocomposites can release silver ions for destroying bacterial cells. Thus, AgNPs fillers are more effective than loaded GO sheets of polyester nanocomposiites in inhibiting bacterial infections. Aliphatic polyester nanocomposites with AgNPs and AgNPs-GO fillers are effective to kill multi-drug resistant bacteria that cause medical device-related infections. © 2019 by the authors. Licensee MDPI, Basel, Switzerland.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :3&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Liao, C.; Department of Materials Science and Engineering, Southern University of Science and TechnologyChina; email: liaocz@sustech.edu.cn</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85071165527&amp;doi=10.3390%2fnano9081102&amp;partnerID=40&amp;md5=c7227210354deb2b5836722eeec83748</style></url></related-urls></urls><custom7><style face="normal" font="default" size="100%">1102</style></custom7><electronic-resource-num><style face="normal" font="default" size="100%">10.3390/nano9081102</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>167</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">167</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Liao, C.</style></author><author><style face="normal" font="default" size="100%">Li, Y.</style></author><author><style face="normal" font="default" size="100%">Tjong, S. C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Materials Science and Engineering, Southern University of Science and Technology, Shenzhen, 518055, China&#xD;Department of Materials Science and Engineering, Liaocheng University, Liaocheng, 252000, China&#xD;Department of Physics, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong</style></auth-address><titles><title><style face="normal" font="default" size="100%">Visible-light active titanium dioxide nanomaterials with bactericidal properties</style></title><secondary-title><style face="normal" font="default" size="100%">Nanomaterials</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Nanomaterials</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Nanomaterials</style></full-title><abbr-1><style face="normal" font="default" size="100%">Nanomaterials</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Nanomaterials</style></full-title><abbr-1><style face="normal" font="default" size="100%">Nanomaterials</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">10</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antibacterial activity</style></keyword><keyword><style face="normal" font="default" size="100%">Doping</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">Nanomaterial</style></keyword><keyword><style face="normal" font="default" size="100%">Photocatalyst</style></keyword><keyword><style face="normal" font="default" size="100%">Reactive oxygen species</style></keyword><keyword><style face="normal" font="default" size="100%">Silver nanoparticle</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Titania</style></keyword><keyword><style face="normal" font="default" size="100%">Visible light</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year></dates><publisher><style face="normal" font="default" size="100%">MDPI AG</style></publisher><isbn><style face="normal" font="default" size="100%">20794991 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">This article provides an overview of current research into the development, synthesis, photocatalytic bacterial activity, biocompatibility and cytotoxic properties of various visible-light active titanium dioxide (TiO2) nanoparticles (NPs) and their nanocomposites. To achieve antibacterial inactivation under visible light, TiO2 NPs are doped with metal and non-metal elements, modified with carbonaceous nanomaterials, and coupled with other metal oxide semiconductors. Transition metals introduce a localized d-electron state just below the conduction band of TiO2 NPs, thereby narrowing the bandgap and causing a red shift of the optical absorption edge into the visible region. Silver nanoparticles of doped TiO2 NPs experience surface plasmon resonance under visible light excitation, leading to the injection of hot electrons into the conduction band of TiO2 NPs to generate reactive oxygen species (ROS) for bacterial killing. The modification of TiO2 NPs with carbon nanotubes and graphene sheets also achieve the efficient creation of ROS under visible light irradiation. Furthermore, titanium-based alloy implants in orthopedics with enhanced antibacterial activity and biocompatibility can be achieved by forming a surface layer of Ag-doped titania nanotubes. By incorporating TiO2 NPs and Cu-doped TiO2 NPs into chitosan or the textile matrix, the resulting polymer nanocomposites exhibit excellent antimicrobial properties that can have applications as fruit/food wrapping films, self-cleaning fabrics, medical scaffolds and wound dressings. Considering the possible use of visible-light active TiO2 nanomaterials for various applications, their toxicity impact on the environment and public health is also addressed. © 2020 by the authors. Licensee MDPI, Basel, Switzerland.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Liao, C.; Department of Materials Science and Engineering, Southern University of Science and TechnologyChina; email: liaocz@sustech.edu.cn</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85078252460&amp;doi=10.3390%2fnano10010124&amp;partnerID=40&amp;md5=0d83b676ccce9ef94e16597e36c4b072</style></url></related-urls></urls><custom7><style face="normal" font="default" size="100%">124</style></custom7><electronic-resource-num><style face="normal" font="default" size="100%">10.3390/nano10010124</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>168</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">168</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Lobdell, K. W.</style></author><author><style face="normal" font="default" size="100%">Haden, D. W.</style></author><author><style face="normal" font="default" size="100%">Mistry, K. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Sanger Heart and Vascular Institute, Carolinas HealthCare System, PO Box 32861, Charlotte, NC 28232, United States&#xD;Carolinas HealthCare System, PO Box 32861, Charlotte, NC 28232, United States&#xD;Cardiovascular Critical Care, Boston Children&apos;s Hospital, Boston, MA, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Cardiothoracic Critical Care</style></title><secondary-title><style face="normal" font="default" size="100%">Surgical Clinics of North America</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Surg. Clin. North Am.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Surgical Clinics of North America</style></full-title><abbr-1><style face="normal" font="default" size="100%">Surg. Clin. North Am.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Surgical Clinics of North America</style></full-title><abbr-1><style face="normal" font="default" size="100%">Surg. Clin. North Am.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">811-834</style></pages><volume><style face="normal" font="default" size="100%">97</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Cardiothoracic surgery</style></keyword><keyword><style face="normal" font="default" size="100%">Critical care</style></keyword><keyword><style face="normal" font="default" size="100%">Quality</style></keyword><keyword><style face="normal" font="default" size="100%">Safety</style></keyword><keyword><style face="normal" font="default" size="100%">Value</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">anticoagulant agent</style></keyword><keyword><style face="normal" font="default" size="100%">atypical antipsychotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">chlorhexidine</style></keyword><keyword><style face="normal" font="default" size="100%">chloride</style></keyword><keyword><style face="normal" font="default" size="100%">dexmedetomidine</style></keyword><keyword><style face="normal" font="default" size="100%">hypertensive factor</style></keyword><keyword><style face="normal" font="default" size="100%">inotropic agent</style></keyword><keyword><style face="normal" font="default" size="100%">methylene blue</style></keyword><keyword><style face="normal" font="default" size="100%">noradrenalin</style></keyword><keyword><style face="normal" font="default" size="100%">oxygen</style></keyword><keyword><style face="normal" font="default" size="100%">placebo</style></keyword><keyword><style face="normal" font="default" size="100%">vasopressin</style></keyword><keyword><style face="normal" font="default" size="100%">acute kidney failure</style></keyword><keyword><style face="normal" font="default" size="100%">acute lung injury</style></keyword><keyword><style face="normal" font="default" size="100%">adult respiratory distress syndrome</style></keyword><keyword><style face="normal" font="default" size="100%">anamnesis</style></keyword><keyword><style face="normal" font="default" size="100%">anemia</style></keyword><keyword><style face="normal" font="default" size="100%">aortic dissection</style></keyword><keyword><style face="normal" font="default" size="100%">artificial ventilation</style></keyword><keyword><style face="normal" font="default" size="100%">assisted circulation</style></keyword><keyword><style face="normal" font="default" size="100%">atelectasis</style></keyword><keyword><style face="normal" font="default" size="100%">atrial fibrillation</style></keyword><keyword><style face="normal" font="default" size="100%">bed rest</style></keyword><keyword><style face="normal" font="default" size="100%">blood clot lysis</style></keyword><keyword><style face="normal" font="default" size="100%">blood clotting disorder</style></keyword><keyword><style face="normal" font="default" size="100%">blood transfusion</style></keyword><keyword><style face="normal" font="default" size="100%">bradycardia</style></keyword><keyword><style face="normal" font="default" size="100%">brain hemorrhage</style></keyword><keyword><style face="normal" font="default" size="100%">cardiac output monitor</style></keyword><keyword><style face="normal" font="default" size="100%">cardiothoracic disease</style></keyword><keyword><style face="normal" font="default" size="100%">catheter infection</style></keyword><keyword><style face="normal" font="default" size="100%">cerebrovascular accident</style></keyword><keyword><style face="normal" font="default" size="100%">checklist</style></keyword><keyword><style face="normal" font="default" size="100%">chronic obstructive lung disease</style></keyword><keyword><style face="normal" font="default" size="100%">clinical competence</style></keyword><keyword><style face="normal" font="default" size="100%">communication aid</style></keyword><keyword><style face="normal" font="default" size="100%">congenital heart disease</style></keyword><keyword><style face="normal" font="default" size="100%">convalescence</style></keyword><keyword><style face="normal" font="default" size="100%">coronary artery bypass surgery</style></keyword><keyword><style face="normal" font="default" size="100%">counterpulsation</style></keyword><keyword><style face="normal" font="default" size="100%">delirium</style></keyword><keyword><style face="normal" font="default" size="100%">device therapy</style></keyword><keyword><style face="normal" font="default" size="100%">diaphragm disease</style></keyword><keyword><style face="normal" font="default" size="100%">drug dose increase</style></keyword><keyword><style face="normal" font="default" size="100%">drug megadose</style></keyword><keyword><style face="normal" font="default" size="100%">enteric feeding</style></keyword><keyword><style face="normal" font="default" size="100%">esophagus cancer</style></keyword><keyword><style face="normal" font="default" size="100%">esophagus resection</style></keyword><keyword><style face="normal" font="default" size="100%">extubation</style></keyword><keyword><style face="normal" font="default" size="100%">goal attainment</style></keyword><keyword><style face="normal" font="default" size="100%">goal sheet</style></keyword><keyword><style face="normal" font="default" size="100%">goal-directed therapy</style></keyword><keyword><style face="normal" font="default" size="100%">group dynamics</style></keyword><keyword><style face="normal" font="default" size="100%">hand-off tool</style></keyword><keyword><style face="normal" font="default" size="100%">health care quality</style></keyword><keyword><style face="normal" font="default" size="100%">heart disease</style></keyword><keyword><style face="normal" font="default" size="100%">heart tamponade</style></keyword><keyword><style face="normal" font="default" size="100%">heart ventricle failure</style></keyword><keyword><style face="normal" font="default" size="100%">high-flow nasal oxygen device</style></keyword><keyword><style face="normal" font="default" size="100%">high-performance organization</style></keyword><keyword><style face="normal" font="default" size="100%">high-reliability organization</style></keyword><keyword><style face="normal" font="default" size="100%">high-value cardiothoracic critical care</style></keyword><keyword><style face="normal" font="default" size="100%">hospital cost</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">hospital readmission</style></keyword><keyword><style face="normal" font="default" size="100%">hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">hyperglycemia</style></keyword><keyword><style face="normal" font="default" size="100%">hypotension</style></keyword><keyword><style face="normal" font="default" size="100%">incidence</style></keyword><keyword><style face="normal" font="default" size="100%">infection risk</style></keyword><keyword><style face="normal" font="default" size="100%">institutional learning</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care</style></keyword><keyword><style face="normal" font="default" size="100%">leadership</style></keyword><keyword><style face="normal" font="default" size="100%">learning</style></keyword><keyword><style face="normal" font="default" size="100%">left ventricular assist device</style></keyword><keyword><style face="normal" font="default" size="100%">length of stay</style></keyword><keyword><style face="normal" font="default" size="100%">liver dysfunction</style></keyword><keyword><style face="normal" font="default" size="100%">lung assist device</style></keyword><keyword><style face="normal" font="default" size="100%">lung cancer</style></keyword><keyword><style face="normal" font="default" size="100%">lung disease</style></keyword><keyword><style face="normal" font="default" size="100%">lung edema</style></keyword><keyword><style face="normal" font="default" size="100%">lung lobectomy</style></keyword><keyword><style face="normal" font="default" size="100%">lung resection</style></keyword><keyword><style face="normal" font="default" size="100%">malnutrition</style></keyword><keyword><style face="normal" font="default" size="100%">mediastinitis</style></keyword><keyword><style face="normal" font="default" size="100%">medical procedures</style></keyword><keyword><style face="normal" font="default" size="100%">medical specialist</style></keyword><keyword><style face="normal" font="default" size="100%">mobilization</style></keyword><keyword><style face="normal" font="default" size="100%">neurologic disease</style></keyword><keyword><style face="normal" font="default" size="100%">noninvasive positive pressure ventilation</style></keyword><keyword><style face="normal" font="default" size="100%">occlusive cerebrovascular disease</style></keyword><keyword><style face="normal" font="default" size="100%">oliguria</style></keyword><keyword><style face="normal" font="default" size="100%">organization</style></keyword><keyword><style face="normal" font="default" size="100%">pain</style></keyword><keyword><style face="normal" font="default" size="100%">parenteral nutrition</style></keyword><keyword><style face="normal" font="default" size="100%">patient acuity</style></keyword><keyword><style face="normal" font="default" size="100%">patient safety</style></keyword><keyword><style face="normal" font="default" size="100%">physiotherapy</style></keyword><keyword><style face="normal" font="default" size="100%">positive end expiratory pressure</style></keyword><keyword><style face="normal" font="default" size="100%">postoperative care</style></keyword><keyword><style face="normal" font="default" size="100%">postoperative complication</style></keyword><keyword><style face="normal" font="default" size="100%">postoperative delirium</style></keyword><keyword><style face="normal" font="default" size="100%">postoperative hemorrhage</style></keyword><keyword><style face="normal" font="default" size="100%">prevalence</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">prophylaxis</style></keyword><keyword><style face="normal" font="default" size="100%">pulmonary artery catheter</style></keyword><keyword><style face="normal" font="default" size="100%">reimbursement</style></keyword><keyword><style face="normal" font="default" size="100%">renal replacement therapy</style></keyword><keyword><style face="normal" font="default" size="100%">reoperation</style></keyword><keyword><style face="normal" font="default" size="100%">respiratory failure</style></keyword><keyword><style face="normal" font="default" size="100%">Review</style></keyword><keyword><style face="normal" font="default" size="100%">risk assessment</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">risk management</style></keyword><keyword><style face="normal" font="default" size="100%">risk reduction</style></keyword><keyword><style face="normal" font="default" size="100%">septicemia</style></keyword><keyword><style face="normal" font="default" size="100%">surgical infection</style></keyword><keyword><style face="normal" font="default" size="100%">surgical mortality</style></keyword><keyword><style face="normal" font="default" size="100%">surgical risk</style></keyword><keyword><style face="normal" font="default" size="100%">teamwork</style></keyword><keyword><style face="normal" font="default" size="100%">thorax disease</style></keyword><keyword><style face="normal" font="default" size="100%">transthoracic echocardiography</style></keyword><keyword><style face="normal" font="default" size="100%">urine volume</style></keyword><keyword><style face="normal" font="default" size="100%">vasoplegia</style></keyword><keyword><style face="normal" font="default" size="100%">ventilator associated pneumonia</style></keyword><keyword><style face="normal" font="default" size="100%">x-ray computed tomography</style></keyword><keyword><style face="normal" font="default" size="100%">Heart Diseases</style></keyword><keyword><style face="normal" font="default" size="100%">organization and management</style></keyword><keyword><style face="normal" font="default" size="100%">Thoracic Diseases</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">W.B. Saunders</style></publisher><isbn><style face="normal" font="default" size="100%">00396109 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">High-value CCC is rapidly evolving to meet the demands of increased patient acuity and to incorporate advances in technology. The high-performing CCC system and culture should aim to learn quickly and continuously improve. CCC demands a proactive, interactive, precise, an expert team, and continuity. © 2017 Elsevier Inc.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :2&#xD;Export Date: 26 March 2020&#xD;CODEN: SCNAA&#xD;Correspondence Address: Lobdell, K.W.; Sanger Heart and Vascular Institute, Carolinas HealthCare System, PO Box 32861, United States; email: kevin.lobdell@carolinas.org</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85029561651&amp;doi=10.1016%2fj.suc.2017.03.001&amp;partnerID=40&amp;md5=999936625107e1547f83f60138050a38</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">28728718</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.suc.2017.03.001</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>169</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">169</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Luo, J.</style></author><author><style face="normal" font="default" size="100%">Hein, C.</style></author><author><style face="normal" font="default" size="100%">Pierson, J. F.</style></author><author><style face="normal" font="default" size="100%">Mücklich, F.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Functional Materials, Saarland University, Saarbruecken, 66123, Germany&#xD;Université de Lorraine, CNRS, IJL, Nancy, F-54000, France&#xD;Inorganic Solid State Chemistry, Saarland University, Saarbruecken, 66123, Germany</style></auth-address><titles><title><style face="normal" font="default" size="100%">Early-stage corrosion, ion release, and the antibacterial effect of copper and cuprous oxide in physiological buffers: Phosphate-buffered saline vs Na-4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</style></title><secondary-title><style face="normal" font="default" size="100%">Biointerphases</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Biointerphases</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Biointerphases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Biointerphases</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Biointerphases</style></full-title><abbr-1><style face="normal" font="default" size="100%">Biointerphases</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">6</style></number><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><publisher><style face="normal" font="default" size="100%">American Institute of Physics Inc.</style></publisher><isbn><style face="normal" font="default" size="100%">19348630 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Copper surfaces are well known for their antibacterial effects due to the release of copper ions. This benefit has been shown in many antibacterial efficiency tests, however, without considering the corrosion behaviors of copper in the physiological solutions, which could play an indispensable role in ion release from the metallic surface. This study compared the ground copper surface and sputtered cuprous oxide (Cu2O) coating in two common physiological buffers: phosphate-buffered saline (PBS) and Na-4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Na-HEPES). The growth of the cuprous oxide (Cu2O) layer was found on copper in pure PBS, inhibiting further copper ion release. In contrast, a continuous release of copper ions was recorded in Na-HEPES for 3 h, where no oxide formation was observed. The antibacterial efficiency of copper (against E. coli) was measured and discussed with the ion release kinetics in the presence of E. coli. Similar results were obtained from Cu2O coating, ruling out its assisting role in showing the antibacterial property from copper surfaces, but they did indicate the importance of taking environmental parameters into consideration in interpreting the antibacterial efficiency of copper surfaces. © 2019 Author(s).</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85076394602&amp;doi=10.1063%2f1.5123039&amp;partnerID=40&amp;md5=9beb34a13fe93950b52aeef8af22ce2a</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">31830792</style></custom2><custom7><style face="normal" font="default" size="100%">061004</style></custom7><electronic-resource-num><style face="normal" font="default" size="100%">10.1063/1.5123039</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>170</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">170</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Malik, R. E.</style></author><author><style face="normal" font="default" size="100%">Cooper, R. A.</style></author><author><style face="normal" font="default" size="100%">Griffith, C. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">School of Applied Sciences, University of Wales Institute, Llandaff Campus, Cardiff, United Kingdom&#xD;School of Applied Sciences, University of Wales Institute, Llandaff Campus, Western Avenue, Cardiff CF5 2YB, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Use of audit tools to evaluate the efficacy of cleaning systems in hospitals</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></full-title><abbr-1><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></full-title><abbr-1><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">181-187</style></pages><volume><style face="normal" font="default" size="100%">31</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">adenosine triphosphate</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bioluminescence</style></keyword><keyword><style face="normal" font="default" size="100%">cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">cost effectiveness analysis</style></keyword><keyword><style face="normal" font="default" size="100%">hospital hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">national health service</style></keyword><keyword><style face="normal" font="default" size="100%">United Kingdom</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2003</style></year></dates><publisher><style face="normal" font="default" size="100%">Mosby Inc.</style></publisher><isbn><style face="normal" font="default" size="100%">01966553 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Recent publicity has highlighted both the inadequacies of hospital cleaning and high levels of methicillin-resistant Staphylococcus aureus infections in UK hospitals. &quot;Standards for Environmental Cleanliness&quot; (SEC) was a checklist developed in April 1999 by the Infection Control Nurses Association and the Association of Domestic Managers to evaluate cleaning services regardless of who is the provider. More recently, the National Health Service plan (July 2000) was an attempt to generate a rapid improvement in the cleanliness and tidiness of hospitals via a National Health Service patient environment audit (PEA). On the basis of models used in the food industry to manage cleaning practices cost-effectively, a risk-based audit checklist incorporating rapid hygiene monitoring was developed to assess the adequacy of cleaning programs and standards in hospitals. This checklist (Audit for Cleaning Efficacy, or ACE) as well as the SEC and PEA approaches were applied at 4 hospitals, and environmental microbial surface counts were compared. SEC and PEA rely on visual assessment, whereas the ACE approach is more comprehensive and included more specific questions relating to the management and monitoring of cleaning as well as standards on the basis of rapid hygiene monitoring. Methods: Two wards in each of the 4 hospitals were visited on 3 separate occasions immediately after cleaning was completed. visual assessment, adenosine triphosphate bioluminescence, and microbiologic sampling of selected environmental sites were performed to evaluate the effectiveness of cleaning. The 3 audits were completed during the final hospital visit. Results: visual assessment indicated that 90% of sites were satisfactory, whereas adenosine triphosphate bioluminescence showed that 100% and microbiologic sampling showed that 90% of sites did not meet benchmark values. There was no significant difference between the SEC and PEA audits (P = .311), which used visual assessment, and the results suggest that they both are similar in passing surfaces that have microbiologic benchmark values that are too high. However, the ACE audit showed a significant difference (P = &lt; .001) in results compared with the SEC and the PEA audits and did not pass surfaces with microbiologic benchmark values that were too high. The ACE audit, which incorporates rapid hygiene testing, showed a much stronger association with the microbial counts; this was not apparent with the SEC and the PEA audits. Conclusion: The data suggest that visual assessment is a poor indicator of cleaning efficacy and that the ACE audit gives a better assessment of cleaning programs compared with the other 2 audit methods in relation to microbial surface counts. It is recommended that hospital cleaning regimes be designed to ensure that surfaces are cleaned adequately and that efficacy is assessed with use of internal auditing and rapid hygiene testing.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :114&#xD;Export Date: 26 March 2020&#xD;CODEN: AJICD&#xD;Correspondence Address: Cooper, R.A.; School of Applied Sciences, University of Wales Institute, Llandaff Campus, Western Avenue, Cardiff CF5 2YB, United Kingdom</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0038053206&amp;doi=10.1067%2fmic.2003.34&amp;partnerID=40&amp;md5=83d64cbdeaffe0872291280032b72d86</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">12734526</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1067/mic.2003.34</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>171</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">171</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Malnick, S.</style></author><author><style face="normal" font="default" size="100%">Bardenstein, R.</style></author><author><style face="normal" font="default" size="100%">Huszar, M.</style></author><author><style face="normal" font="default" size="100%">Gabbay, J.</style></author><author><style face="normal" font="default" size="100%">Borkow, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Internal Medicine C, Kaplan Medical Center, Rehovot, Israel&#xD;Microbiology Laboratory, Kaplan Medical Centre, Rehovot, Israel&#xD;Department of Pathology, Kaplan Medical Centre, Rehovot, Israel&#xD;Cupron Inc., Greensboro, NC, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Pyjamas and sheets as a potential source of nosocomial pathogens</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">89-92</style></pages><volume><style face="normal" font="default" size="100%">70</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">antibiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">meticillin</style></keyword><keyword><style face="normal" font="default" size="100%">oxacillin</style></keyword><keyword><style face="normal" font="default" size="100%">penicillin G</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic sensitivity</style></keyword><keyword><style face="normal" font="default" size="100%">Bacillus</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial transmission</style></keyword><keyword><style face="normal" font="default" size="100%">clinical article</style></keyword><keyword><style face="normal" font="default" size="100%">clothing</style></keyword><keyword><style face="normal" font="default" size="100%">coagulase negative Staphylococcus</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">Corynebacterium</style></keyword><keyword><style face="normal" font="default" size="100%">disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus faecalis</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">glove</style></keyword><keyword><style face="normal" font="default" size="100%">hand washing</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">hospital bed</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">infection sensitivity</style></keyword><keyword><style face="normal" font="default" size="100%">letter</style></keyword><keyword><style face="normal" font="default" size="100%">medical instrumentation</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">microbial contamination</style></keyword><keyword><style face="normal" font="default" size="100%">microbiological examination</style></keyword><keyword><style face="normal" font="default" size="100%">microflora</style></keyword><keyword><style face="normal" font="default" size="100%">patient care</style></keyword><keyword><style face="normal" font="default" size="100%">Proteus mirabilis</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">textile</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Bedding and Linens</style></keyword><keyword><style face="normal" font="default" size="100%">Colony Count, Microbial</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year></dates><isbn><style face="normal" font="default" size="100%">01956701 (ISSN)</style></isbn><notes><style face="normal" font="default" size="100%">Cited By :27&#xD;Export Date: 26 March 2020&#xD;CODEN: JHIND&#xD;Correspondence Address: Borkow, G.; Cupron Inc., Greensboro, NC, United States; email: gadi@cupron.com</style></notes><work-type><style face="normal" font="default" size="100%">Letter</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-48749085430&amp;doi=10.1016%2fj.jhin.2008.05.021&amp;partnerID=40&amp;md5=6356872d4b1828a22847293faf29480a</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">18621446</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.jhin.2008.05.021</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>172</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">172</key></foreign-keys><ref-type name="Book">6</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Marik, P. E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Pulmonary and Critical Care Medicine, Eastern Virginia Medical School, Norfolk, VA, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evidence-based critical care, third edition</style></title><secondary-title><style face="normal" font="default" size="100%">Evidence-Based Critical Care, Third Edition</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Evidence-Based Critical Care, Third Edition</style></alt-title></titles><pages><style face="normal" font="default" size="100%">1-835</style></pages><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319110202 (ISBN); 9783319110196 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">This is the premier evidence-based textbook in critical care medicine. The Third Edition features updated and revised chapters, numerous new references, streamlined content, and new chapters on key topics such as the new paradigm in critical care medicine, cardiac output monitoring, surgical optimization, vital signs, and arterial blood gas analysis. The book maintains the author&apos;s trademark humor and engaging writing style and is suitable for a broad and diverse audience of medical students, residents, fellows, physicians, nurses, and respiratory therapists who seek the latest and best evidence in critical care. From reviews of previous editions: &quot;This is an excellent introduction to the concept of evidence-based medicine.The writing is clear, logical, and highly organized, which makes for fast and enjoyable reading. I believe this book will get daily use in most intensive care units, by a wide range of readers.&quot; -Respiratory Care &quot;This is one of the most comprehensive handbooks on critical care medicine with a strong emphasis on evidence base. Overall, this book should be useful for junior doctors or intensive care trainees who are starting their term in an intensive care unit.&quot; -Anaesthesia and Intensive Care. © Springer International Publishing Switzerland 2015.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Marik, P.E.; Division of Pulmonary and Critical Care Medicine, Eastern Virginia Medical SchoolUnited States</style></notes><work-type><style face="normal" font="default" size="100%">Book</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84955139444&amp;doi=10.1007%2f978-3-319-11020-2&amp;partnerID=40&amp;md5=6e49c57bb17066b570e31a90b74bb629</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-11020-2</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>173</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">173</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">McFarland, L. V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Medicinal Chemistry, University of Washington, Puget Sound VA HCS, Seattle, WA, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Primary prevention of Clostridium difficile infections–how difficult can it be?</style></title><secondary-title><style face="normal" font="default" size="100%">Expert Review of Gastroenterology and Hepatology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Expert Rev. Gastroenterol. Hepatol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Expert Review of Gastroenterology and Hepatology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Expert Rev. Gastroenterol. Hepatol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Expert Review of Gastroenterology and Hepatology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Expert Rev. Gastroenterol. Hepatol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">507-521</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">antibiotic stewardship</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotics</style></keyword><keyword><style face="normal" font="default" size="100%">clostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">healthcare costs</style></keyword><keyword><style face="normal" font="default" size="100%">Infection control</style></keyword><keyword><style face="normal" font="default" size="100%">nosocomial</style></keyword><keyword><style face="normal" font="default" size="100%">primary prevention</style></keyword><keyword><style face="normal" font="default" size="100%">probiotics</style></keyword><keyword><style face="normal" font="default" size="100%">vaccines</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">bezlotoxumab</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile toxin A</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile toxin B</style></keyword><keyword><style face="normal" font="default" size="100%">fidaxomicin</style></keyword><keyword><style face="normal" font="default" size="100%">metronidazole</style></keyword><keyword><style face="normal" font="default" size="100%">probiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">proton pump inhibitor</style></keyword><keyword><style face="normal" font="default" size="100%">vancomycin</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial vaccine</style></keyword><keyword><style face="normal" font="default" size="100%">Article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial transmission</style></keyword><keyword><style face="normal" font="default" size="100%">clinical effectiveness</style></keyword><keyword><style face="normal" font="default" size="100%">clinical outcome</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile infection</style></keyword><keyword><style face="normal" font="default" size="100%">disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">evidence based medicine</style></keyword><keyword><style face="normal" font="default" size="100%">expert system</style></keyword><keyword><style face="normal" font="default" size="100%">hand washing</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">health program</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">immunization</style></keyword><keyword><style face="normal" font="default" size="100%">infection prevention</style></keyword><keyword><style face="normal" font="default" size="100%">infection sensitivity</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">Peptoclostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">program sustainability</style></keyword><keyword><style face="normal" font="default" size="100%">protective equipment</style></keyword><keyword><style face="normal" font="default" size="100%">recurrent infection</style></keyword><keyword><style face="normal" font="default" size="100%">antimicrobial stewardship</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium infection</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">odds ratio</style></keyword><keyword><style face="normal" font="default" size="100%">pathogenicity</style></keyword><keyword><style face="normal" font="default" size="100%">procedures</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">transmission</style></keyword><keyword><style face="normal" font="default" size="100%">treatment outcome</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Vaccines</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">Taylor and Francis Ltd</style></publisher><isbn><style face="normal" font="default" size="100%">17474124 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Introduction: C. difficile infections (CDI) have been a challenging disease to treat, much less to prevent, for decades. Efforts for primary prevention have mainly focused on improving infection control practices, but CDI outbreaks continue to plague healthcare facilities. Areas covered: A literature search from 1970-December 2016 found 13 facility-level and 2 patient-level strategies that were evidence-based. The aim of this manuscript is to assess the current state of the literature on primary prevention of CDI and offer insights into which strategies may be more effective. Expert commentary: The strongest evidence for primary prevention is based on multi-faceted infection control bundles, while there is promising moderate evidence involving facility-wide use of specific probiotics. Moderate-level evidence was found for patient-level use of specific probiotics and low level evidence for vaccines. Future suggestions include use of consistent outcome metrics, measurements of implementation compliance and program sustainability. © 2017 Informa UK Limited, trading as Taylor &amp; Francis Group.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :5&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: McFarland, L.V.; Puget Sound VA HCS, S-152, 1660 South Columbian Way, United States; email: lvmcfarl@u.washington.edu</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85017100120&amp;doi=10.1080%2f17474124.2017.1312343&amp;partnerID=40&amp;md5=fe2bc2181a13687470113d7708c7e16c</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">28347160</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1080/17474124.2017.1312343</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>174</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">174</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">McQueen, R. H.</style></author><author><style face="normal" font="default" size="100%">Ehnes, B.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Human Ecology, University of Alberta, 116th Street and 89th Avenue, Edmonton, AB T6G 2N1, Canada</style></auth-address><titles><title><style face="normal" font="default" size="100%">Antimicrobial textiles and infection prevention: Clothing and the inanimate environment</style></title><secondary-title><style face="normal" font="default" size="100%">Infection Prevention: New Perspectives and Controversies</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Infect. Prev.: New Perspect. and Controversies</style></alt-title></titles><pages><style face="normal" font="default" size="100%">117-126</style></pages><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319609805 (ISBN); 9783319609782 (ISBN)</style></isbn><notes><style face="normal" font="default" size="100%">Cited By :4&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: McQueen, R.H.; Department of Human Ecology, University of Alberta, 116th Street and 89th Avenue, Canada; email: rachel.mcqueen@ualberta.ca</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85034765767&amp;doi=10.1007%2f978-3-319-60980-5_13&amp;partnerID=40&amp;md5=c3a967ef248fb25e3688c9424e878173</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-60980-5_13</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>175</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">175</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Michels, H. T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Technical and Information Services, Copper Development Association, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Anti-microbial characteristics of copper</style></title><secondary-title><style face="normal" font="default" size="100%">Standardization News</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Stand News</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Standardization News</style></full-title><abbr-1><style face="normal" font="default" size="100%">Stand News</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Standardization News</style></full-title><abbr-1><style face="normal" font="default" size="100%">Stand News</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">34</style></volume><number><style face="normal" font="default" size="100%">10</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antibiotic resistant bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Antimicrobial property</style></keyword><keyword><style face="normal" font="default" size="100%">Disease causing bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Public facilities</style></keyword><keyword><style face="normal" font="default" size="100%">Antibiotics</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Disease control</style></keyword><keyword><style face="normal" font="default" size="100%">Food processing</style></keyword><keyword><style face="normal" font="default" size="100%">Health care</style></keyword><keyword><style face="normal" font="default" size="100%">Viruses</style></keyword><keyword><style face="normal" font="default" size="100%">Copper alloys</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2006</style></year></dates><isbn><style face="normal" font="default" size="100%">10944656 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">The antimicrobial property of copper has been the focus of study to determine their effectiveness in controlling infectious diseases in healthcare and public facilities, the food processing industry, heating, ventilation, and air condition applications. A study sponsored by the Copper Development Association Inc. and the International Copper Association, Ltd., have shown that uncoated copper and copper alloys can inactivate common disease-causing bacteria. Copper alloy surface has even proven effective against antibiotic-resistant bacteria associated with hospital-acquired infections, such as methicillin-resistant Staphylococcus aureus (MRSA). Another study at the University of Southampton showed that Infleunza A viruses are virtually eradicated within six hours on copper surfaces. The antimicrobial property of copper is also a potential solution to help prevent cross-contamination and subsequent human infections emanating from food-processing industry.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :11&#xD;Export Date: 26 March 2020&#xD;CODEN: STDNA&#xD;Correspondence Address: Michels, H.T.; Technical and Information Services, Copper Development AssociationUnited States</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750693957&amp;partnerID=40&amp;md5=aae89c9f67a0374a2d6f2dd6cb12b36f</style></url></related-urls></urls><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>176</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">176</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mitra, D.</style></author><author><style face="normal" font="default" size="100%">Kang, E. T.</style></author><author><style face="normal" font="default" size="100%">Neoh, K. G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Chemical and Biomolecular Engineering, National University of Singapore, Kent Ridge, Singapore, 117576, Singapore</style></auth-address><titles><title><style face="normal" font="default" size="100%">Antimicrobial Copper-Based Materials and Coatings: Potential Multifaceted Biomedical Applications</style></title><secondary-title><style face="normal" font="default" size="100%">ACS Applied Materials and Interfaces</style></secondary-title><alt-title><style face="normal" font="default" size="100%">ACS Appl. Mater. Interfaces</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">ACS Applied Materials and Interfaces</style></full-title><abbr-1><style face="normal" font="default" size="100%">ACS Appl. Mater. Interfaces</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">ACS Applied Materials and Interfaces</style></full-title><abbr-1><style face="normal" font="default" size="100%">ACS Appl. Mater. Interfaces</style></abbr-1></alt-periodical><keywords><keyword><style face="normal" font="default" size="100%">antimicrobial coatings</style></keyword><keyword><style face="normal" font="default" size="100%">antimicrobial mechanisms</style></keyword><keyword><style face="normal" font="default" size="100%">contact killing</style></keyword><keyword><style face="normal" font="default" size="100%">copper</style></keyword><keyword><style face="normal" font="default" size="100%">hospital-acquired infection</style></keyword><keyword><style face="normal" font="default" size="100%">Antibiotics</style></keyword><keyword><style face="normal" font="default" size="100%">Coatings</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals</style></keyword><keyword><style face="normal" font="default" size="100%">Medical applications</style></keyword><keyword><style face="normal" font="default" size="100%">Microorganisms</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-microbial properties</style></keyword><keyword><style face="normal" font="default" size="100%">Antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Antimicrobial materials</style></keyword><keyword><style face="normal" font="default" size="100%">Biomedical applications</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital acquired infection</style></keyword><keyword><style face="normal" font="default" size="100%">Surface contaminations</style></keyword><keyword><style face="normal" font="default" size="100%">Copper alloys</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2020</style></year></dates><publisher><style face="normal" font="default" size="100%">American Chemical Society</style></publisher><isbn><style face="normal" font="default" size="100%">19448244 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Surface contamination by microbes leads to several detrimental consequences like hospital- and device-associated infections. One measure to inhibit surface contamination is to confer the surfaces with antimicrobial properties. Copper&apos;s antimicrobial properties have been known since ancient times, and the recent resurgence in exploiting copper for application as antimicrobial materials or coatings is motivated by the growing concern about antibiotic resistance and the pressure to reduce antibiotic use. Copper, unlike silver, demonstrates rapid and high microbicidal efficacy against pathogens that are in close contact under ambient indoor conditions, which enhances its range of applicability. This review highlights the mechanisms behind copper&apos;s potent antimicrobial property, the design and fabrication of different copper-based antimicrobial materials and coatings comprising metallic copper/copper alloys, copper nanoparticles or ions, and their potential for practical applications. Finally, as the antimicrobial coatings market is expected to grow, we offer our perspectives on the implications of increased copper release into the environment and the potential ecotoxicity effects and possibility of development of resistant genes in pathogens. © 2019 American Chemical Society.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Neoh, K.G.; Department of Chemical and Biomolecular Engineering, National University of Singapore, Kent Ridge, Singapore; email: chenkg@nus.edu.sg</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85077659211&amp;doi=10.1021%2facsami.9b17815&amp;partnerID=40&amp;md5=80816ed2adabc11ea636f7095dbcb95b</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1021/acsami.9b17815</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>177</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">177</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Montero, D. A.</style></author><author><style face="normal" font="default" size="100%">Arellano, C.</style></author><author><style face="normal" font="default" size="100%">Pardo, M.</style></author><author><style face="normal" font="default" size="100%">Vera, R.</style></author><author><style face="normal" font="default" size="100%">Gálvez, R.</style></author><author><style face="normal" font="default" size="100%">Cifuentes, M.</style></author><author><style face="normal" font="default" size="100%">Berasain, M. A.</style></author><author><style face="normal" font="default" size="100%">Gómez, M.</style></author><author><style face="normal" font="default" size="100%">Ramírez, C.</style></author><author><style face="normal" font="default" size="100%">Vidal, R. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Programa de Microbiologiá y Micologiá, Instituto de Ciencias Biomédicas, Facultad de Medicina, Santiago, Chile&#xD;Instituto de Química, Facultad de Ciencias, Pontificia Universidad Católica de Valparaíso, Valparaíso, Chile&#xD;Unidad de Cuidados Intensivos, Facultad de Medicina, Hospital Clínico, Santiago, Chile&#xD;ATACAMALAB, Lampa, Chile&#xD;Instituto Milenio de Inmunologiá e Inmunoterapia, Facultad de Medicina, Universidad de Chile, Santiago, Chile</style></auth-address><titles><title><style face="normal" font="default" size="100%">Antimicrobial properties of a novel copper-based composite coating with potential for use in healthcare facilities 06 Biological Sciences 0605 Microbiology 11 Medical and Health Sciences 1117 Public Health and Health Services</style></title><secondary-title><style face="normal" font="default" size="100%">Antimicrobial Resistance and Infection Control</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Antimicrob. Resist. Infect. Control</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Antimicrobial Resistance and Infection Control</style></full-title><abbr-1><style face="normal" font="default" size="100%">Antimicrob. Resist. Infect. Control</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Antimicrobial Resistance and Infection Control</style></full-title><abbr-1><style face="normal" font="default" size="100%">Antimicrob. Resist. Infect. Control</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antimicrobial copper</style></keyword><keyword><style face="normal" font="default" size="100%">Copper-based composite</style></keyword><keyword><style face="normal" font="default" size="100%">Healthcare-associated infections</style></keyword><keyword><style face="normal" font="default" size="100%">High-touch surfaces</style></keyword><keyword><style face="normal" font="default" size="100%">Self-sanitizing coating</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">copper</style></keyword><keyword><style face="normal" font="default" size="100%">disinfectant agent</style></keyword><keyword><style face="normal" font="default" size="100%">antimicrobial activity</style></keyword><keyword><style face="normal" font="default" size="100%">Article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial virulence</style></keyword><keyword><style face="normal" font="default" size="100%">bactericidal activity</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">drug coating</style></keyword><keyword><style face="normal" font="default" size="100%">drug screening</style></keyword><keyword><style face="normal" font="default" size="100%">environmental sanitation</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli O157</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">in vitro study</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care unit</style></keyword><keyword><style face="normal" font="default" size="100%">Listeria monocytogenes</style></keyword><keyword><style face="normal" font="default" size="100%">microbial contamination</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">pathogen load</style></keyword><keyword><style face="normal" font="default" size="100%">pilot study</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">chemistry</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">drug effect</style></keyword><keyword><style face="normal" font="default" size="100%">growth, development and aging</style></keyword><keyword><style face="normal" font="default" size="100%">hospital equipment</style></keyword><keyword><style face="normal" font="default" size="100%">medical device contamination</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Disinfectants</style></keyword><keyword><style face="normal" font="default" size="100%">Equipment and Supplies, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Equipment Contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Pilot Projects</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><publisher><style face="normal" font="default" size="100%">BioMed Central Ltd.</style></publisher><isbn><style face="normal" font="default" size="100%">20472994 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Healthcare-associated infections (HAIs) have a major impact on public health worldwide. Particularly, hospital surfaces contaminated with bacterial pathogens are often the origin of both sporadic cases and outbreaks of HAIs. It has been demonstrated that copper surfaces reduce the microbial burden of high touch surfaces in the hospital environment. Here we report the antimicrobial characterization of a novel composite coating with embedded copper particles, named Copper Armour™. Methods: The Copper Armour™ bactericidal activity was evaluated in in vitro assays against several bacterial pathogens, including Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli O157:H7 and Listeria monocytogenes. Additionally, its antimicrobial properties were also evaluated in a pilot study over a nine-week period at an adult intensive care unit. For this, four high touch surfaces, including bed rails, overbed table, bedside table and IV Pole, were coated with Cooper Armour™, and its microbial burden was determined over a nine-week period. Results: Copper Armour™ coated samples showed an in vitro reduction in bacterial burden of &gt; 99.9% compared to control samples. Moreover, pilot study results indicate that Copper Armour™ significantly reduces the level of microbial contamination on high-touch surfaces in the hospital environment, as compared with standard surfaces. Conclusions: Based on its antimicrobial properties, Copper Armour™ is a novel self-sanitizing coating that exhibits bactericidal activity against important human pathogens and significantly reduces the microbial burden of hospital surfaces. This composite could be used as a self-sanitizing coating to complement infection control strategies in healthcare facilities. © 2019 The Author(s).</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :3&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Vidal, R.M.; Programa de Microbiologiá y Micologiá, Instituto de Ciencias Biomédicas, Facultad de MedicinaChile; email: rvidal@uchile.cl</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059589203&amp;doi=10.1186%2fs13756-018-0456-4&amp;partnerID=40&amp;md5=01943ded279e4ce1cbd0657319f7e47a</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">30627427</style></custom2><custom7><style face="normal" font="default" size="100%">3</style></custom7><electronic-resource-num><style face="normal" font="default" size="100%">10.1186/s13756-018-0456-4</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>178</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">178</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Morgan, D. J.</style></author><author><style face="normal" font="default" size="100%">Liang, S. Y.</style></author><author><style face="normal" font="default" size="100%">Smith, C. L.</style></author><author><style face="normal" font="default" size="100%">Johnson, J. K.</style></author><author><style face="normal" font="default" size="100%">Harris, A. D.</style></author><author><style face="normal" font="default" size="100%">Furuno, J. P.</style></author><author><style face="normal" font="default" size="100%">Thom, K. A.</style></author><author><style face="normal" font="default" size="100%">Snyder, G. M.</style></author><author><style face="normal" font="default" size="100%">Day, H. R.</style></author><author><style face="normal" font="default" size="100%">Perencevich, E. N.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Departments of Epidemiology and Preventive Medicine, University of Maryland, Baltimore, United States&#xD;Department of Medicine, University of Maryland, Baltimore, United States&#xD;Department of Pathology, University of Maryland, Baltimore, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Frequent multidrug-resistant acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers</style></title><secondary-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">716-721</style></pages><volume><style face="normal" font="default" size="100%">31</style></volume><number><style face="normal" font="default" size="100%">7</style></number><keywords><keyword><style face="normal" font="default" size="100%">Acinetobacter baumannii</style></keyword><keyword><style face="normal" font="default" size="100%">airway</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial colonization</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial transmission</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium contamination</style></keyword><keyword><style face="normal" font="default" size="100%">cohort analysis</style></keyword><keyword><style face="normal" font="default" size="100%">hand</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">incidence</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">multidrug resistance</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">nurse practitioner</style></keyword><keyword><style face="normal" font="default" size="100%">patient care</style></keyword><keyword><style face="normal" font="default" size="100%">physician</style></keyword><keyword><style face="normal" font="default" size="100%">prospective study</style></keyword><keyword><style face="normal" font="default" size="100%">protective clothing</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">wound dressing</style></keyword><keyword><style face="normal" font="default" size="100%">Acinetobacter infection</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">drug effects</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care unit</style></keyword><keyword><style face="normal" font="default" size="100%">isolation and purification</style></keyword><keyword><style face="normal" font="default" size="100%">medical device contamination</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">transmission</style></keyword><keyword><style face="normal" font="default" size="100%">United States</style></keyword><keyword><style face="normal" font="default" size="100%">Acinetobacter Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Resistance, Multiple, Bacterial</style></keyword><keyword><style face="normal" font="default" size="100%">Equipment Contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Gloves, Protective</style></keyword><keyword><style face="normal" font="default" size="100%">Health Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infectious Disease Transmission, Patient-to-Professional</style></keyword><keyword><style face="normal" font="default" size="100%">Intensive Care Units</style></keyword><keyword><style face="normal" font="default" size="100%">Maryland</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year></dates><isbn><style face="normal" font="default" size="100%">0899823X (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">BACKGROUND. Multidrug-resistant (MDR) gram-negative bacilli are important nosocomial pathogens. OBJECTIVE. To determine the incidence of transmission of MDR Acinetobacter baumannii and Pseudomonas aeruginosa from patients to healthcare workers (HCWs) during routine patient care. DESIGN. Prospective cohort study. SETTING. Medical and surgical intensive care units. METHODS. We observed HCWs who entered the rooms of patients colonized with MDR A. baumannii or colonized with both MDR A. baumannii and MDR P. aeruginosa. We examined their hands before room entry, their disposable gloves and/or gowns upon completion of patient care, and their hands after removal of gloves and/or gowns and before hand hygiene. RESULTS. Sixty-five interactions occurred with patients colonized with MDR A. baumannii and 134 with patients colonized with both MDR A. baumannii and MDR P. aeruginosa. Of 199 interactions between HCWs and patients colonized with MDR A. baumannii, 77 (38.7% [95% confidence interval {CI}, 31.9%-45.5%]) resulted in HCW contamination of gloves and/or gowns, and 9 (4.5% [95% CI, 1.6%-7.4%]) resulted in contamination of HCW hands after glove removal before hand hygiene. Of 134 interactions with patients colonized with MDR P. aeruginosa, 11 (8.2% [95% CI, 3.6%-12.9%]) resulted in HCW contamination of gloves and/or gowns, and 1 resulted in HCW contamination of hands. Independent risk factors for contamination with MDR A. baumannii were manipulation of wound dressing (adjusted odds ratio [aOR], 25.9 [95% CI, 3.1-208.8]), manipulation of artificial airway (aOR, 2.1 [95% CI, 1.1-4.0]), time in room longer than 5 minutes (aOR, 4.3 [95% CI, 2.0-9.1]), being a physician or nurse practitioner (aOR, 7.4 [95% CI, 1.6-35.2]), and being a nurse (aOR, 2.3 [95% CI, 1.1-4.8]). CONCLUSIONS. Gowns, gloves, and unwashed hands of HCWs were frequently contaminated with MDR A. baumannii. MDRA. baumannii appears to be more easily transmitted than MDR P. aeruginosa and perhaps more easily transmitted than previously studied methicillinresistant Staphylococcus aureus or vancomycin-resistant Enterococcus. This ease of transmission may help explain the emergence of MDR A. baumannii. © 2010 by The Society for Healthcare Epidemiology of America.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :122&#xD;Export Date: 26 March 2020&#xD;CODEN: ICEPE&#xD;Correspondence Address: Morgan, D. J.; Departments of Epidemiology and Preventive Medicine, University of Maryland, Baltimore, United States</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-77953856073&amp;doi=10.1086%2f653201&amp;partnerID=40&amp;md5=3acf3db24e4f3d56b18ae96620ee692f</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">20486855</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1086/653201</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>179</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">179</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mudiar, R.</style></author><author><style face="normal" font="default" size="100%">Kelkar-Mane, V.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Biotechnology, University of Mumbai, Santacruz (E), Mumbai, 400098, India</style></auth-address><titles><title><style face="normal" font="default" size="100%">Targeting fungal menace through copper nanoparticles and Tamrajal</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Ayurveda and Integrative Medicine</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Ayurveda Integr. Med.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Ayurveda and Integrative Medicine</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Ayurveda Integr. Med.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Ayurveda and Integrative Medicine</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Ayurveda Integr. Med.</style></abbr-1></alt-periodical><keywords><keyword><style face="normal" font="default" size="100%">Biofilm</style></keyword><keyword><style face="normal" font="default" size="100%">Candida species</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Germ tube</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><publisher><style face="normal" font="default" size="100%">Elsevier B.V.</style></publisher><isbn><style face="normal" font="default" size="100%">09759476 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background: WHO reports, an escalation of antibiotic resistance in opportunistic pathogens like Candida. Tamrajal, i.e., water stored in copper vessels has been proclaimed as health elixir by ancient Ayurveda. Vis-a-Vis the use of copper contact surfaces and nanoparticles has gained significance for their antimicrobial effects. It thus seems imperative to examine copper nanoparticles and tamrajal as promising alternatives to existing antifungals. Objective: This study not only assessed the influence of Tamrajal and copper nanoparticles on the morphological alterations of the Candida and its biofilm forming ability, but also on their ability to destroy preformed biofilms. Materials and methods: Copper oxide nanoparticles as well as Tamrajal were evaluated as complementary as well as stand-alone antimicrobial agents. ‘Time kill assay’ and ‘germ tube inhibition test’ were performed as end-point analysis for pathogenesis, while biofilm quantification, performed to assess the colonizing capability of Candida. Scanning Electron Microscope was used for visualizing the cells, whilst ICP-AES to determine the copper concentration. Results: 92–100% cytotoxicity to the fluconazole resistant Candida species was observed with copper oxide nanoparticles as well as tamrajal during 24hr time kill assay. The study also confirmed complete germ tube inhibition by copper in both its forms in addition to the reduction in the biofilm production. Conclusion: Compared to the classes of antifungals like azoles, echinocandins etc, copper based anti-candidal agents highlight a potential way to combat resistant candidiasis. The possibility of accumulation of NP resulting in cytotoxicity puts tamrajal as the choice due to its efficacy as well as non-toxicity as per the EPA. © 2018 Transdisciplinary University, Bangalore and World Ayurveda Foundation</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :1&#xD;Export Date: 26 March 2020&#xD;Article in Press&#xD;Correspondence Address: Kelkar-Mane, V.; Department of Biotechnology, University of Mumbai, Santacruz (E), India; email: drvkelkar@mu.ac.in</style></notes><work-type><style face="normal" font="default" size="100%">Article in Press</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85059023726&amp;doi=10.1016%2fj.jaim.2018.02.134&amp;partnerID=40&amp;md5=c8ebe87e1bdd4a892ed7dcc94098ea4a</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.jaim.2018.02.134</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>180</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">180</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Mulvey, D.</style></author><author><style face="normal" font="default" size="100%">Redding, P.</style></author><author><style face="normal" font="default" size="100%">Robertson, C.</style></author><author><style face="normal" font="default" size="100%">Woodall, C.</style></author><author><style face="normal" font="default" size="100%">Kingsmore, P.</style></author><author><style face="normal" font="default" size="100%">Bedwell, D.</style></author><author><style face="normal" font="default" size="100%">Dancer, S. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">BluTest Laboratories Limited, Robertson Building, University of Glasgow, Glasgow, United Kingdom&#xD;Department of Microbiology, Southern General Hospital, Glasgow, United Kingdom&#xD;Department of Statistics and Modelling Science, University of Strathclyde, Glasgow, United Kingdom&#xD;Health Facilities Scotland, Glasgow, United Kingdom&#xD;Department of Microbiology, Hairmyres Hospital, East Kilbride, Glasgow, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Finding a benchmark for monitoring hospital cleanliness</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">25-30</style></pages><volume><style face="normal" font="default" size="100%">77</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">ATP</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental monitoring</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">Meticillin-resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Standards</style></keyword><keyword><style face="normal" font="default" size="100%">adenosine triphosphate</style></keyword><keyword><style face="normal" font="default" size="100%">detergent</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bioluminescence</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">hospital cleanliness</style></keyword><keyword><style face="normal" font="default" size="100%">hospital management</style></keyword><keyword><style face="normal" font="default" size="100%">intestine flora</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">microbial growth</style></keyword><keyword><style face="normal" font="default" size="100%">microbiological examination</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">pathogenesis</style></keyword><keyword><style face="normal" font="default" size="100%">pollution</style></keyword><keyword><style face="normal" font="default" size="100%">prediction</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Load</style></keyword><keyword><style face="normal" font="default" size="100%">Benchmarking</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental Microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals</style></keyword><keyword><style face="normal" font="default" size="100%">Housekeeping, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infection Control</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2011</style></year></dates><isbn><style face="normal" font="default" size="100%">01956701 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">This study evaluated three methods for monitoring hospital cleanliness. The aim was to find a benchmark that could indicate risk to patients from a contaminated environment. We performed visual monitoring, ATP bioluminescence and microbiological screening of five clinical surfaces before and after detergent-based cleaning on two wards over a four-week period. Five additional sites that were not featured in the routine domestic specification were also sampled. Measurements from all three methods were integrated and compared in order to choose appropriate levels for routine monitoring. We found that visual assessment did not reflect ATP values nor environmental contamination with microbial flora including Staphylococcus aureus and meticillin-resistant S. aureus (MRSA). There was a relationship between microbial growth categories and the proportion of ATP values exceeding a chosen benchmark but neither reliably predicted the presence of S. aureus or MRSA. ATP values were occasionally diverse. Detergent-based cleaning reduced levels of organic soil by 32% (95% confidence interval: 16-44%; P&amp;lt;0.001) but did not necessarily eliminate indicator staphylococci, some of which survived the cleaning process. An ATP benchmark value of 100 relative light units offered the closest correlation with microbial growth levels &amp;lt;2.5cfu/cm2 (receiver operating characteristic ROC curve sensitivity: 57%; specificity: 57%). In conclusion, microbiological and ATP monitoring confirmed environmental contamination, persistence of hospital pathogens and measured the effect on the environment from current cleaning practices. This study has provided provisional benchmarks to assist with future assessment of hospital cleanliness. Further work is required to refine practical sampling strategy and choice of benchmarks. © 2010 The Hospital Infection Society.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :138&#xD;Export Date: 26 March 2020&#xD;CODEN: JHIND&#xD;Correspondence Address: Dancer, S.J.; Department of Microbiology, Hairmyres Hospital, East Kilbride, Glasgow G75 8RG, United Kingdom; email: stephanie.dancer@lanarkshire.scot.nhs.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-78650514084&amp;doi=10.1016%2fj.jhin.2010.08.006&amp;partnerID=40&amp;md5=13117dab8afd4114a63cb5586729d097</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">21129820</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.jhin.2010.08.006</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>181</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">181</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Neely, A. N.</style></author><author><style face="normal" font="default" size="100%">Maley, M. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Shriners Hospitals for Children, Cincinnati, OH, United States&#xD;Department of Surgery, University of Cincinnati, College of Medicine, Cincinnati, OH, United States&#xD;Shriners Hospitals for Children, 3229 Burnet Ave., Cincinnati, OH 45229-3095, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Survival of enterococci and staphylococci on hospital fabrics and plastic</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Clinical Microbiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Clin. Microbiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Clinical Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Clin. Microbiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Clinical Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Clin. Microbiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">724-726</style></pages><volume><style face="normal" font="default" size="100%">38</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic sensitivity</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">cell survival</style></keyword><keyword><style face="normal" font="default" size="100%">clothing</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus casseliflavus</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus faecalis</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus faecium</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus gallinarum</style></keyword><keyword><style face="normal" font="default" size="100%">hospital hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">inoculation</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">species difference</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Colony Count, Microbial</style></keyword><keyword><style face="normal" font="default" size="100%">Gram-Positive Bacterial Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin Resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Penicillins</style></keyword><keyword><style face="normal" font="default" size="100%">Plastics</style></keyword><keyword><style face="normal" font="default" size="100%">Polyesters</style></keyword><keyword><style face="normal" font="default" size="100%">Polypropylenes</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcal Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus</style></keyword><keyword><style face="normal" font="default" size="100%">Textiles</style></keyword><keyword><style face="normal" font="default" size="100%">Vancomycin</style></keyword><keyword><style face="normal" font="default" size="100%">Vancomycin Resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria (microorganisms)</style></keyword><keyword><style face="normal" font="default" size="100%">Gossypium hirsutum</style></keyword><keyword><style face="normal" font="default" size="100%">Posibacteria</style></keyword><keyword><style face="normal" font="default" size="100%">staphylococci</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2000</style></year></dates><isbn><style face="normal" font="default" size="100%">00951137 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">The transfer of gram-positive bacteria, particularly multiresistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE), among patients is a growing concern. One critical aspect of bacterial transfer is the ability of the microorganism to survive on various common hospital surfaces. The purpose of this study was to determine the survival of 22 gram-positive bacteria (vancomycin-sensitive and -resistant enterococci and methicillin-sensitive and -resistant staphylococci) on five common hospital materials: smooth 100% cotton (clothing), 100% cotton terry (towels), 60% cotton-40% polyester blend (scrub suits and lab coats), 100% polyester (privacy drapes), and 100% polypropylene plastic (splash aprons). Swatches were inoculated with 104 to 105 CFU of a microorganism, assayed daily by placing the swatches in nutritive media, and examining for growth after 48 h. All isolates survived for at least 1 day, and some survived for more than 90 days on the various materials. Smaller inocula (102) survived for shorter times but still generally for days. Antibiotic sensitivity had no consistent effect on survival. The long survival of these bacteria, including MRSA and VRE, on commonly used hospital fabrics, such as scrub suits, lab coats, and hospital privacy drapes, underscores the need for meticulous contact control procedures and careful disinfection to limit the spread of these bacteria.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :473&#xD;Export Date: 26 March 2020&#xD;CODEN: JCMID&#xD;Correspondence Address: Neely, A.N.; Shriners Hospitals for Children, 3229 Burnet Ave., Cincinnati, OH 45229-3095, United States; email: aneely@shrinenet.org</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033976370&amp;partnerID=40&amp;md5=bd77ac4668576f9f4f048ea8fe093c08</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">10655374</style></custom2><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>182</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">182</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Niven, D. J.</style></author><author><style face="normal" font="default" size="100%">Gaudet, J. E.</style></author><author><style face="normal" font="default" size="100%">Laupland, K. B.</style></author><author><style face="normal" font="default" size="100%">Mrklas, K. J.</style></author><author><style face="normal" font="default" size="100%">Roberts, D. J.</style></author><author><style face="normal" font="default" size="100%">Stelfox, H. T.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Critical Care Medicine, Peter Lougheed Centre, 3500 26th Avenue Northeast, Calgary, AB T1Y 6J4, Canada&#xD;Department of Medicine, Royal Inland Hospital, 311 Columbia Street, Kamloops, BC V2C 2T1, Canada&#xD;Foothills Medical Centre, South Tower, 1403 29th Street Northwest, Calgary, AB T2N 2T9, Canada&#xD;Department of Critical Care Medicine, Foothills Medical Centre, 3134 Hospital Drive Northwest, Calgary, AB T2N 5A1, Canada&#xD;Teaching, Research, and Wellness Building, University of Calgary, 3280 Hospital Drive Northwest, Calgary, AB T2N 4Z6, Canada</style></auth-address><titles><title><style face="normal" font="default" size="100%">Accuracy of peripheral thermometers for estimating temperature: A systematic review and meta-analysis</style></title><secondary-title><style face="normal" font="default" size="100%">Annals of Internal Medicine</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Ann. Intern. Med.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Annals of Internal Medicine</style></full-title><abbr-1><style face="normal" font="default" size="100%">Ann. Intern. Med.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Annals of Internal Medicine</style></full-title><abbr-1><style face="normal" font="default" size="100%">Ann. Intern. Med.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">768-777</style></pages><volume><style face="normal" font="default" size="100%">163</style></volume><number><style face="normal" font="default" size="100%">10</style></number><keywords><keyword><style face="normal" font="default" size="100%">axillary thermometer</style></keyword><keyword><style face="normal" font="default" size="100%">body temperature measurement</style></keyword><keyword><style face="normal" font="default" size="100%">core temperature</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic accuracy</style></keyword><keyword><style face="normal" font="default" size="100%">diagnostic test accuracy study</style></keyword><keyword><style face="normal" font="default" size="100%">esophageal thermometer</style></keyword><keyword><style face="normal" font="default" size="100%">fever</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">hypothermia</style></keyword><keyword><style face="normal" font="default" size="100%">meta analysis</style></keyword><keyword><style face="normal" font="default" size="100%">oral thermometer</style></keyword><keyword><style face="normal" font="default" size="100%">patient selection</style></keyword><keyword><style face="normal" font="default" size="100%">peripheral thermometer</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">pulmonary artery catheter</style></keyword><keyword><style face="normal" font="default" size="100%">pulmonary artery thermometer</style></keyword><keyword><style face="normal" font="default" size="100%">receiver operating characteristic</style></keyword><keyword><style face="normal" font="default" size="100%">rectal thermometer</style></keyword><keyword><style face="normal" font="default" size="100%">Review</style></keyword><keyword><style face="normal" font="default" size="100%">sensitivity and specificity</style></keyword><keyword><style face="normal" font="default" size="100%">systematic review</style></keyword><keyword><style face="normal" font="default" size="100%">temporal artery thermometer</style></keyword><keyword><style face="normal" font="default" size="100%">thermometer</style></keyword><keyword><style face="normal" font="default" size="100%">tympanic thermometer</style></keyword><keyword><style face="normal" font="default" size="100%">urinary bladder thermometer</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">axilla</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">eardrum</style></keyword><keyword><style face="normal" font="default" size="100%">mouth</style></keyword><keyword><style face="normal" font="default" size="100%">standards</style></keyword><keyword><style face="normal" font="default" size="100%">temporal artery</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Temporal Arteries</style></keyword><keyword><style face="normal" font="default" size="100%">Thermometers</style></keyword><keyword><style face="normal" font="default" size="100%">Tympanic Membrane</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><publisher><style face="normal" font="default" size="100%">American College of Physicians</style></publisher><isbn><style face="normal" font="default" size="100%">00034819 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Body temperature is commonly used to screen patients for infectious diseases, establish diagnoses, monitor therapy, and guide management decisions. Purpose: To determine the accuracy of peripheral thermometers for estimating core body temperature in adults and children. Data Sources: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and CINAHL Plus from inception to July 2015. Study Selection: Prospective studies comparing the accuracy of peripheral (tympanic membrane, temporal artery, axillary, or oral) thermometers with central (pulmonary artery catheter, urinary bladder, esophageal, or rectal) thermometers. Data Extraction: 2 reviewers extracted data on study characteristics, methods, and outcomes and assessed the quality of individual studies. Data Synthesis: 75 studies (8682 patients) were included. Most studies were at high or unclear risk of patient selection bias (74%) or index test bias (67%). Compared with central thermometers, peripheral thermometers had pooled 95% limits of agreement (random-effects meta-analysis) outside the predefined clinically acceptable range (± 0.5 °C), especially among patients with fever (-1.44 °C to 1.46 °C for adults;-1.49 °C to 0.43 °C for children) and hypothermia (-2.07 °C to 1.90 °C for adults; no data for children). For detection of fever (bivariate randomeffects meta-analysis), sensitivity was low (64% [95% CI, 55% to 72%]; I2 = 95.7%; P &amp;lt; 0.001) but specificity was high (96% [CI, 93% to 97%]; I2 = 96.3%; P &amp;lt; 0.001). Only 1 study reported sensitivity and specificity for the detection of hypothermia. Limitations: High-quality data for some temperature measurement techniques are limited. Pooled data are associated with interstudy heterogeneity that is not fully explained by stratified and metaregression analyses. Conclusion: Peripheral thermometers do not have clinically acceptable accuracy and should not be used when accurate measurement of body temperature will influence clinical decisions. Primary Funding Source: None.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :76&#xD;Export Date: 26 March 2020&#xD;CODEN: AIMEA&#xD;Correspondence Address: Niven, D.J.; Department of Critical Care Medicine, Peter Lougheed Centre, 3500 26th Avenue Northeast, Canada; email: Daniel.niven@albertahealthservices.ca</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84947423868&amp;doi=10.7326%2fM15-1150&amp;partnerID=40&amp;md5=09d8f86360332f65aca64e8f5d31f278</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">26571241</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.7326/M15-1150</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>183</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">183</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Noyce, J. O.</style></author><author><style face="normal" font="default" size="100%">Michels, H.</style></author><author><style face="normal" font="default" size="100%">Keevil, C. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Environmental Healthcare Unit, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton SO16 7PX, United Kingdom&#xD;Copper Development Association Inc., 260 Madison Avenue, New York, NY 10016, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Use of copper cast alloys to control Escherichia coli O157 cross-contamination during food processing</style></title><secondary-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Appl. Environ. Microbiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">APPL. ENVIRON. MICROBIOL.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">APPL. ENVIRON. MICROBIOL.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">4239-4244</style></pages><volume><style face="normal" font="default" size="100%">72</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">Cells</style></keyword><keyword><style face="normal" font="default" size="100%">Contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Copper alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Food processing</style></keyword><keyword><style face="normal" font="default" size="100%">Stainless steel</style></keyword><keyword><style face="normal" font="default" size="100%">Antimicrobial properties</style></keyword><keyword><style face="normal" font="default" size="100%">Copper cast alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Food safety</style></keyword><keyword><style face="normal" font="default" size="100%">Ground beef</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">5 cyano 2,3 ditolyl tetrazolium</style></keyword><keyword><style face="normal" font="default" size="100%">alloy</style></keyword><keyword><style face="normal" font="default" size="100%">brass</style></keyword><keyword><style face="normal" font="default" size="100%">copper cast alloy</style></keyword><keyword><style face="normal" font="default" size="100%">copper derivative</style></keyword><keyword><style face="normal" font="default" size="100%">fluorochrome</style></keyword><keyword><style face="normal" font="default" size="100%">indicator</style></keyword><keyword><style face="normal" font="default" size="100%">silicon bronze</style></keyword><keyword><style face="normal" font="default" size="100%">tetrazolium</style></keyword><keyword><style face="normal" font="default" size="100%">unclassified drug</style></keyword><keyword><style face="normal" font="default" size="100%">coliform bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">copper</style></keyword><keyword><style face="normal" font="default" size="100%">antibacterial activity</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial count</style></keyword><keyword><style face="normal" font="default" size="100%">bactericidal activity</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium contamination</style></keyword><keyword><style face="normal" font="default" size="100%">cell viability</style></keyword><keyword><style face="normal" font="default" size="100%">colony forming unit</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli O157</style></keyword><keyword><style face="normal" font="default" size="100%">food contamination</style></keyword><keyword><style face="normal" font="default" size="100%">meat</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">plate count</style></keyword><keyword><style face="normal" font="default" size="100%">staining</style></keyword><keyword><style face="normal" font="default" size="100%">Alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Animals</style></keyword><keyword><style face="normal" font="default" size="100%">Food Handling</style></keyword><keyword><style face="normal" font="default" size="100%">Kinetics</style></keyword><keyword><style face="normal" font="default" size="100%">Metals</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2006</style></year></dates><isbn><style face="normal" font="default" size="100%">00992240 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">The most notable method of infection from Escherichia coli O157 (E. coli O157) is through contaminated food products, usually ground beef. The objective of this study was to evaluate seven cast copper alloys (61 to 95% Cu) for their ability to reduce the viability of E. coli O157, mixed with or without ground beef juice, and to compare these results to those for stainless steel. E. coli O157 (NCTC 12900) (2 × 107 CFU) mixed with extracted beef juice (25%) was inoculated onto coupons of each copper cast alloy or stainless steel and incubated at either 22°C or 4°C for up to 6 h. E. coli O157 viability was determined by plate counts in addition to staining in situ with the respiratory indicator fluorochrome 5-cyano-2,3-ditolyl tetrazolium. Without beef extract, three alloys completely killed the inoculum during the 6-h exposure at 22°C. At 4°C, only the high-copper alloys (&amp;gt;85%) significantly reduced the numbers of O157. With beef juice, only one alloy (95% Cu) completely killed the inoculum at 22°C. For stainless steel, no significant reduction in cell numbers occurred. At 4°C, only alloys C83300 (93% Cu) and C87300 (95% Cu) significantly reduced the numbers of E. coli O157, with 1.5- and 5-log kills, respectively. Reducing the inoculum to 103 CFU resulted in a complete kill for all seven cast copper alloys in 20 min or less at 22°C. These results clearly demonstrate the antimicrobial properties of cast copper alloys with regard to E. coli O157, and consequently these alloys have the potential to aid in food safety. Copyright © 2006, American Society for Microbiology. All Rights Reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :130&#xD;Export Date: 26 March 2020&#xD;CODEN: AEMID&#xD;Correspondence Address: Noyce, J.O.; Environmental Healthcare Unit, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton SO16 7PX, United Kingdom; email: J.O.Noyce@Soton.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-33745126634&amp;doi=10.1128%2fAEM.02532-05&amp;partnerID=40&amp;md5=d6bdfa32145644afde6951a881847ff3</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">16751537</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1128/AEM.02532-05</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>184</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">184</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Noyce, J. O.</style></author><author><style face="normal" font="default" size="100%">Michels, H.</style></author><author><style face="normal" font="default" size="100%">Keevil, C. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Environmental Healthcare Unit, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton SO16 7PX, United Kingdom&#xD;Copper Development Association, Inc., 260 Madison Avenue, New York, NY 10016, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Inactivation of influenza A virus on copper versus stainless steel surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Appl. Environ. Microbiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">APPL. ENVIRON. MICROBIOL.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">APPL. ENVIRON. MICROBIOL.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">2748-2750</style></pages><volume><style face="normal" font="default" size="100%">73</style></volume><number><style face="normal" font="default" size="100%">8</style></number><keywords><keyword><style face="normal" font="default" size="100%">Atmospheric humidity</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Fluorescence microscopy</style></keyword><keyword><style face="normal" font="default" size="100%">Monolayers</style></keyword><keyword><style face="normal" font="default" size="100%">Stainless steel</style></keyword><keyword><style face="normal" font="default" size="100%">Incubation</style></keyword><keyword><style face="normal" font="default" size="100%">Influenza A virus</style></keyword><keyword><style face="normal" font="default" size="100%">Viruses</style></keyword><keyword><style face="normal" font="default" size="100%">infectivity</style></keyword><keyword><style face="normal" font="default" size="100%">influenza</style></keyword><keyword><style face="normal" font="default" size="100%">steel</style></keyword><keyword><style face="normal" font="default" size="100%">virus</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">humidity</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">Influenza virus A</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">survival</style></keyword><keyword><style face="normal" font="default" size="100%">virus inactivation</style></keyword><keyword><style face="normal" font="default" size="100%">virus infectivity</style></keyword><keyword><style face="normal" font="default" size="100%">virus particle</style></keyword><keyword><style face="normal" font="default" size="100%">virus transmission</style></keyword><keyword><style face="normal" font="default" size="100%">Influenza A Virus, H1N1 Subtype</style></keyword><keyword><style face="normal" font="default" size="100%">Microbial Viability</style></keyword><keyword><style face="normal" font="default" size="100%">Microscopy, Fluorescence</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2007</style></year></dates><isbn><style face="normal" font="default" size="100%">00992240 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Influenza A virus particles (2 × 106) were inoculated onto copper or stainless steel and incubated at 22°C at 50 to 60% relative humidity. Infectivity of survivors was determined by utilizing a defined monolayer with fluorescent microscopy analysis. After incubation for 24 h on stainless steel, 500,000 virus particles were still infectious. After incubation for 6 h on copper, only 500 particles were active. Copyright © 2007, American Society for Microbiology. All Rights Reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :124&#xD;Export Date: 26 March 2020&#xD;CODEN: AEMID&#xD;Correspondence Address: Keevil, C.W.; Environmental Healthcare Unit, University of Southampton, Biomedical Sciences Building, Bassett Crescent East, Southampton SO16 7PX, United Kingdom; email: cwk@Soton.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-34247555521&amp;doi=10.1128%2fAEM.01139-06&amp;partnerID=40&amp;md5=f7b2af1819fbf35145a142e261b0e2b3</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">17259354</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1128/AEM.01139-06</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>185</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">185</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ogen-Shtern, N.</style></author><author><style face="normal" font="default" size="100%">Chumin, K.</style></author><author><style face="normal" font="default" size="100%">Cohen, G.</style></author><author><style face="normal" font="default" size="100%">Borkow, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">The Skin Research Institute, The Dead-Sea &amp; Arava Science Center, Masada, Israel&#xD;Cupron Inc., Herzeliya, Israel</style></auth-address><titles><title><style face="normal" font="default" size="100%">Increased pro-collagen 1, elastin, and TGF-β1 expression by copper ions in an ex-vivo human skin model</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Cosmetic Dermatology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Cosmet. Dermatol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Cosmetic Dermatology</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Cosmet. Dermatol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Cosmetic Dermatology</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Cosmet. Dermatol.</style></abbr-1></alt-periodical><keywords><keyword><style face="normal" font="default" size="100%">copper oxide</style></keyword><keyword><style face="normal" font="default" size="100%">cuprous oxide</style></keyword><keyword><style face="normal" font="default" size="100%">elastin</style></keyword><keyword><style face="normal" font="default" size="100%">ex-vivo skin model</style></keyword><keyword><style face="normal" font="default" size="100%">pro-collagen</style></keyword><keyword><style face="normal" font="default" size="100%">TGF-β1</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><publisher><style face="normal" font="default" size="100%">Blackwell Publishing Ltd</style></publisher><isbn><style face="normal" font="default" size="100%">14732130 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background: Clinical studies demonstrated that continued exposure to copper oxide–embedded textiles, such as pillowcases, significantly reduces depth of facial wrinkles and skin sagging and enhances skin elasticity. Objective: Study the mechanisms by which the exposure to copper ions improve the well-being of the skin. Methods: Human skin explants, cultured ex-vivo, were exposed topically to saline alone or saline containing 0.02 or 1 µmol/L copper ions. The skin explants viability, histology and secretion of elastin, pro-collagen 1, and TGF-β1 to the culture medium were determined at various time intervals. Results: Exposure to saline containing 0.02 or 1 µmol/L copper ions did not affect the viability or morphological profile of the explants as compared to control explants treated with saline only. Notably, exposure of the skin grafts to 0.02 or to 1 µmol/L of copper ions resulted in ~100% and ~20% increases in elastin and pro-collagen 1 concentrations, respectively, in the culture supernatants already after 1 day of incubation, which remained statistically significantly elevated also after 6 days on incubation, as compared to the control explants. In addition, ~2- and ~4-fold increases in TGF-ß1 levels in the culture supernatants of explants exposed to the copper ions were detected after 4 and 6 days of culture, as compared to the explants exposed to saline alone. Conclusion: This study substantiated the anti-aging effect that copper ions have on the skin and gave insights into the mechanisms by which exposure of the skin to copper ions improves the skin well-being. © 2019 Wiley Periodicals, Inc.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Borkow, G.; Cupron Inc.Israel; email: gadi@cupron.com</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85074009034&amp;doi=10.1111%2fjocd.13186&amp;partnerID=40&amp;md5=c3125af9fb3bd3a7d089936a5668c912</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">31603269</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/jocd.13186</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>186</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">186</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Otter, J. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Infectious Diseases, Guy&apos;s and St. Thomas NHS Foundation Trust and King&apos;s College London, St. Thomas&apos; Hospital, North Wing, Lambeth Palace Road, London, SE1 7EH, United Kingdom&#xD;Bioquell (UK) Ltd., Andover, Hampshire, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">An overview of the options for antimicrobial hard surfaces in hospitals</style></title><secondary-title><style face="normal" font="default" size="100%">Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Use of Biocidal Surf. for Red. of Healthc. Acquired Infect.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">137-166</style></pages><volume><style face="normal" font="default" size="100%">9783319080574</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Copper alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Cost effectiveness</style></keyword><keyword><style face="normal" font="default" size="100%">Enzyme inhibition</style></keyword><keyword><style face="normal" font="default" size="100%">Health care</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-microbial activity</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">Contaminated surfaces</style></keyword><keyword><style face="normal" font="default" size="100%">Light-activated antimicrobial</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin-resistant staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Microbial contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Multi-disciplinary approach</style></keyword><keyword><style face="normal" font="default" size="100%">Quaternary ammonium compound</style></keyword><keyword><style face="normal" font="default" size="100%">Antimicrobial agents</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319080574 (ISBN); 3319080563 (ISBN); 9783319080567 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">Contaminated surfaces make an important contribution to the transmission of several important pathogens, including methicillin-resistant Staphylococcus aureus (MRSA), Clostridium difficile and a number of resistant Gram-negative rods, including Acinetobacter baumannii. Several different approaches are available for improving hospital hygiene, including improving the effectiveness of existing methods and a range of new approaches, including novel disinfectants. A complimentary approach is the introduction of antimicrobial surfaces (AMS), which exert a continuous reduction on the level of microbial contamination on hospitals surfaces. There are several approaches to making a hospital surface &apos;antimicrobial&apos;: permanently &apos;manufacture in&apos; an agent with antimicrobial activity; periodically apply an agent with antimicrobial activity; or physically alter the properties of a surface to make it less able to support microbial contamination and/or easier to clean. Promising options for AMS in healthcare settings include metals (principally copper or silver), chemicals (organosilanes, quaternary ammonium compounds, light-activated antimicrobials, and polycationic polymers) and physical alteration of the surface to reduce microbial attachment or improve cleanability. Before widespread adoption of AMS, promising candidates require rigorous in vitro and in situ assessment, including an evaluation of their clinical impact and cost effectiveness. Copper alloy surfaces are the most closely evaluated option for AMS, and have demonstrated in vitro activity against a range of pathogens (although their sporicidal capacity remains equivocal), evidence of efficacy in in situ studies and their introduction has been associated with a reduction in healthcare-associated infections (HAI). However, their long-term durability, acceptability and cost-effectiveness have not been evaluated formally. Finding and evaluating the optimal AMS will require a multidisciplinary approach, involving industrial partners, materials scientists, healthcare scientists and epidemiologists to refine and test the available options. © 2014 Springer International Publishing Switzerland. All rights are reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :5&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Otter, J.A.; Department of Infectious Diseases, Guy&apos;s and St. Thomas NHS Foundation Trust and King&apos;s College London, St. Thomas&apos; Hospital, North Wing, Lambeth Palace Road, United Kingdom</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930334099&amp;doi=10.1007%2f978-3-319-08057-4_7&amp;partnerID=40&amp;md5=37d47bbb3ac510881d0752d0131582ea</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-08057-4_7</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>187</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">187</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Otter, J. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Centre for Clinical Infection and Diagnostics Research (CIDR), Guy&apos;s and St Thomas&apos; NHS Foundation Trust and King&apos;s College London, Department of Infection, St. Thomas&apos; Hospital, 5th Floor, North Wing, London, SE1 7EH, United Kingdom&#xD;Bioquell UK Ltd, United Kingdom&#xD;Infection Prevention Society Scientific Programme Committee, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Infection Prevention 2013 - a potted overview</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Infection Prevention</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Infect. Prevent.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Infection Prevention</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Infect. Prevent.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Infection Prevention</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Infect. Prevent.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">9-12</style></pages><volume><style face="normal" font="default" size="100%">15</style></volume><number><style face="normal" font="default" size="100%">1</style></number><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><isbn><style face="normal" font="default" size="100%">17571774 (ISSN)</style></isbn><notes><style face="normal" font="default" size="100%">Cited By :1&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Otter, J. A.; Centre for Clinical Infection and Diagnostics Research (CIDR), Guy&apos;s and St Thomas&apos; NHS Foundation Trust and King&apos;s College London, Department of Infection, St. Thomas&apos; Hospital, 5th Floor, North Wing, London, SE1 7EH, United Kingdom; email: jonathan.otter@kcl.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84891856289&amp;doi=10.1177%2f1757177413514842&amp;partnerID=40&amp;md5=cd06a2f9c641ed5890a3b8fb4c6cbbfe</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1177/1757177413514842</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>188</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">188</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Otter, J. A.</style></author><author><style face="normal" font="default" size="100%">Yezli, S.</style></author><author><style face="normal" font="default" size="100%">French, G. L.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Centre for Clinical Infection and Diagnostics Research (CIDR), Guy&apos;s and St. Thomas NHS Foundation Trust and King&apos;s College London, St. Thomas&apos; Hospital, North Wing, Lambeth Palace Road, London, SE1 7EH, United Kingdom&#xD;Bioquell (UK) Ltd., Andover Hampshire, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">The role of contaminated surfaces in the transmission of nosocomial pathogens</style></title><secondary-title><style face="normal" font="default" size="100%">Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Use of Biocidal Surf. for Red. of Healthc. Acquired Infect.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">27-58</style></pages><volume><style face="normal" font="default" size="100%">9783319080574</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Acinetobacter baumannii</style></keyword><keyword><style face="normal" font="default" size="100%">Cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">Disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental contamination</style></keyword><keyword><style face="normal" font="default" size="100%">MRSA</style></keyword><keyword><style face="normal" font="default" size="100%">Norovirus</style></keyword><keyword><style face="normal" font="default" size="100%">Pseudomonas aeruginosa</style></keyword><keyword><style face="normal" font="default" size="100%">VRE</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium</style></keyword><keyword><style face="normal" font="default" size="100%">Contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Decontamination</style></keyword><keyword><style face="normal" font="default" size="100%">Disease control</style></keyword><keyword><style face="normal" font="default" size="100%">Enzyme inhibition</style></keyword><keyword><style face="normal" font="default" size="100%">Health care</style></keyword><keyword><style face="normal" font="default" size="100%">Baumannii</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319080574 (ISBN); 3319080563 (ISBN); 9783319080567 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">Studies in the 1970s and 1980s suggested that environmental surface contamination had a negligible role in the endemic transmission of healthcare-associated infections. However, recent studies demonstrate that several major nosocomial pathogens are shed by patients and contaminate hospital surfaces at concentrations sufficient for transmission, survive for extended periods, persist despite attempts to disinfect or remove them and can be transferred to the hands of healthcare workers. Evidence is accumulating that contaminated surfaces make an important contribution to the epidemic and endemic transmission of C. difficile, vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, Acinetobacter baumannii, Pseudomonas aeruginosa and norovirus and that improved environmental decontamination contributes to the control of outbreaks. Efforts to improve environmental hygiene should include enhancing the efficacy of cleaning and disinfection and reducing the shedding of pathogens. Further high quality studies are needed to clarify the role of surfaces in nosocomial transmission and determine the effectiveness of different interventions in reducing associated infection rates. © 2014 Springer International Publishing Switzerland. All rights are reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :7&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Otter, J.A.; Centre for Clinical Infection and Diagnostics Research (CIDR), Guy&apos;s and St. Thomas NHS Foundation Trust and King&apos;s College London, St. Thomas&apos; Hospital, North Wing, Lambeth Palace Road, United Kingdom</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84930370581&amp;doi=10.1007%2f978-3-319-08057-4_3&amp;partnerID=40&amp;md5=9a637cef04dddd7e4afe8c337a8610bb</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-08057-4_3</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>189</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">189</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Phillips, M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Division of Infectious Disease and Immunology, New York University School of Medicine, New York, NY, United States&#xD;Hospital Epidemiologist and Director of Infection Prevention and Control, NYU Langone Medical Center, New York, NY, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Acinetobacter Species</style></title><secondary-title><style face="normal" font="default" size="100%">Mandell, Douglas, and Bennett&apos;s Principles and Practice of Infectious Diseases</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Mandell, Douglas, and Bennett&apos;s Princ. and Pract. of Infect. Dis.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">2552-2558</style></pages><volume><style face="normal" font="default" size="100%">2</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Acinetobacter baumannii</style></keyword><keyword><style face="normal" font="default" size="100%">Antimicrobial resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Burn wound infections</style></keyword><keyword><style face="normal" font="default" size="100%">Carbapenem resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Gram-negative</style></keyword><keyword><style face="normal" font="default" size="100%">Health care-associated infections</style></keyword><keyword><style face="normal" font="default" size="100%">Infection control</style></keyword><keyword><style face="normal" font="default" size="100%">Nosocomial infections</style></keyword><keyword><style face="normal" font="default" size="100%">Opportunistic infections</style></keyword><keyword><style face="normal" font="default" size="100%">Outbreak</style></keyword><keyword><style face="normal" font="default" size="100%">Pneumonia</style></keyword><keyword><style face="normal" font="default" size="100%">Surgical infections</style></keyword><keyword><style face="normal" font="default" size="100%">Trauma</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><publisher><style face="normal" font="default" size="100%">Elsevier Inc.</style></publisher><isbn><style face="normal" font="default" size="100%">9996096742 (ISBN); 9781455748013 (ISBN)</style></isbn><notes><style face="normal" font="default" size="100%">Cited By :3&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Phillips, M.; Division of Infectious Disease and Immunology, New York University School of MedicineUnited States</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84944612379&amp;doi=10.1016%2fB978-1-4557-4801-3.00224-1&amp;partnerID=40&amp;md5=b963df2f60a30f2dc8e63d8b69022a62</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/B978-1-4557-4801-3.00224-1</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>190</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">190</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Purves, J.</style></author><author><style face="normal" font="default" size="100%">Thomas, J.</style></author><author><style face="normal" font="default" size="100%">Riboldi, G. P.</style></author><author><style face="normal" font="default" size="100%">Zapotoczna, M.</style></author><author><style face="normal" font="default" size="100%">Tarrant, E.</style></author><author><style face="normal" font="default" size="100%">Andrew, P. W.</style></author><author><style face="normal" font="default" size="100%">Londoño, A.</style></author><author><style face="normal" font="default" size="100%">Planet, P. J.</style></author><author><style face="normal" font="default" size="100%">Geoghegan, J. A.</style></author><author><style face="normal" font="default" size="100%">Waldron, K. J.</style></author><author><style face="normal" font="default" size="100%">Morrissey, J. A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Genetics, University of Leicester, University Road, Leicester, LE1 7RH, United Kingdom&#xD;Department of Infection, Immunity and Inflammation, University of Leicester, University Road, Leicester, LE1 9HN, United Kingdom&#xD;Institute for Cell &amp; Molecular Biosciences, Faculty of Medical Sciences, Newcastle University, Framlington Place, Newcastle upon Tyne, NE2 4HH, United Kingdom&#xD;Department of Microbiology, Moyne Institute of Preventive Medicine, School of Genetics and Microbiology, Trinity College Dublin, Ireland&#xD;Department of Pediatrics, Columbia University, New York, NY, United States&#xD;Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">A horizontally gene transferred copper resistance locus confers hyper-resistance to antibacterial copper toxicity and enables survival of community acquired methicillin resistant Staphylococcus aureus USA300 in macrophages</style></title><secondary-title><style face="normal" font="default" size="100%">Environmental Microbiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Environ. Microbiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Environ. Microbiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Environ. Microbiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">1576-1589</style></pages><volume><style face="normal" font="default" size="100%">20</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">carrier protein</style></keyword><keyword><style face="normal" font="default" size="100%">copper</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">drug effect</style></keyword><keyword><style face="normal" font="default" size="100%">genetics</style></keyword><keyword><style face="normal" font="default" size="100%">growth, development and aging</style></keyword><keyword><style face="normal" font="default" size="100%">horizontal gene transfer</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">immunology</style></keyword><keyword><style face="normal" font="default" size="100%">innate immunity</style></keyword><keyword><style face="normal" font="default" size="100%">macrophage</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">operon</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus infection</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Resistance, Bacterial</style></keyword><keyword><style face="normal" font="default" size="100%">Gene Transfer, Horizontal</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Immunity, Innate</style></keyword><keyword><style face="normal" font="default" size="100%">Macrophages</style></keyword><keyword><style face="normal" font="default" size="100%">Membrane Transport Proteins</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin-Resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcal Infections</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><publisher><style face="normal" font="default" size="100%">Blackwell Publishing Ltd</style></publisher><isbn><style face="normal" font="default" size="100%">14622912 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Excess copper is highly toxic and forms part of the host innate immune system&apos;s antibacterial arsenal, accumulating at sites of infection and acting within macrophages to kill engulfed pathogens. We show for the first time that a novel, horizontally gene transferred copper resistance locus (copXL), uniquely associated with the SCCmec elements of the highly virulent, epidemic, community acquired methicillin resistant Staphylococcus aureus (CA-MRSA) USA300, confers copper hyper-resistance. These genes are additional to existing core genome copper resistance mechanisms, and are not found in typical S. aureus lineages, but are increasingly identified in emerging pathogenic isolates. Our data show that CopX, a putative P1B-3-ATPase efflux transporter, and CopL, a novel lipoprotein, confer copper hyper-resistance compared to typical S. aureus strains. The copXL genes form an operon that is tightly repressed in low copper environments by the copper regulator CsoR. Significantly, CopX and CopL are important for S. aureus USA300 intracellular survival within macrophages. Therefore, the emergence of new S. aureus clones with the copXL locus has significant implications for public health because these genes confer increased resistance to antibacterial copper toxicity, enhancing bacterial fitness by altering S. aureus interaction with innate immunity. © 2018 The Authors. Environmental Microbiology published by Society for Applied Microbiology and John Wiley &amp; Sons Ltd.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :14&#xD;Export Date: 26 March 2020&#xD;CODEN: ENMIF&#xD;Correspondence Address: Morrissey, J.A.; Department of Genetics, University of Leicester, University RoadUnited Kingdom; email: jam26@leicester.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044435807&amp;doi=10.1111%2f1462-2920.14088&amp;partnerID=40&amp;md5=e28349250464b471b9a692515b12ac16</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">29521441</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/1462-2920.14088</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>191</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">191</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Querido, M. M.</style></author><author><style face="normal" font="default" size="100%">Aguiar, L.</style></author><author><style face="normal" font="default" size="100%">Neves, P.</style></author><author><style face="normal" font="default" size="100%">Pereira, C. C.</style></author><author><style face="normal" font="default" size="100%">Teixeira, J. P.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">National Institute of Health, Environmental Health Department, Porto, Portugal&#xD;EPIUnit – Institute of Public Health, University of Porto, Porto, Portugal</style></auth-address><titles><title><style face="normal" font="default" size="100%">Self-disinfecting surfaces and infection control</style></title><secondary-title><style face="normal" font="default" size="100%">Colloids and Surfaces B: Biointerfaces</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Colloids Surf. B Biointerfaces</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Colloids and Surfaces B: Biointerfaces</style></full-title><abbr-1><style face="normal" font="default" size="100%">Colloids Surf. B Biointerfaces</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Colloids and Surfaces B: Biointerfaces</style></full-title><abbr-1><style face="normal" font="default" size="100%">Colloids Surf. B Biointerfaces</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">8-21</style></pages><volume><style face="normal" font="default" size="100%">178</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Healthcare facilities</style></keyword><keyword><style face="normal" font="default" size="100%">Infection control</style></keyword><keyword><style face="normal" font="default" size="100%">Microbiological risk assessment</style></keyword><keyword><style face="normal" font="default" size="100%">Public spaces</style></keyword><keyword><style face="normal" font="default" size="100%">Self-disinfecting surfaces</style></keyword><keyword><style face="normal" font="default" size="100%">Adhesives</style></keyword><keyword><style face="normal" font="default" size="100%">Disease control</style></keyword><keyword><style face="normal" font="default" size="100%">Health care</style></keyword><keyword><style face="normal" font="default" size="100%">Metals</style></keyword><keyword><style face="normal" font="default" size="100%">Microorganisms</style></keyword><keyword><style face="normal" font="default" size="100%">Surface treatment</style></keyword><keyword><style face="normal" font="default" size="100%">Antimicrobial substance</style></keyword><keyword><style face="normal" font="default" size="100%">Healthcare facility</style></keyword><keyword><style face="normal" font="default" size="100%">Infectious disease outbreaks</style></keyword><keyword><style face="normal" font="default" size="100%">Microbiological risk assessments</style></keyword><keyword><style face="normal" font="default" size="100%">Public space</style></keyword><keyword><style face="normal" font="default" size="100%">Surface contaminations</style></keyword><keyword><style face="normal" font="default" size="100%">World Health Organization</style></keyword><keyword><style face="normal" font="default" size="100%">Risk assessment</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">antimicrobial material</style></keyword><keyword><style face="normal" font="default" size="100%">biomaterial</style></keyword><keyword><style face="normal" font="default" size="100%">polypeptide antibiotic agent</style></keyword><keyword><style face="normal" font="default" size="100%">silver</style></keyword><keyword><style face="normal" font="default" size="100%">titanium dioxide</style></keyword><keyword><style face="normal" font="default" size="100%">unclassified drug</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">chemical modification</style></keyword><keyword><style face="normal" font="default" size="100%">cold plasma technology</style></keyword><keyword><style face="normal" font="default" size="100%">colony forming unit</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">material coating</style></keyword><keyword><style face="normal" font="default" size="100%">material state</style></keyword><keyword><style face="normal" font="default" size="100%">medical technology</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">practice guideline</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">public health</style></keyword><keyword><style face="normal" font="default" size="100%">Review</style></keyword><keyword><style face="normal" font="default" size="100%">surface area</style></keyword><keyword><style face="normal" font="default" size="100%">surface property</style></keyword><keyword><style face="normal" font="default" size="100%">ultraviolet radiation</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">procedures</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Infective Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Surface Properties</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><publisher><style face="normal" font="default" size="100%">Elsevier B.V.</style></publisher><isbn><style face="normal" font="default" size="100%">09277765 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">According to World Health Organization, every year in the European Union, 4 million patients acquire a healthcare associated infection. Even though some microorganisms represent no threat to healthy people, hospitals harbor different levels of immunocompetent individuals, namely patients receiving immunosuppressors, with previous infections, or those with extremes of age (young children and elderly), requiring the implementation of effective control measures. Public spaces have also been found an important source of infectious disease outbreaks due to poor or none infection control measures applied. In both places, surfaces play a major role on microorganisms’ propagation, yet they are very often neglected, with very few guidelines about efficient cleaning measures and microbiological assessment available. To overcome surface contamination problems, new strategies are being designed to limit the microorganisms’ ability to survive over surfaces and materials. Surface modification and/or functionalization to prevent contamination is a hot-topic of research and several different approaches have been developed lately. Surfaces with anti-adhesive properties, with incorporated antimicrobial substances or modified with biological active metals are some of the strategies recently proposed. This review intends to summarize the problems associated with contaminated surfaces and their importance on infection spreading, and to present some of the strategies developed to prevent this public health problem, namely some already being commercialized. © 2019 Elsevier B.V.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :4&#xD;Export Date: 26 March 2020&#xD;CODEN: CSBBE&#xD;Correspondence Address: Pereira, C.C.; National Institute of Health, Environmental Health Department, Rua Alexandre Herculano, Portugal; email: cristianacostapereira@gmail.com</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062039331&amp;doi=10.1016%2fj.colsurfb.2019.02.009&amp;partnerID=40&amp;md5=d37f213c53cd83d497d72837a6031749</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">30822681</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.colsurfb.2019.02.009</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>192</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">192</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Radetić, M.</style></author><author><style face="normal" font="default" size="100%">Marković, D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Faculty of Technology and Metallurgy, University of Belgrade, Belgrade, Serbia&#xD;Innovation Center of the Faculty of Technology and Metallurgy, University of Belgrade, Belgrade, Serbia</style></auth-address><titles><title><style face="normal" font="default" size="100%">Nano-finishing of cellulose textile materials with copper and copper oxide nanoparticles</style></title><secondary-title><style face="normal" font="default" size="100%">Cellulose</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Cellulose</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Cellulose</style></full-title><abbr-1><style face="normal" font="default" size="100%">Cellulose</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Cellulose</style></full-title><abbr-1><style face="normal" font="default" size="100%">Cellulose</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">8971-8991</style></pages><volume><style face="normal" font="default" size="100%">26</style></volume><number><style face="normal" font="default" size="100%">17</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antimicrobial activity</style></keyword><keyword><style face="normal" font="default" size="100%">Cotton</style></keyword><keyword><style face="normal" font="default" size="100%">Cu/Cu2O/CuO nanoparticles</style></keyword><keyword><style face="normal" font="default" size="100%">Cu2+-ions release</style></keyword><keyword><style face="normal" font="default" size="100%">Lyocell</style></keyword><keyword><style face="normal" font="default" size="100%">Viscose</style></keyword><keyword><style face="normal" font="default" size="100%">Cellulose</style></keyword><keyword><style face="normal" font="default" size="100%">Chemical modification</style></keyword><keyword><style face="normal" font="default" size="100%">Copper oxides</style></keyword><keyword><style face="normal" font="default" size="100%">Metal nanoparticles</style></keyword><keyword><style face="normal" font="default" size="100%">Metals</style></keyword><keyword><style face="normal" font="default" size="100%">Microorganisms</style></keyword><keyword><style face="normal" font="default" size="100%">Nanocomposites</style></keyword><keyword><style face="normal" font="default" size="100%">Silver nanoparticles</style></keyword><keyword><style face="normal" font="default" size="100%">Textile industry</style></keyword><keyword><style face="normal" font="default" size="100%">Textiles</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-microbial activity</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Binding efficiency</style></keyword><keyword><style face="normal" font="default" size="100%">Cellulose wound dressings</style></keyword><keyword><style face="normal" font="default" size="100%">Copper oxide nanoparticles</style></keyword><keyword><style face="normal" font="default" size="100%">Lyocells</style></keyword><keyword><style face="normal" font="default" size="100%">Metal and metal oxide nanoparticles</style></keyword><keyword><style face="normal" font="default" size="100%">Textile finishing</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer Netherlands</style></publisher><isbn><style face="normal" font="default" size="100%">09690239 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Abstract: Nano-finishing of textile materials with metal and metal oxide nanoparticles has been in the focus of science and textile industry almost two decades. The emergence of bacteria resistance to silver nanoparticles due to over-use, cheaper precursor salts and excellent antimicrobial activity recently brought copper and copper oxide nanoparticles to scientific attention particularly for the utilization in the field of medical textiles. This paper is aimed to give an overview of the latest achievements in the finishing of cellulose fabrics with copper-based nanoparticles. Special emphasis has been given to difficulties met throughout the characterization of such textile nanocomposites caused by the copper instability. In addition the effect of various chemical modifications of cellulose fibers prior to impregnation with copper-based nanoparticles on their binding efficiency was considered. Much attention has been also paid to antimicrobial activity of such textile nanocomposites and the possibility to develop efficient antimicrobial cellulose wound dressings. Graphic abstract: [Figure not available: see fulltext.]. © 2019, Springer Nature B.V.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :1&#xD;Export Date: 26 March 2020&#xD;CODEN: CELLE&#xD;Correspondence Address: Radetić, M.; Faculty of Technology and Metallurgy, University of BelgradeSerbia; email: maja@tmf.bg.ac.rs</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85072015335&amp;doi=10.1007%2fs10570-019-02714-4&amp;partnerID=40&amp;md5=40a4663f11818b3a2fab2eeeb00d4e18</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/s10570-019-02714-4</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>193</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">193</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Ramsden, J. J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Chiyoda-ku, Tokyo, 101-0062, Japan&#xD;Clore Laboratory, University of BuckinghamMK18 1EG, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Photocatalytic antimicrobial coatings</style></title><secondary-title><style face="normal" font="default" size="100%">Nanotechnology Perceptions</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Nanotechnol. Percept.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Nanotechnology Perceptions</style></full-title><abbr-1><style face="normal" font="default" size="100%">Nanotechnol. Percept.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Nanotechnology Perceptions</style></full-title><abbr-1><style face="normal" font="default" size="100%">Nanotechnol. Percept.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">146-168</style></pages><volume><style face="normal" font="default" size="100%">11</style></volume><number><style face="normal" font="default" size="100%">3</style></number><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><publisher><style face="normal" font="default" size="100%">Collegium Basilea</style></publisher><isbn><style face="normal" font="default" size="100%">16606795 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">The application of photocatalytic antimicrobial coatings (PAC) to diminish the occurrence of healthcare-associated infections (HAI) is critically evaluated. There is little doubt that PAC have a microbiocidal action and, hence, must reduce the environmental burden of microbes wherever PAC are deployed, but the link thence to reducing HAI is not straightforward and needs to be carefully examined in order to ensure that PAC are deployed cost-effectively. The likely mechanism of the microbicidal action is examined, especially with respect to the possible development of resistance. The relative merits of nanoparticulate versus monolithic films are discussed, as well as the choice of catalyst. Titanium dioxide is the preferred material, but suffers from the small overlap of its optical absorption with the visible spectrum. Efforts to increase the degree of visible light activation of catalysis are surveyed. The overall goal of this article is to provide the scientific and technical basis for the effectiveness of PAC in order to serve as a guide to appropriate decisions within healthcare environments. © 2015 Collegium Basilea.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :6&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Ramsden, J.J.; Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, 2-3-10 Kanda-Surugadai, Japan; email: jeremy.ramsden@buckingham.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84974721047&amp;doi=10.4024%2fN12RA15A.ntp.011.03&amp;partnerID=40&amp;md5=2b4ef68e065cddabbb868f121fc7b8a1</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.4024/N12RA15A.ntp.011.03</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>194</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">194</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rogers, J.</style></author><author><style face="normal" font="default" size="100%">Dowsett, A. B.</style></author><author><style face="normal" font="default" size="100%">Dennis, P. J.</style></author><author><style face="normal" font="default" size="100%">Lee, J. V.</style></author><author><style face="normal" font="default" size="100%">Keevil, C. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Pathology Division, PHLS CAMR, Porton Down, Salisbury, Wiltshire, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Influence of temperature and plumbing material selection on biofilm formation and growth of Legionella pneumophila in a model potable water system containing complex microbial flora</style></title><secondary-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">APPL. ENVIRON. MICROBIOL.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">APPL. ENVIRON. MICROBIOL.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">APPL. ENVIRON. MICROBIOL.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">1585-1592</style></pages><volume><style face="normal" font="default" size="100%">60</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">copper ion</style></keyword><keyword><style face="normal" font="default" size="100%">polyvinylchloride</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial colonization</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial flora</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial growth</style></keyword><keyword><style face="normal" font="default" size="100%">biofilm</style></keyword><keyword><style face="normal" font="default" size="100%">cell survival</style></keyword><keyword><style face="normal" font="default" size="100%">legionella pneumophila</style></keyword><keyword><style face="normal" font="default" size="100%">plankton</style></keyword><keyword><style face="normal" font="default" size="100%">statistical analysis</style></keyword><keyword><style face="normal" font="default" size="100%">temperature measurement</style></keyword><keyword><style face="normal" font="default" size="100%">water contamination</style></keyword><keyword><style face="normal" font="default" size="100%">water supply</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Adhesion</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Glass</style></keyword><keyword><style face="normal" font="default" size="100%">Microscopy, Electron, Scanning</style></keyword><keyword><style face="normal" font="default" size="100%">Polyenes</style></keyword><keyword><style face="normal" font="default" size="100%">Polyvinyl Chloride</style></keyword><keyword><style face="normal" font="default" size="100%">Sanitary Engineering</style></keyword><keyword><style face="normal" font="default" size="100%">Temperature</style></keyword><keyword><style face="normal" font="default" size="100%">Water Microbiology</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1994</style></year></dates><isbn><style face="normal" font="default" size="100%">00992240 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Survival and growth of Legionella pneumophila in both biofilm and planktonic phases were determined with a two-stage model system. The model used filter-sterilized tap water as the sole source of nutrient to culture a naturally occurring mixed population of microorganisms including virulent L. pneumophila. At 20°C, L. pneumophila accounted for a low proportion of biofilm flora on polybutylene and chlorinated polyvinyl chloride, but was absent from copper surfaces. The pathogen was most abundant on biofilms on plastics at 40°C, where if accounted for up to 50% of the total biofilm flora. Copper surfaces were inhibitory to total biofouling and included only low numbers of L. pneumophila organisms. The pathogen was able to survive in biofilms on the surface of the plastic materials at 50°C, but was absent from the copper surfaces at the same temperature. L. pneumophila could not be detected in the model system at 60°C. In the presence of copper surfaces, biofilms forming on adjacent control glass surfaces were found to incorporate copper ions which subsequently inhibited colonization of their surfaces. This work suggests that the use of copper tubing in water systems may help to limit the colonization of water systems by L. pneumophila.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :202&#xD;Export Date: 26 March 2020&#xD;CODEN: AEMID&#xD;Correspondence Address: Rogers, J.; Pathology Division, PHLS CAMR, Porton Down, Salisbury, Wiltshire, United Kingdom</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028212860&amp;partnerID=40&amp;md5=9a4f790879ea28790e0fd2daae1e7b8e</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">8017938</style></custom2><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>195</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">195</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rosenberg, M.</style></author><author><style face="normal" font="default" size="100%">Vija, H.</style></author><author><style face="normal" font="default" size="100%">Kahru, A.</style></author><author><style face="normal" font="default" size="100%">Keevil, C.</style></author><author><style face="normal" font="default" size="100%">Ivask, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Laboratory of Environmental Toxicology, National Institute of Chemical Physics and Biophysics, Tallinn, Estonia&#xD;Department of Natural Sciences, Tallinn University of Technology, Tallinn, Estonia&#xD;Estonian Academy of Sciences, Kohtu 6, Tallinn, Estonia&#xD;Faculty of Natural and Environmental Sciences, Centre for Biological Sciences, University of Southampton, Southampton, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Rapid in situ assessment of Cu-ion mediated effects and antibacterial efficacy of copper surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Scientific Reports</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Sci. Rep.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Scientific Reports</style></full-title><abbr-1><style face="normal" font="default" size="100%">Sci. Rep.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Scientific Reports</style></full-title><abbr-1><style face="normal" font="default" size="100%">Sci. Rep.</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">8</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">copper</style></keyword><keyword><style face="normal" font="default" size="100%">drug effect</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">genetic procedures</style></keyword><keyword><style face="normal" font="default" size="100%">luminescence</style></keyword><keyword><style face="normal" font="default" size="100%">microbial viability</style></keyword><keyword><style face="normal" font="default" size="100%">physiology</style></keyword><keyword><style face="normal" font="default" size="100%">procedures</style></keyword><keyword><style face="normal" font="default" size="100%">surface property</style></keyword><keyword><style face="normal" font="default" size="100%">time factor</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Biosensing Techniques</style></keyword><keyword><style face="normal" font="default" size="100%">Luminescent Measurements</style></keyword><keyword><style face="normal" font="default" size="100%">Surface Properties</style></keyword><keyword><style face="normal" font="default" size="100%">Time Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2018</style></year></dates><publisher><style face="normal" font="default" size="100%">Nature Publishing Group</style></publisher><isbn><style face="normal" font="default" size="100%">20452322 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Release of metal ions from metal-based surfaces has been considered one of the main drivers of their antimicrobial activity. Here we describe a method that enables parallel assessment of metal ion release from solid metallic surfaces and antimicrobial efficacy of these surfaces in a short time period. The protocol involves placement of a small volume of bioluminescent bacteria onto the tested surface and direct measurement of bioluminescence at various time points. In this study, two recombinant Escherichia coli strains, one expressing bioluminescence constitutively and applicable for general antimicrobial testing, and the other induced by Cu ions, were selected. Decrease in bioluminescence of constitutive E. coli on the surfaces showed a good correlation with the decrease in bacterial viability. Response of Cu-inducible E. coli showed a correlation with Cu content in the tested surfaces but not with Cu dissolution suggesting the role of direct bacteria-surface contact in Cu ion-driven antibacterial effects. In summary, the presented protocol enables the analysis of microbial toxicity and bioavailability of surface-released metal ions directly on solid surfaces within 30-60 min. Although optimized for copper and copper alloy surfaces and E. coli, the method can be extended to other types of metallic surfaces and bacterial strains. © 2018 The Author(s).</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :9&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Keevil, C.; Faculty of Natural and Environmental Sciences, Centre for Biological Sciences, University of SouthamptonUnited Kingdom; email: C.W.Keevil@soton.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85047630495&amp;doi=10.1038%2fs41598-018-26391-8&amp;partnerID=40&amp;md5=0bcace88e2c6e4255106715935062d98</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">29802355</style></custom2><custom7><style face="normal" font="default" size="100%">8172</style></custom7><electronic-resource-num><style face="normal" font="default" size="100%">10.1038/s41598-018-26391-8</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>196</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">196</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Salgado, C.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Medical University of South Carolina, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Harnessing the killing power of copper</style></title><secondary-title><style face="normal" font="default" size="100%">Hospital Infection Control and Prevention</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Hosp. Infect. Control. Prev.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Hospital Infection Control and Prevention</style></full-title><abbr-1><style face="normal" font="default" size="100%">Hosp. Infect. Control. Prev.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Hospital Infection Control and Prevention</style></full-title><abbr-1><style face="normal" font="default" size="100%">Hosp. Infect. Control. Prev.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">66-67</style></pages><volume><style face="normal" font="default" size="100%">40</style></volume><number><style face="normal" font="default" size="100%">6</style></number><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><isbn><style face="normal" font="default" size="100%">0098180X (ISSN)</style></isbn><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Salgado, C.; Medical University of South CarolinaUnited States</style></notes><work-type><style face="normal" font="default" size="100%">Short Survey</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84879994919&amp;partnerID=40&amp;md5=4d0bd98415dc4f8ed6a49ba3a0d7f46e</style></url></related-urls></urls><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>197</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">197</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Salgado, C. D.</style></author><author><style face="normal" font="default" size="100%">Giannetta, E. T.</style></author><author><style face="normal" font="default" size="100%">Hayden, F. G.</style></author><author><style face="normal" font="default" size="100%">Farr, B. M.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Medical University of South Carolina, Charleston, SC, United States&#xD;University of Virginia Health System, Charlottesville, VA, United States&#xD;Department of Medicine, Hospital Epidemiologist, Medical University of South Carolina, 100 Doughty Street, Charleston, SC 29425, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Preventing nosocomial influenza by improving the vaccine acceptance rate of clinicians</style></title><secondary-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Infection Control and Hospital Epidemiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Infect. Control Hosp. Epidemiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">923-928</style></pages><volume><style face="normal" font="default" size="100%">25</style></volume><number><style face="normal" font="default" size="100%">11</style></number><keywords><keyword><style face="normal" font="default" size="100%">influenza vaccine</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">clinical practice</style></keyword><keyword><style face="normal" font="default" size="100%">epidemic</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">hospitalization</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">influenza</style></keyword><keyword><style face="normal" font="default" size="100%">Influenza virus A</style></keyword><keyword><style face="normal" font="default" size="100%">logistic regression analysis</style></keyword><keyword><style face="normal" font="default" size="100%">patient compliance</style></keyword><keyword><style face="normal" font="default" size="100%">virus transmission</style></keyword><keyword><style face="normal" font="default" size="100%">Adult</style></keyword><keyword><style face="normal" font="default" size="100%">Attitude of Health Personnel</style></keyword><keyword><style face="normal" font="default" size="100%">Child</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Health Knowledge, Attitudes, Practice</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Immunization Programs</style></keyword><keyword><style face="normal" font="default" size="100%">Incidence</style></keyword><keyword><style face="normal" font="default" size="100%">Infection Control</style></keyword><keyword><style face="normal" font="default" size="100%">Influenza Vaccines</style></keyword><keyword><style face="normal" font="default" size="100%">Influenza, Human</style></keyword><keyword><style face="normal" font="default" size="100%">Logistic Models</style></keyword><keyword><style face="normal" font="default" size="100%">Patient Acceptance of Health Care</style></keyword><keyword><style face="normal" font="default" size="100%">Personnel, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Virginia</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2004</style></year></dates><isbn><style face="normal" font="default" size="100%">0899823X (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">OBJECTIVES: To assess the effects of interventions to prevent transmission of influenza and to increase employee compliance with influenza vaccination. DESIGN: The change in the proportion of hospitalized patients with laboratory-confirmed nosocomial influenza was observed over time and assessed using chi-square for trend analysis. The association between nosocomial influenza in patients and healthcare worker (HCW) compliance with vaccine was assessed by logistic regression. SETTING: A 600-bed, tertiary-care academic hospital. METHODS: After an outbreak of influenza A at this hospital in 1988, a mobile cart program was instituted with increased efforts to motivate employees to be vaccinated and furloughed when ill as well as new measures to prevent nosocomial spread. RESULTS: HCW vaccination rates increased from 4% in 1987-1988 to 67% in 1999-2000 (P &lt; .0001). Proportions of nosocomially acquired influenza cases among employees or patients both declined significantly (P &lt; .0001). Logistic regression analysis revealed a significant inverse association between HCW compliance with vaccination and the rate of nosocomial influenza among patients (P &lt; .001). CONCLUSION: A mobile cart vaccination program and an increased emphasis on HCWs to receive the vaccine were associated with a significant increase in vaccine acceptance and a significant decrease in the rate of nosocomial influenza among patients.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :218&#xD;Export Date: 26 March 2020&#xD;CODEN: ICEPE&#xD;Correspondence Address: Salgado, C.D.; Department of Medicine, Hospital Epidemiologist, Medical University of South Carolina, 100 Doughty Street, Charleston, SC 29425, United States</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-9244249139&amp;doi=10.1086%2f502321&amp;partnerID=40&amp;md5=4dfa8882fe4b66e112b6509027645338</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">15566025</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1086/502321</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>198</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">198</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Samore, M. H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">New England Deaconess Hospital, Division of Infectious Diseases, 185 Pilgrim Road, Boston, MA 02215, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Medicine</style></secondary-title><alt-title><style face="normal" font="default" size="100%">AM. J. MED.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Medicine</style></full-title><abbr-1><style face="normal" font="default" size="100%">AM. J. MED.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">American Journal of Medicine</style></full-title><abbr-1><style face="normal" font="default" size="100%">AM. J. MED.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">32-40</style></pages><volume><style face="normal" font="default" size="100%">100</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">cytotoxin</style></keyword><keyword><style face="normal" font="default" size="100%">restriction endonuclease</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium contamination</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium culture</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium isolation</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">diarrhea</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">feces analysis</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">hospital personnel</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">prospective study</style></keyword><keyword><style face="normal" font="default" size="100%">pulsed field gel electrophoresis</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">1996</style></year></dates><publisher><style face="normal" font="default" size="100%">Elsevier Inc.</style></publisher><isbn><style face="normal" font="default" size="100%">00029343 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">PURPOSE: A prospective clinical and molecular epidemiologic study was conducted to define the frequency of nosocomial Clostridium difficile patient-to-patient transmission in an urban tertiary referral hospital. PATIENTS AND METHODS: Over a 6-month period, environmental cultures for C difficile were obtained from patients with new positive stool cytotoxin assay (index cases); stool samples were obtained from selected patient contacts (the roommate, occupants of adjacent rooms, and the patient occupying the index room after discharge of the index case); and hand cultures were obtained from personnel contacts. C difficile isolates were analyzed by pulse-field gel electrophoresis (PFGE) or, for isolates that were nontypeable by PFGE, by restriction enzyme analysis. RESULTS: During the study period, we identified 98 index cases of C difficile toxin-associated diarrhea, including focal outbreaks on two wards totaling 26 cases within a 2-month interval. Environmental contamination was detected at ≥1 sites in 58% of rooms and often involved wide dispersed areas. Among 99 prospectively identified patient contacts, C difficile was cultured from the stool of 31 (31%), including 12 with diarrhea and 19 who were asymptomatic. C difficile was cultured from the hands of 10 (14%) of 73 personnel. Molecular analysis resolved 31 typing profiles among the index isolates; the most common profile (designated strain D1) was represented by 30 isolates. Among the isolates from patient contacts, 5 of 12 from symptomatic contacts matched the corresponding index isolate, and only 1 of 19 from asymptomatically colonized contacts matched. Transmission to personnel or patient contacts of the strain cultured from the corresponding index case was correlated strongly with the intensity of environmental contamination. Strain D1 was frequently represented among isolates associated with heavy environmental contamination, with personnel carriage, and with development of symptomatic illness among prospectively identified contacts. CONCLUSIONS: Intense environmental contamination and transmission to close personnel and patient contacts represented coordinated properties of an individual epidemic strain. For most epidemiologically linked contacts, positive cultures for C difficile did not result from transmission from the presumed index case.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :273&#xD;Export Date: 26 March 2020&#xD;CODEN: AJMEA&#xD;Correspondence Address: Samore, M.H.; Division of Infectious Diseases, New England Deaconess Hospital, 185 Pilgrim Road, Boston, MA 02215, United States</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0030061122&amp;doi=10.1016%2fS0002-9343%2896%2990008-X&amp;partnerID=40&amp;md5=a4c3142ee2833f47923473dbda660293</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">8579084</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/S0002-9343(96)90008-X</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>199</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">199</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sanchez Ramirez, D. O.</style></author><author><style face="normal" font="default" size="100%">Varesano, A.</style></author><author><style face="normal" font="default" size="100%">Carletto, R. A.</style></author><author><style face="normal" font="default" size="100%">Vineis, C.</style></author><author><style face="normal" font="default" size="100%">Perelshtein, I.</style></author><author><style face="normal" font="default" size="100%">Natan, M.</style></author><author><style face="normal" font="default" size="100%">Perkas, N.</style></author><author><style face="normal" font="default" size="100%">Banin, E.</style></author><author><style face="normal" font="default" size="100%">Gedanken, A.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">CNR-ISMAC, Institute for Macromolecular Studies, C.so G. Pella 16Biella 13900, Italy&#xD;Department of Chemistry, Bar-Ilan University, Ramat Gan, 5290002, Israel&#xD;Institute for Nanotechnology and Advanced Materials (BINA), Bar-Ilan University, Ramat Gan, 5290002, Israel&#xD;The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan, 5290002, Israel</style></auth-address><titles><title><style face="normal" font="default" size="100%">Antibacterial properties of polypyrrole-treated fabrics by ultrasound deposition</style></title><secondary-title><style face="normal" font="default" size="100%">Materials Science and Engineering C</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Mater. Sci. Eng. C</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Materials Science and Engineering C</style></full-title><abbr-1><style face="normal" font="default" size="100%">Mater. Sci. Eng. C</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Materials Science and Engineering C</style></full-title><abbr-1><style face="normal" font="default" size="100%">Mater. Sci. Eng. C</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">164-170</style></pages><volume><style face="normal" font="default" size="100%">102</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Antibacterial fabric</style></keyword><keyword><style face="normal" font="default" size="100%">Conjugated polymer</style></keyword><keyword><style face="normal" font="default" size="100%">Nanoparticle</style></keyword><keyword><style face="normal" font="default" size="100%">Sonochemical coating</style></keyword><keyword><style face="normal" font="default" size="100%">Ultrasound</style></keyword><keyword><style face="normal" font="default" size="100%">Conjugated polymers</style></keyword><keyword><style face="normal" font="default" size="100%">Deposition</style></keyword><keyword><style face="normal" font="default" size="100%">Dispersions</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">Fabrics</style></keyword><keyword><style face="normal" font="default" size="100%">Nanoparticles</style></keyword><keyword><style face="normal" font="default" size="100%">Polypyrroles</style></keyword><keyword><style face="normal" font="default" size="100%">Synthesis (chemical)</style></keyword><keyword><style face="normal" font="default" size="100%">Ultrasonics</style></keyword><keyword><style face="normal" font="default" size="100%">Antibacterial coatings</style></keyword><keyword><style face="normal" font="default" size="100%">Antibacterial properties</style></keyword><keyword><style face="normal" font="default" size="100%">Antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Antimicrobial textiles</style></keyword><keyword><style face="normal" font="default" size="100%">Chemical oxidative polymerization</style></keyword><keyword><style face="normal" font="default" size="100%">Pathogenic microorganisms</style></keyword><keyword><style face="normal" font="default" size="100%">Sonochemical coatings</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Plastic coatings</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">polymer</style></keyword><keyword><style face="normal" font="default" size="100%">polypyrrole</style></keyword><keyword><style face="normal" font="default" size="100%">pyrrole derivative</style></keyword><keyword><style face="normal" font="default" size="100%">chemistry</style></keyword><keyword><style face="normal" font="default" size="100%">drug effect</style></keyword><keyword><style face="normal" font="default" size="100%">infrared spectroscopy</style></keyword><keyword><style face="normal" font="default" size="100%">microbial sensitivity test</style></keyword><keyword><style face="normal" font="default" size="100%">textile</style></keyword><keyword><style face="normal" font="default" size="100%">thermogravimetry</style></keyword><keyword><style face="normal" font="default" size="100%">viscosity</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Microbial Sensitivity Tests</style></keyword><keyword><style face="normal" font="default" size="100%">Polymers</style></keyword><keyword><style face="normal" font="default" size="100%">Pyrroles</style></keyword><keyword><style face="normal" font="default" size="100%">Spectroscopy, Fourier Transform Infrared</style></keyword><keyword><style face="normal" font="default" size="100%">Textiles</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><publisher><style face="normal" font="default" size="100%">Elsevier Ltd</style></publisher><isbn><style face="normal" font="default" size="100%">09284931 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Antimicrobial textiles can contribute to the fighting against antibiotic resistance pathogenic microorganisms. Polypyrrole is a conjugated polymer that exerts a biocidal action thanks to positive charges on its backbone chain produced during it synthesis. In this work, dispersions of stable polypyrrole nanoparticles were produced by chemical oxidative polymerization at room temperature in water. An ultrasound-assisted coating process was then used to effectively treat a polyester fabric with the nanoparticles to obtain an optimal antibacterial coating which efficiently eradicates the bacteria. The results showed that the treated fabric with about 4 g/m2 of polypyrrole had log bacteria reductions of 6.0 against Staphylococcus aureus and 7.5 against Escherichia coli. The combination of a polypyrrole synthesis in the form of water nanoparticles dispersions and a continuous coating of fabrics supported by ultrasound overcomes some issues of upscaling of the traditional in-situ chemical deposition used until now for the production of polypyrrole-coated textiles. © 2019</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :1&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Varesano, A.; CNR-ISMAC, Institute for Macromolecular Studies, C.so G. Pella 16, Italy; email: a.varesano@bi.ismac.cnr.it</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85064491172&amp;doi=10.1016%2fj.msec.2019.04.016&amp;partnerID=40&amp;md5=a89e60892aede17aa6ad4434f6ca4eb2</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">31146987</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.msec.2019.04.016</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>200</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">200</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Santo, C. E.</style></author><author><style face="normal" font="default" size="100%">Taudte, N.</style></author><author><style face="normal" font="default" size="100%">Nies, D. H.</style></author><author><style face="normal" font="default" size="100%">Grass, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Departamento de Bioquímica, Faculdade de Ciências e Tecnologia, Universidade de Coimbra, Portugal&#xD;Institut für Biologie/Mikrobiologie, Martin-Luther-Universität, Halle-Wittenberg, Germany&#xD;Institut für Biologie/Mikrobiologie, Martin-Luther-Universität, Halle-Wittenberg, Kurt-Mothes-Str. 3, 06120 Halle, Germany</style></auth-address><titles><title><style face="normal" font="default" size="100%">Contribution of copper ion resistance to survival of Escherichia coli on metallic copper surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Appl. Environ. Microbiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">APPL. ENVIRON. MICROBIOL.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Applied and Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">APPL. ENVIRON. MICROBIOL.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">977-986</style></pages><volume><style face="normal" font="default" size="100%">74</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">Antibiotics</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Detoxification</style></keyword><keyword><style face="normal" font="default" size="100%">Disinfectants</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial inactivation</style></keyword><keyword><style face="normal" font="default" size="100%">Copper ion resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Osmotic stress</style></keyword><keyword><style face="normal" font="default" size="100%">Reactive oxygen species</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">chelating agent</style></keyword><keyword><style face="normal" font="default" size="100%">copper ion</style></keyword><keyword><style face="normal" font="default" size="100%">metal</style></keyword><keyword><style face="normal" font="default" size="100%">reactive oxygen metabolite</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">public health</style></keyword><keyword><style face="normal" font="default" size="100%">survival</style></keyword><keyword><style face="normal" font="default" size="100%">toxicity</style></keyword><keyword><style face="normal" font="default" size="100%">anaerobic metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial survival</style></keyword><keyword><style face="normal" font="default" size="100%">bactericidal activity</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium contamination</style></keyword><keyword><style face="normal" font="default" size="100%">cold</style></keyword><keyword><style face="normal" font="default" size="100%">germ cell</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">sensitivity analysis</style></keyword><keyword><style face="normal" font="default" size="100%">surface property</style></keyword><keyword><style face="normal" font="default" size="100%">wild type</style></keyword><keyword><style face="normal" font="default" size="100%">Cations</style></keyword><keyword><style face="normal" font="default" size="100%">Oxidation-Reduction</style></keyword><keyword><style face="normal" font="default" size="100%">Survival Analysis</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria (microorganisms)</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year></dates><isbn><style face="normal" font="default" size="100%">00992240 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Bacterial contamination of touch surfaces poses a serious threat for public health. The use of bactericidal surface materials, such as copper and its alloys, might constitute a way to aid the use of antibiotics and disinfectants, thus minimizing the risk of emergence and spread of multiresistant germs. The survival of Escherichia coli on metallic copper surfaces has been studied previously; however, the mechanisms underlying bacterial inactivation on copper surfaces have not been elucidated. Data presented in this study suggest that bacteria are killed rapidly on dry copper surfaces. Several factors, such as copper ion toxicity, copper chelators, cold, osmotic stress, and reactive oxygen species, but not anaerobiosis, influenced killing rates. Strains deleted in copper detoxification systems were slightly more sensitive than was the wild type. Preadaptation to copper enhanced survival rates upon copper surface exposure. This study constitutes a first step toward understanding the reasons for metallic copper surface-mediated killing of bacteria. Copyright © 2008, American Society for Microbiology. All Rights Reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :167&#xD;Export Date: 26 March 2020&#xD;CODEN: AEMID&#xD;Correspondence Address: Grass, G.; Institut für Biologie/Mikrobiologie, Martin-Luther-Universität, Halle-Wittenberg, Kurt-Mothes-Str. 3, 06120 Halle, Germany; email: g.grass@mikrobiologie.uni-halle.de</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-39649093183&amp;doi=10.1128%2fAEM.01938-07&amp;partnerID=40&amp;md5=86400ccdcb61e9af24b6153e62ce6bbf</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">18156321</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1128/AEM.01938-07</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>201</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">201</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Schmidt, M. G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Sterilization, disinfection, and antisepsis</style></title><secondary-title><style face="normal" font="default" size="100%">Practical Handbook of Microbiology, Third Edition</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Practical Handb. of Microbiology, Third Edition</style></alt-title></titles><pages><style face="normal" font="default" size="100%">3-18</style></pages><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><publisher><style face="normal" font="default" size="100%">CRC Press</style></publisher><isbn><style face="normal" font="default" size="100%">9781466587403 (ISBN); 9781466587397 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">The techniques to control the growth of microorganisms have been shaped by both cultural and scientific advances. From the days of early food preservation, fermentation of milk products, and smoking of meats to extend the shelf life of foods, practical needs have contributed to the development of the techniques and tools required from sterilization, disinfection, and antisepsis. © 2015 by Taylor &amp; Francis Group, LLC.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Schmidt, M.G.; Department of Microbiology and Immunology, Medical University of South CarolinaUnited States</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85054257925&amp;doi=10.1201%2fb17871&amp;partnerID=40&amp;md5=c78ec003736489eb2336ec4af216e6b9</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1201/b17871</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>202</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">202</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Schmidt, M. G.</style></author><author><style face="normal" font="default" size="100%">Banks, A. L.</style></author><author><style face="normal" font="default" size="100%">Salgado, C. D.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Ave-MSC504, BSB 214A, Charleston, SC 29425, United States&#xD;Department of Medicine, Division of Infectious Diseases, Medical University of South Carolina, 135 Rutledge Tower- MSC752, Charleston, SC 29425, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Role of the microbial burden in the acquisition and control of healthcare associated infections: The utility of solid copper surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Use of Biocidal Surfaces for Reduction of Healthcare Acquired Infections</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Use of Biocidal Surf. for Red. of Healthc. Acquired Infect.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">59-83</style></pages><volume><style face="normal" font="default" size="100%">9783319080574</style></volume><keywords><keyword><style face="normal" font="default" size="100%">Antimicrobial Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital Associated Infections (HAI)</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">Mergers and acquisitions</style></keyword><keyword><style face="normal" font="default" size="100%">Built environment</style></keyword><keyword><style face="normal" font="default" size="100%">Clinical environments</style></keyword><keyword><style face="normal" font="default" size="100%">Copper surface</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental burdens</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental surfaces</style></keyword><keyword><style face="normal" font="default" size="100%">Healthcare workers</style></keyword><keyword><style face="normal" font="default" size="100%">Microbial burdens</style></keyword><keyword><style face="normal" font="default" size="100%">Scientific evidence</style></keyword><keyword><style face="normal" font="default" size="100%">Health care</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2014</style></year></dates><publisher><style face="normal" font="default" size="100%">Springer International Publishing</style></publisher><isbn><style face="normal" font="default" size="100%">9783319080574 (ISBN); 3319080563 (ISBN); 9783319080567 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">For more than a century, healthcare has been challenged to keep environmental surfaces clean to control microbes and improve patient outcomes. However despite an annual cost exceeding ten billion dollars cleaning with disinfection has done little to reduce the incidence of healthcare-associated infections (HAI). This chapter will review the scientific evidence delineating the role that the environment and healthcare workers play in the acquisition and movement of the microbes implicated in HAI and how through controlling the microbial burden of the built clinical environment it is possible to mitigate the rate of HAI acquisition. Specifically evidence demonstrating the effectiveness of solid copper surfaces for its ability to continuously limit the concentration of bacteria found on surfaces and objects within the built environment will be reviewed in concert with a discussion of how through the mitigation of the environmental burden copper surfaces are able to concomitantly reduce the incidence of HAI. Insights provided by this chapter are intended to facilitate an understanding and importance of the need to use a comprehensive or systems based approach to fight healthcare associated infections. © 2014 Springer International Publishing Switzerland. All rights are reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :1&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Schmidt, M.G.; Department of Microbiology and Immunology, Medical University of South Carolina, 173 Ashley Ave-MSC504, BSB 214A, United States</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84928889496&amp;doi=10.1007%2f978-3-319-08057-4_4&amp;partnerID=40&amp;md5=89eb6dd62ebf35ad9086249be5252c8b</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-3-319-08057-4_4</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>203</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">203</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Schmidt, M. G.</style></author><author><style face="normal" font="default" size="100%">John, J. F.</style></author><author><style face="normal" font="default" size="100%">Johnson Va, R. H.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Medical University of South Carolina, 169 Ashley Avenue, Charleston, SC 29403, United States&#xD;Medical University of South Carolina, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">The role of continuous microbial debulking in the hospital environment and its effect on reducing hospital-acquired infections (HAI)</style></title><secondary-title><style face="normal" font="default" size="100%">Decontamination in Hospitals and Healthcare</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Decontam. in Hospitals and Healthc.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">232-253</style></pages><keywords><keyword><style face="normal" font="default" size="100%">Antimicrobial copper</style></keyword><keyword><style face="normal" font="default" size="100%">Effectiveness of cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental burden</style></keyword><keyword><style face="normal" font="default" size="100%">Hospital-acquired infections (HAI)</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><publisher><style face="normal" font="default" size="100%">Elsevier Ltd.</style></publisher><isbn><style face="normal" font="default" size="100%">9780857096579 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">Healthcare-acquired infections (HAI) result in significant patient morbidity and mortality. Biofilms are ubiquitous. They represent the dominant form of life on inanimate objects and the surfaces of all living organisms. Routine hygienic measures and extraordinary disinfection can limit the risk posed by microbes but have been found lacking in being able to reduce the incidence of HAI and emergence of resistance to antimicrobials. Recent work has found that when microbes come in direct contact with solid copper surfaces their number and ability to move antibiotic resistance determinants are continuously mitigated. In the latter half of the 19th century Nightingale appreciated that when hospitals were kept clean, deaths from infectious diseases were lower. This chapter will address whether the use of solid copper in hospitals to control bacteria and biofilms represents a transformation to medicine similar in signficance to the observation made by Nightingale. © 2014 Woodhead Publishing Limited. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Schmidt, M.G.; Medical University of South Carolina, 169 Ashley Avenue, Charleston, SC 29403, United States; email: schmidtm@musc.edu</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902052849&amp;doi=10.1533%2f9780857096692.2.232&amp;partnerID=40&amp;md5=54622344e46dcbfa844c871025b992b3</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1533/9780857096692.2.232</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>204</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shanmugam, J.</style></author><author><style face="normal" font="default" size="100%">Anitha, T. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Central Inter-Disciplinary Research Facility, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed University), Puducherry, 607 603, India</style></auth-address><titles><title><style face="normal" font="default" size="100%">Copper - A promising antimicrobial metal having potential application to reduce healthcare acquired infections</style></title><secondary-title><style face="normal" font="default" size="100%">Journal International Medical Sciences Academy</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Int. Med. Sci. Acad.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal International Medical Sciences Academy</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Int. Med. Sci. Acad.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal International Medical Sciences Academy</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Int. Med. Sci. Acad.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">215-217</style></pages><volume><style face="normal" font="default" size="100%">28</style></volume><number><style face="normal" font="default" size="100%">4</style></number><keywords><keyword><style face="normal" font="default" size="100%">alloy</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">copper</style></keyword><keyword><style face="normal" font="default" size="100%">disinfectant agent</style></keyword><keyword><style face="normal" font="default" size="100%">antimicrobial activity</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium contamination</style></keyword><keyword><style face="normal" font="default" size="100%">healthcare associated infection</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">medical research</style></keyword><keyword><style face="normal" font="default" size="100%">Review</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2015</style></year></dates><publisher><style face="normal" font="default" size="100%">International Medical Sciences Academy</style></publisher><isbn><style face="normal" font="default" size="100%">0971071X (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Copper (Cu) and its alloys (brasses, bronzes, cupronickel, copper-nickel-zinc, and others) are known to have inherent antimicrobial properties since the dawn of civilization. It has been demonstrated by in vitro studies that copper has rapid, broad spectrum antimicrobial efficacy against some of the most pathogenic species of bacteria, fungi and viruses. The antimicrobial copper surfaces have been proven to harbor 83-100% less bacterial contamination than the conventional touch surfaces of stainless steel or plastic. Molecular mechanisms liable for the antibacterial activity of copper have been a subject of intensive research. Recently, the intrinsic efficacies of copper alloy &quot;touch surfaces&quot; to destroy a wide range of microorganisms which can cause healthcare acquired infections (HAIs) has been reported. In the year 2008, the US Environmental Protection Agency has confirmed copper as the first solid antimicrobial disinfectant. A renewed interest has been shown by researchers in few countries to explore the mechanism of antimicrobial properties of copper and their potential uses in the hospitals in order to reduce HAIs. This review provides a deep insight on the intrinsic values of copper and its alloys as solid antimicrobial material and their applications in wards and ICUs as supportive preventive measures to reduce the HAIs.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;CODEN: JMSAE&#xD;Correspondence Address: Shanmugam, J.; Central Inter-Disciplinary Research Facility, Mahatma Gandhi Medical College and Research Institute, Sri Balaji Vidyapeeth (Deemed University)India; email: drjshanmugam@gmail.com</style></notes><work-type><style face="normal" font="default" size="100%">Review</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84962237843&amp;partnerID=40&amp;md5=d2b775fa27ed10e3edb3dd4ddf47be58</style></url></related-urls></urls><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>205</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">205</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shiomori, T.</style></author><author><style face="normal" font="default" size="100%">Miyamoto, H.</style></author><author><style face="normal" font="default" size="100%">Makishima, K.</style></author><author><style face="normal" font="default" size="100%">Yoshida, M.</style></author><author><style face="normal" font="default" size="100%">Fujiyoshi, T.</style></author><author><style face="normal" font="default" size="100%">Udaka, T.</style></author><author><style face="normal" font="default" size="100%">Inaba, T.</style></author><author><style face="normal" font="default" size="100%">Hiraki, N.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Otorhinolaryngology, Univ. of Occupational/Environ. Hlth., School of Medicine, Kitakyushu 807-8555, Japan&#xD;Department of Microbiology, Univ. of Occupational/Environ. Hlth., School of Medicine, Kitakyushu 807-8555, Japan</style></auth-address><titles><title><style face="normal" font="default" size="100%">Evaluation of bedmaking-related airborne and surface methicillin-resistant Staphylococcus aureus contamination</style></title><secondary-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></secondary-title><alt-title><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Journal of Hospital Infection</style></full-title><abbr-1><style face="normal" font="default" size="100%">J. Hosp. Infect.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">30-35</style></pages><volume><style face="normal" font="default" size="100%">50</style></volume><number><style face="normal" font="default" size="100%">1</style></number><keywords><keyword><style face="normal" font="default" size="100%">Air contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Andersen air sampler</style></keyword><keyword><style face="normal" font="default" size="100%">Bedmaking</style></keyword><keyword><style face="normal" font="default" size="100%">MRSA</style></keyword><keyword><style face="normal" font="default" size="100%">adult</style></keyword><keyword><style face="normal" font="default" size="100%">aged</style></keyword><keyword><style face="normal" font="default" size="100%">air sampler</style></keyword><keyword><style face="normal" font="default" size="100%">air sampling</style></keyword><keyword><style face="normal" font="default" size="100%">airborne infection</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial colonization</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial transmission</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium contamination</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium detection</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium isolation</style></keyword><keyword><style face="normal" font="default" size="100%">child</style></keyword><keyword><style face="normal" font="default" size="100%">clinical article</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">female</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">hospital bed</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">male</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus infection</style></keyword><keyword><style face="normal" font="default" size="100%">bed</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">drug effect</style></keyword><keyword><style face="normal" font="default" size="100%">environmental exposure</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">hospital service</style></keyword><keyword><style face="normal" font="default" size="100%">isolation and purification</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">penicillin resistance</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Air Microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Bedding and Linens</style></keyword><keyword><style face="normal" font="default" size="100%">Housekeeping, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin Resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Patients&apos; Rooms</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcal Infections</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2002</style></year></dates><isbn><style face="normal" font="default" size="100%">01956701 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">The number of airborne methicillin-resistant Staphylococcus aureus (MRSA) before, during and after bedmaking was investigated. Air was sampled with an Andersen air sampler in the rooms of 13 inpatients with MRSA infection or colonization. Sampling of surfaces, including floors and bedsheets, was performed by stamp methods. MRSA-containing particles were isolated on all the sampler stages-stage 1 (&gt;7 μm diameter) to stage 6 (0.65-1.1 μm). The MRSA-containing particles were mostly 2-3 μm diameter before bedmaking and &gt;5 μm during bedmaking. The number was significantly higher 15 min after bedmaking than during the resting period, but the differences in counts after 30 and 60 min were not significant. MRSA was detected on many surfaces. The results suggest that MRSA was recirculated in the air, especially after movement. To prevent airborne transmission, healthcare staff should exercise great care to disinfect inanimate environments. Further studies will be needed to confirm the level of MRSA contamination of air during bedmaking and establish measures for prevention of airborne transmission. © 2002 The Hospital Infection Society.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :135&#xD;Export Date: 26 March 2020&#xD;CODEN: JHIND&#xD;Correspondence Address: Makishima, K.; Department of Otorhinolaryngology, Univ. of Occupational/Environ. Hlth., School of Medicine, Kitakyushu 807-8555, Japan</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-0036369469&amp;doi=10.1053%2fjhin.2001.1136&amp;partnerID=40&amp;md5=6e64394730032d78702736fd7e38b1c3</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">11825049</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1053/jhin.2001.1136</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>206</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">206</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Siegel, J. D.</style></author><author><style face="normal" font="default" size="100%">Rhinehart, E.</style></author><author><style face="normal" font="default" size="100%">Jackson, M.</style></author><author><style face="normal" font="default" size="100%">Chiarello, L.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></full-title><abbr-1><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></full-title><abbr-1><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">S65-S164</style></pages><volume><style face="normal" font="default" size="100%">35</style></volume><number><style face="normal" font="default" size="100%">10 SUPPL. 2</style></number><keywords><keyword><style face="normal" font="default" size="100%">ambulatory care</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">biological warfare</style></keyword><keyword><style face="normal" font="default" size="100%">botulism</style></keyword><keyword><style face="normal" font="default" size="100%">bronchoscopy</style></keyword><keyword><style face="normal" font="default" size="100%">burn unit</style></keyword><keyword><style face="normal" font="default" size="100%">cerebrospinal fluid analysis</style></keyword><keyword><style face="normal" font="default" size="100%">chemoprophylaxis</style></keyword><keyword><style face="normal" font="default" size="100%">clinical practice</style></keyword><keyword><style face="normal" font="default" size="100%">computer assisted tomography</style></keyword><keyword><style face="normal" font="default" size="100%">device</style></keyword><keyword><style face="normal" font="default" size="100%">diarrhea</style></keyword><keyword><style face="normal" font="default" size="100%">disease course</style></keyword><keyword><style face="normal" font="default" size="100%">disease predisposition</style></keyword><keyword><style face="normal" font="default" size="100%">disease severity</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">Ebola virus</style></keyword><keyword><style face="normal" font="default" size="100%">Enterobacteriaceae</style></keyword><keyword><style face="normal" font="default" size="100%">Enterovirus</style></keyword><keyword><style face="normal" font="default" size="100%">environmental factor</style></keyword><keyword><style face="normal" font="default" size="100%">epidemic</style></keyword><keyword><style face="normal" font="default" size="100%">exposure</style></keyword><keyword><style face="normal" font="default" size="100%">gene therapy</style></keyword><keyword><style face="normal" font="default" size="100%">geographic distribution</style></keyword><keyword><style face="normal" font="default" size="100%">hand washing</style></keyword><keyword><style face="normal" font="default" size="100%">health behavior</style></keyword><keyword><style face="normal" font="default" size="100%">health care delivery</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">health care policy</style></keyword><keyword><style face="normal" font="default" size="100%">health care system</style></keyword><keyword><style face="normal" font="default" size="100%">health education</style></keyword><keyword><style face="normal" font="default" size="100%">health program</style></keyword><keyword><style face="normal" font="default" size="100%">health promotion</style></keyword><keyword><style face="normal" font="default" size="100%">health service</style></keyword><keyword><style face="normal" font="default" size="100%">health survey</style></keyword><keyword><style face="normal" font="default" size="100%">hemorrhagic fever</style></keyword><keyword><style face="normal" font="default" size="100%">Herpes simplex virus</style></keyword><keyword><style face="normal" font="default" size="100%">high risk population</style></keyword><keyword><style face="normal" font="default" size="100%">home care</style></keyword><keyword><style face="normal" font="default" size="100%">hospital</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">immunoprophylaxis</style></keyword><keyword><style face="normal" font="default" size="100%">infection control</style></keyword><keyword><style face="normal" font="default" size="100%">infection risk</style></keyword><keyword><style face="normal" font="default" size="100%">infection sensitivity</style></keyword><keyword><style face="normal" font="default" size="100%">instrument sterilization</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care unit</style></keyword><keyword><style face="normal" font="default" size="100%">isolation procedure</style></keyword><keyword><style face="normal" font="default" size="100%">Lassa virus</style></keyword><keyword><style face="normal" font="default" size="100%">long term care</style></keyword><keyword><style face="normal" font="default" size="100%">Marburg virus</style></keyword><keyword><style face="normal" font="default" size="100%">Measles virus</style></keyword><keyword><style face="normal" font="default" size="100%">medical information</style></keyword><keyword><style face="normal" font="default" size="100%">meningitis</style></keyword><keyword><style face="normal" font="default" size="100%">monkeypox</style></keyword><keyword><style face="normal" font="default" size="100%">morbidity</style></keyword><keyword><style face="normal" font="default" size="100%">mortality</style></keyword><keyword><style face="normal" font="default" size="100%">Mycobacterium tuberculosis</style></keyword><keyword><style face="normal" font="default" size="100%">Neisseria meningitidis</style></keyword><keyword><style face="normal" font="default" size="100%">Norovirus</style></keyword><keyword><style face="normal" font="default" size="100%">nursing home</style></keyword><keyword><style face="normal" font="default" size="100%">pathogenesis</style></keyword><keyword><style face="normal" font="default" size="100%">patient care</style></keyword><keyword><style face="normal" font="default" size="100%">patient safety</style></keyword><keyword><style face="normal" font="default" size="100%">personal hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">plague</style></keyword><keyword><style face="normal" font="default" size="100%">polymerase chain reaction</style></keyword><keyword><style face="normal" font="default" size="100%">practice guideline</style></keyword><keyword><style face="normal" font="default" size="100%">prion</style></keyword><keyword><style face="normal" font="default" size="100%">prion disease</style></keyword><keyword><style face="normal" font="default" size="100%">prophylaxis</style></keyword><keyword><style face="normal" font="default" size="100%">protective equipment</style></keyword><keyword><style face="normal" font="default" size="100%">rash</style></keyword><keyword><style face="normal" font="default" size="100%">respiratory tract infection</style></keyword><keyword><style face="normal" font="default" size="100%">risk assessment</style></keyword><keyword><style face="normal" font="default" size="100%">risk factor</style></keyword><keyword><style face="normal" font="default" size="100%">severe acute respiratory syndrome</style></keyword><keyword><style face="normal" font="default" size="100%">skin infection</style></keyword><keyword><style face="normal" font="default" size="100%">smallpox</style></keyword><keyword><style face="normal" font="default" size="100%">Smallpox virus</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Streptococcus pneumonia</style></keyword><keyword><style face="normal" font="default" size="100%">tularemia</style></keyword><keyword><style face="normal" font="default" size="100%">Vaccinia virus</style></keyword><keyword><style face="normal" font="default" size="100%">Varicella zoster virus</style></keyword><keyword><style face="normal" font="default" size="100%">Antibiotic Prophylaxis</style></keyword><keyword><style face="normal" font="default" size="100%">Centers for Disease Control and Prevention (U.S.)</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Disease Transmission, Horizontal</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Inservice Training</style></keyword><keyword><style face="normal" font="default" size="100%">Mass Immunization</style></keyword><keyword><style face="normal" font="default" size="100%">Patient Isolation</style></keyword><keyword><style face="normal" font="default" size="100%">Protective Clothing</style></keyword><keyword><style face="normal" font="default" size="100%">Sentinel Surveillance</style></keyword><keyword><style face="normal" font="default" size="100%">United States</style></keyword><keyword><style face="normal" font="default" size="100%">Universal Precautions</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2007</style></year></dates><isbn><style face="normal" font="default" size="100%">01966553 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">This updated guideline responds to changes in health care delivery and addresses new concerns about transmission of infectious agents to patients and HCWs in the United States and infection control. The primary objective of the guideline is to improve the safety of the nation&apos;s health care delivery system by reducing the rates of HAIs.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :947&#xD;Export Date: 26 March 2020&#xD;CODEN: AJICD</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-36749097325&amp;doi=10.1016%2fj.ajic.2007.10.007&amp;partnerID=40&amp;md5=0c01124aabe58c6ef5c759b1bd2ad9db</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">18068815</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.ajic.2007.10.007</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>207</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">207</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Stichler, J. F.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Designing Safe Patient Rooms</style></title><secondary-title><style face="normal" font="default" size="100%">Health Environments Research and Design Journal</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Health Environ. Res. Des. J.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Health Environments Research and Design Journal</style></full-title><abbr-1><style face="normal" font="default" size="100%">Health Environ. Res. Des. J.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Health Environments Research and Design Journal</style></full-title><abbr-1><style face="normal" font="default" size="100%">Health Environ. Res. Des. J.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">7-11</style></pages><volume><style face="normal" font="default" size="100%">10</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">furniture</style></keyword><keyword><style face="normal" font="default" size="100%">health care facility</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">patient safety</style></keyword><keyword><style face="normal" font="default" size="100%">standards</style></keyword><keyword><style face="normal" font="default" size="100%">Health Facility Environment</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Interior Design and Furnishings</style></keyword><keyword><style face="normal" font="default" size="100%">Patients&apos; Rooms</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">SAGE Publications Inc.</style></publisher><isbn><style face="normal" font="default" size="100%">19375867 (ISSN)</style></isbn><notes><style face="normal" font="default" size="100%">Cited By :2&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Stichler, J.F.</style></notes><work-type><style face="normal" font="default" size="100%">Editorial</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85032343188&amp;doi=10.1177%2f1937586717723735&amp;partnerID=40&amp;md5=3253286b311e8dcbeee8ce848e2dbf44</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">29056093</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1177/1937586717723735</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>208</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">208</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Warnes, S. L.</style></author><author><style face="normal" font="default" size="100%">Caves, V.</style></author><author><style face="normal" font="default" size="100%">Keevil, C. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Environmental Healthcare Unit, University of Southampton, Highfield, Southampton SO171BJ, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Mechanism of copper surface toxicity in Escherichia coli O157:H7 and Salmonella involves immediate membrane depolarization followed by slower rate of DNA destruction which differs from that observed for Gram-positive bacteria</style></title><secondary-title><style face="normal" font="default" size="100%">Environmental Microbiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Environ. Microbiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Environ. Microbiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">Environmental Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Environ. Microbiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">1730-1743</style></pages><volume><style face="normal" font="default" size="100%">14</style></volume><number><style face="normal" font="default" size="100%">7</style></number><keywords><keyword><style face="normal" font="default" size="100%">alloy</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial DNA</style></keyword><keyword><style face="normal" font="default" size="100%">copper</style></keyword><keyword><style face="normal" font="default" size="100%">disinfectant agent</style></keyword><keyword><style face="normal" font="default" size="100%">reactive oxygen metabolite</style></keyword><keyword><style face="normal" font="default" size="100%">stainless steel</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">cell membrane</style></keyword><keyword><style face="normal" font="default" size="100%">DNA damage</style></keyword><keyword><style face="normal" font="default" size="100%">drug effect</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli O157</style></keyword><keyword><style face="normal" font="default" size="100%">membrane potential</style></keyword><keyword><style face="normal" font="default" size="100%">metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Salmonella</style></keyword><keyword><style face="normal" font="default" size="100%">Alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Anti-Bacterial Agents</style></keyword><keyword><style face="normal" font="default" size="100%">Disinfectants</style></keyword><keyword><style face="normal" font="default" size="100%">DNA, Bacterial</style></keyword><keyword><style face="normal" font="default" size="100%">Membrane Potentials</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin-Resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Reactive Oxygen Species</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria (microorganisms)</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">Negibacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Posibacteria</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year></dates><isbn><style face="normal" font="default" size="100%">14622912 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">We have reported previously that copper I and II ionic species, and superoxide but not Fenton reaction generated hydroxyl radicals, are important in the killing mechanism of pathogenic enterococci on copper surfaces. In this new work we determined if the mechanism was the same in non-pathogenic ancestral (K12) and laboratory (DH5α) strains, and a pathogenic strain (O157), of Escherichia coli. The pathogenic strain exhibited prolonged survival on stainless steel surfaces compared with the other E. coli strains but all died within 10min on copper surfaces using a &apos;dry&apos; inoculum protocol (with approximately 107cfucm-2) to mimic dry touch contamination. We observed immediate cytoplasmic membrane depolarization, not seen with enterococci or methicillin resistant Staphylococcus aureus, and loss of outer membrane integrity, inhibition of respiration and in situ generation of reactive oxygen species on copper and copper alloy surfaces that did not occur on stainless steel. Chelation of copper (I) and (II) ionic species still had the most significant impact on bacterial survival but protection by d-mannitol suggests hydroxyl radicals are involved in the killing mechanism. We also observed a much slower rate of DNA destruction on copper surfaces compared with previous results for enterococci. This may be due to protection of the nucleic acid by the periplasm and the extensive cell aggregation that we observed on copper surfaces. Similar results were obtained for Salmonella species but partial quenching by d-mannitol suggests radicals other than hydroxyl may be involved. The results indicate that copper biocidal surfaces are effective for Gram-positive and Gram-negative bacteria but bacterial morphology affects the mechanism of toxicity. These surfaces could not only help to prevent infection spread but also prevent horizontal gene transmission which is responsible for the evolution of virulent toxin producing and antibiotic resistant bacteria. © 2011 Society for Applied Microbiology and Blackwell Publishing Ltd.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :108&#xD;Export Date: 26 March 2020&#xD;CODEN: ENMIF&#xD;Correspondence Address: Warnes, S.L.; Environmental Healthcare Unit, University of Southampton, Highfield, Southampton SO171BJ, United Kingdom; email: s.l.warnes@soton.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84863191620&amp;doi=10.1111%2fj.1462-2920.2011.02677.x&amp;partnerID=40&amp;md5=473e6345676be8816eba191cff84a9ce</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">22176893</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1111/j.1462-2920.2011.02677.x</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>209</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">209</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Warnes, S. L.</style></author><author><style face="normal" font="default" size="100%">Highmore, C. J.</style></author><author><style face="normal" font="default" size="100%">Keevil, C. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Centre for Biological Sciences, University of Southampton, Highfield Campus, Southampton, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Horizontal transfer of antibiotic resistance genes on abiotic touch surfaces: Implications for public health</style></title><secondary-title><style face="normal" font="default" size="100%">mBio</style></secondary-title><alt-title><style face="normal" font="default" size="100%">mBio</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">mBio</style></full-title><abbr-1><style face="normal" font="default" size="100%">mBio</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">mBio</style></full-title><abbr-1><style face="normal" font="default" size="100%">mBio</style></abbr-1></alt-periodical><volume><style face="normal" font="default" size="100%">3</style></volume><number><style face="normal" font="default" size="100%">6</style></number><keywords><keyword><style face="normal" font="default" size="100%">alloy</style></keyword><keyword><style face="normal" font="default" size="100%">beta lactamase</style></keyword><keyword><style face="normal" font="default" size="100%">carbapenemase</style></keyword><keyword><style face="normal" font="default" size="100%">copper</style></keyword><keyword><style face="normal" font="default" size="100%">extended spectrum beta lactamase CTX M 15</style></keyword><keyword><style face="normal" font="default" size="100%">genomic DNA</style></keyword><keyword><style face="normal" font="default" size="100%">metallo beta lactamase NDM 1</style></keyword><keyword><style face="normal" font="default" size="100%">naked DNA</style></keyword><keyword><style face="normal" font="default" size="100%">plasmid DNA</style></keyword><keyword><style face="normal" font="default" size="100%">stainless steel</style></keyword><keyword><style face="normal" font="default" size="100%">unclassified drug</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic sensitivity</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial gene</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial strain</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial survival</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium conjugation</style></keyword><keyword><style face="normal" font="default" size="100%">carbapenemase gene</style></keyword><keyword><style face="normal" font="default" size="100%">cell viability</style></keyword><keyword><style face="normal" font="default" size="100%">colony forming unit</style></keyword><keyword><style face="normal" font="default" size="100%">controlled study</style></keyword><keyword><style face="normal" font="default" size="100%">DNA degradation</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">extended spectrum beta lactamase CTX M 15 gene</style></keyword><keyword><style face="normal" font="default" size="100%">gene dosage</style></keyword><keyword><style face="normal" font="default" size="100%">horizontal gene transfer</style></keyword><keyword><style face="normal" font="default" size="100%">Klebsiella pneumoniae</style></keyword><keyword><style face="normal" font="default" size="100%">metallo beta lactamase NDM 1 gene</style></keyword><keyword><style face="normal" font="default" size="100%">microbial respiration</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">nucleotide sequence</style></keyword><keyword><style face="normal" font="default" size="100%">priority journal</style></keyword><keyword><style face="normal" font="default" size="100%">surface property</style></keyword><keyword><style face="normal" font="default" size="100%">temperature sensitivity</style></keyword><keyword><style face="normal" font="default" size="100%">Bacterial Adhesion</style></keyword><keyword><style face="normal" font="default" size="100%">beta-Lactamases</style></keyword><keyword><style face="normal" font="default" size="100%">Drug Resistance, Bacterial</style></keyword><keyword><style face="normal" font="default" size="100%">Gene Transfer, Horizontal</style></keyword><keyword><style face="normal" font="default" size="100%">Plasmids</style></keyword><keyword><style face="normal" font="default" size="100%">Surface Properties</style></keyword><keyword><style face="normal" font="default" size="100%">Temperature</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2012</style></year></dates><isbn><style face="normal" font="default" size="100%">21612129 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Horizontal gene transfer (HGT) is largely responsible for increasing the incidence of antibiotic-resistant infections worldwide. While studies have focused on HGT in vivo, this work investigates whether the ability of pathogens to persist in the environment, particularly on touch surfaces, may also play an important role. Escherichia coli, virulent clone ST131, and Klebsiella pneumoniae harboring extended-spectrum-β-lactamase (ESBL) blaCTX-M-15 and metallo-β-lactamase blaNDM-1, respectively, exhibited prolonged survival on stainless steel, with approximately 104 viable cells remaining from an inoculum of 107 CFU per cm2 after 1 month at 21°C. HGT of bla to an antibiotic-sensitive but azide-resistant recipient E. coli strain occurred on stainless steel dry touch surfaces and in suspension but not on dry copper. The conjugation frequency was approximately 10 to 50 times greater and occurred immediately, and resulting transconjugants were more stable with ESBL E. coli as the donor cell than with K. pneumoniae, but blaNDM-1 transfer increased with time. Transconjugants also exhibited the same resistance profile as the donor, suggesting multiple gene transfer. Rapid death, inhibition of respiration, and destruction of genomic and plasmid DNA of both pathogens occurred on copper alloys accompanied by a reduction in bla copy number. Naked E. coli DNA degraded on copper at 21°C and 37°C but slowly at 4°C, suggesting a direct role for the metal. Persistence of viable pathogenic bacteria on touch surfaces may not only increase the risk of infection transmission but may also contribute to the spread of antibiotic resistance by HGT. The use of copper alloys as antimicrobial touch surfaces may help reduce infection and HGT. © 2012 Warnes et al.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :76&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Keevil, C. W.; Centre for Biological Sciences, University of Southampton, Highfield Campus, Southampton, United Kingdom; email: cwk@soton.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84872126507&amp;doi=10.1128%2fmBio.00489-12&amp;partnerID=40&amp;md5=148550a8c5402832c3ab0a17a3efd641</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">23188508</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1128/mBio.00489-12</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>210</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">210</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Weber, D. J.</style></author><author><style face="normal" font="default" size="100%">Rutala, W. A.</style></author><author><style face="normal" font="default" size="100%">Miller, M. B.</style></author><author><style face="normal" font="default" size="100%">Huslage, K.</style></author><author><style face="normal" font="default" size="100%">Sickbert-Bennett, E.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States&#xD;Department of Hospital Epidemiology, UNC Health Care, Chapel Hill, NC, United States&#xD;Department of Pathology, Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States&#xD;McLendon Laboratories, UNC Health Care, Chapel Hill, NC, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Role of hospital surfaces in the transmission of emerging health care-associated pathogens: Norovirus, Clostridium difficile, and Acinetobacter species</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></full-title><abbr-1><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></full-title><abbr-1><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">S25-S33</style></pages><volume><style face="normal" font="default" size="100%">38</style></volume><number><style face="normal" font="default" size="100%">5 SUPPL.</style></number><keywords><keyword><style face="normal" font="default" size="100%">Acinetobactor</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">disinfectants</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental surfaces</style></keyword><keyword><style face="normal" font="default" size="100%">norovirus</style></keyword><keyword><style face="normal" font="default" size="100%">antiinfective agent</style></keyword><keyword><style face="normal" font="default" size="100%">disinfectant agent</style></keyword><keyword><style face="normal" font="default" size="100%">Acinetobacter</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial survival</style></keyword><keyword><style face="normal" font="default" size="100%">cleaning</style></keyword><keyword><style face="normal" font="default" size="100%">disease transmission</style></keyword><keyword><style face="normal" font="default" size="100%">disinfection</style></keyword><keyword><style face="normal" font="default" size="100%">hand washing</style></keyword><keyword><style face="normal" font="default" size="100%">health care personnel</style></keyword><keyword><style face="normal" font="default" size="100%">hospital design</style></keyword><keyword><style face="normal" font="default" size="100%">hospital infection</style></keyword><keyword><style face="normal" font="default" size="100%">infection prevention</style></keyword><keyword><style face="normal" font="default" size="100%">microbial contamination</style></keyword><keyword><style face="normal" font="default" size="100%">microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">surface property</style></keyword><keyword><style face="normal" font="default" size="100%">virus survival</style></keyword><keyword><style face="normal" font="default" size="100%">Acinetobacter Infections</style></keyword><keyword><style face="normal" font="default" size="100%">antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Caliciviridae Infections</style></keyword><keyword><style face="normal" font="default" size="100%">Clostridium Infections</style></keyword><keyword><style face="normal" font="default" size="100%">cross infection</style></keyword><keyword><style face="normal" font="default" size="100%">drug effects</style></keyword><keyword><style face="normal" font="default" size="100%">Enterococcus</style></keyword><keyword><style face="normal" font="default" size="100%">Gram-Positive Bacterial Infections</style></keyword><keyword><style face="normal" font="default" size="100%">hospital</style></keyword><keyword><style face="normal" font="default" size="100%">hospital service</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">isolation and purification</style></keyword><keyword><style face="normal" font="default" size="100%">methicillin resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">microbial viability</style></keyword><keyword><style face="normal" font="default" size="100%">Peptoclostridium difficile</style></keyword><keyword><style face="normal" font="default" size="100%">procedures</style></keyword><keyword><style face="normal" font="default" size="100%">transmission</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental Microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Hospitals</style></keyword><keyword><style face="normal" font="default" size="100%">Housekeeping, Hospital</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Methicillin-Resistant Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">Vancomycin Resistance</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2010</style></year></dates><isbn><style face="normal" font="default" size="100%">01966553 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Health care-associated infections (HAI) remain a major cause of patient morbidity and mortality. Although the main source of nosocomial pathogens is likely the patient&apos;s endogenous flora, an estimated 20% to 40% of HAI have been attributed to cross infection via the hands of health care personnel, who have become contaminated from direct contact with the patient or indirectly by touching contaminated environmental surfaces. Multiple studies strongly suggest that environmental contamination plays an important role in the transmission of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus spp. More recently, evidence suggests that environmental contamination also plays a role in the nosocomial transmission of norovirus, Clostridium difficile, and Acinetobacter spp. All 3 pathogens survive for prolonged periods of time in the environment, and infections have been associated with frequent surface contamination in hospital rooms and health care worker hands. In some cases, the extent of patient-to-patient transmission has been found to be directly proportional to the level of environmental contamination. Improved cleaning/disinfection of environmental surfaces and hand hygiene have been shown to reduce the spread of all of these pathogens. Importantly, norovirus and C difficile are relatively resistant to the most common surface disinfectants and waterless alcohol-based antiseptics. Current hand hygiene guidelines and recommendations for surface cleaning/disinfection should be followed in managing outbreaks because of these emerging pathogens. © 2010 Association for Professionals in Infection Control and Epidemiology, Inc.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :403&#xD;Export Date: 26 March 2020&#xD;CODEN: AJICD&#xD;Correspondence Address: Weber, D.J.; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States; email: dweber@unch.unc.edu</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-77952994819&amp;doi=10.1016%2fj.ajic.2010.04.196&amp;partnerID=40&amp;md5=ef70a02f1f6326c03dda080b80e7f901</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">20569853</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.ajic.2010.04.196</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>211</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">211</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">White, L. F.</style></author><author><style face="normal" font="default" size="100%">Dancer, S. J.</style></author><author><style face="normal" font="default" size="100%">Robertson, C.</style></author><author><style face="normal" font="default" size="100%">McDonald, J.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Microbiology, Southern General Hospital, Glasgow, Scotland, United Kingdom&#xD;Department of Anaesthetics, Southern General Hospital, Glasgow, Scotland, United Kingdom&#xD;Department of Statistics and Modelling Science, University of Strathclyde, Glasgow, Scotland, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">Are hygiene standards useful in assessing infection risk?</style></title><secondary-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></full-title><abbr-1><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">American Journal of Infection Control</style></full-title><abbr-1><style face="normal" font="default" size="100%">Am. J. Infect. Control</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">381-384</style></pages><volume><style face="normal" font="default" size="100%">36</style></volume><number><style face="normal" font="default" size="100%">5</style></number><keywords><keyword><style face="normal" font="default" size="100%">aerobic bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial count</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial transmission</style></keyword><keyword><style face="normal" font="default" size="100%">colony forming unit</style></keyword><keyword><style face="normal" font="default" size="100%">genotype</style></keyword><keyword><style face="normal" font="default" size="100%">hand</style></keyword><keyword><style face="normal" font="default" size="100%">hospital bed</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">hygiene</style></keyword><keyword><style face="normal" font="default" size="100%">infection risk</style></keyword><keyword><style face="normal" font="default" size="100%">intensive care unit</style></keyword><keyword><style face="normal" font="default" size="100%">major clinical study</style></keyword><keyword><style face="normal" font="default" size="100%">medical instrumentation</style></keyword><keyword><style face="normal" font="default" size="100%">microbial growth</style></keyword><keyword><style face="normal" font="default" size="100%">monitoring</style></keyword><keyword><style face="normal" font="default" size="100%">risk assessment</style></keyword><keyword><style face="normal" font="default" size="100%">sampling</style></keyword><keyword><style face="normal" font="default" size="100%">standard</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcus aureus</style></keyword><keyword><style face="normal" font="default" size="100%">statistical significance</style></keyword><keyword><style face="normal" font="default" size="100%">surgical ward</style></keyword><keyword><style face="normal" font="default" size="100%">touch</style></keyword><keyword><style face="normal" font="default" size="100%">Cross Infection</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental Monitoring</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Infection Control</style></keyword><keyword><style face="normal" font="default" size="100%">Intensive Care Units</style></keyword><keyword><style face="normal" font="default" size="100%">Risk Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Staphylococcal Infections</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2008</style></year></dates><isbn><style face="normal" font="default" size="100%">01966553 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Background: We monitored the surface level cleanliness in a 5-bed surgical intensive care unit (SICU) over a 10-week period to evaluate proposed hygiene standards. Methods: Ten environmental sites within the SICU were sampled twice weekly, along with collection of clinical and patient activity data. The standards designate aerobic colony counts (ACCs) &amp;gt; 2.5 colony-forming units/cm2 from hand-touch sites and the presence of Staphylococcus aureus as indicating hygiene failure. Results: Nearly 25% of the 200 samples analyzed did not meet the standards, mostly from hand-touch sites on curtains, beds, and medical equipment. The total number of failures each week was associated with bed occupancy (P = .04), with a trend toward association with SICU-acquired infection (P = .11). Environmental S aureus was associated with the proportion of beds occupied (P = .02). Indistinguishable genotypes were found between patient and environmental staphylococci, with time scales supporting staphylococcal transmission in both directions. Conclusions: Hygiene standards based on microbial growth levels and the presence of S aureus reflect patient activity and provide a means to risk-manage infection. They also expose a staphylococcal reservoir that could represent a more tangible risk to patients. Standards for surface level cleanliness merit further evaluation. © 2008 Association for Professionals in Infection Control and Epidemiology, Inc.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :69&#xD;Export Date: 26 March 2020&#xD;CODEN: AJICD&#xD;Correspondence Address: Dancer, S.J.; Department of Microbiology, Southern General Hospital, Glasgow, Scotland, United Kingdom; email: stephanie.dancer@lanarkshire.scot.nhs.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-44449125778&amp;doi=10.1016%2fj.ajic.2007.10.015&amp;partnerID=40&amp;md5=db58b147512fb9f716f900fb260d515d</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">18538706</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.ajic.2007.10.015</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>212</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">212</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wilks, S. A.</style></author><author><style face="normal" font="default" size="100%">Michels, H.</style></author><author><style face="normal" font="default" size="100%">Keevil, C. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Environmental Healthcare Unit, School of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton, SO16 7PX, United Kingdom&#xD;Copper Development Association Inc., 260 Madison Avenue, New York, NY 10016, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">The survival of Escherichia coli O157 on a range of metal surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">International Journal of Food Microbiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Int. J. Food Microbiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">International Journal of Food Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Int. J. Food Microbiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">International Journal of Food Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Int. J. Food Microbiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">445-454</style></pages><volume><style face="normal" font="default" size="100%">105</style></volume><number><style face="normal" font="default" size="100%">3</style></number><keywords><keyword><style face="normal" font="default" size="100%">Cross-contamination</style></keyword><keyword><style face="normal" font="default" size="100%">E. coli</style></keyword><keyword><style face="normal" font="default" size="100%">Metal alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Surfaces</style></keyword><keyword><style face="normal" font="default" size="100%">Survival</style></keyword><keyword><style face="normal" font="default" size="100%">copper</style></keyword><keyword><style face="normal" font="default" size="100%">metal</style></keyword><keyword><style face="normal" font="default" size="100%">stainless steel</style></keyword><keyword><style face="normal" font="default" size="100%">antibacterial activity</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial strain</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial survival</style></keyword><keyword><style face="normal" font="default" size="100%">corrosion</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli</style></keyword><keyword><style face="normal" font="default" size="100%">exposure</style></keyword><keyword><style face="normal" font="default" size="100%">freezing</style></keyword><keyword><style face="normal" font="default" size="100%">material state</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">room temperature</style></keyword><keyword><style face="normal" font="default" size="100%">surface property</style></keyword><keyword><style face="normal" font="default" size="100%">survival time</style></keyword><keyword><style face="normal" font="default" size="100%">Alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental Microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Equipment Contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli O157</style></keyword><keyword><style face="normal" font="default" size="100%">Food Contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Food Microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Metals</style></keyword><keyword><style face="normal" font="default" size="100%">Temperature</style></keyword><keyword><style face="normal" font="default" size="100%">Time Factors</style></keyword><keyword><style face="normal" font="default" size="100%">Bacteria (microorganisms)</style></keyword><keyword><style face="normal" font="default" size="100%">Escherichia coli O157:H7</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2005</style></year></dates><isbn><style face="normal" font="default" size="100%">01681605 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Escherichia coli O157:H7 is a serious pathogen causing haemorrhagic colitis. It has been responsible for several large-scale outbreaks in recent years. E. coli O157:H7 is able to survive in a range of environments, under various conditions. The risk of infection from contaminated surfaces is recognised, especially due to the low infectious dose required. In this study, a high concentration (107 cells) of E. coli O157 was placed onto different metals and survival time measured. Results showed E. coli O157 to survive for over 28 days at both refrigeration and room temperatures on stainless steel. Copper, in contrast, has strong antibacterial properties (no bacteria can be recovered after only 90 min exposure at 20°C, increasing to 270 min at 4°C) but its poor corrosion resistance and durability make it unsuitable for use as a surface material. Other copper-containing alloys, such as copper nickels and copper silvers, have improved durability and anticorrosion properties and greatly reduce bacterial survival times at these two temperatures (after 120 min at 20°C and 360 min at 4°C, no E. coli could be detected on a copper nickel with a 73% copper content). Use of a surface material with antibacterial properties could aid in preventing cross-contamination events in food processing and domestic environments, if standard hygiene measures fail. © 2005 Elsevier B.V. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :206&#xD;Export Date: 26 March 2020&#xD;CODEN: IJFMD&#xD;Correspondence Address: Wilks, S.A.; Environmental Healthcare Unit, School of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton, SO16 7PX, United Kingdom; email: saw3@soton.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-28444433766&amp;doi=10.1016%2fj.ijfoodmicro.2005.04.021&amp;partnerID=40&amp;md5=2bf93b8c51365ac07cd475d25061f4d7</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">16253366</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.ijfoodmicro.2005.04.021</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>213</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">213</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wilks, S. A.</style></author><author><style face="normal" font="default" size="100%">Michels, H. T.</style></author><author><style face="normal" font="default" size="100%">Keevil, C. W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Environmental Healthcare Unit, School of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton, SO16 7PX, United Kingdom&#xD;Copper Development Association Inc., 260 Madison Avenue, New York, NY 10016, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Survival of Listeria monocytogenes Scott A on metal surfaces: Implications for cross-contamination</style></title><secondary-title><style face="normal" font="default" size="100%">International Journal of Food Microbiology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Int. J. Food Microbiol.</style></alt-title></titles><periodical><full-title><style face="normal" font="default" size="100%">International Journal of Food Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Int. J. Food Microbiol.</style></abbr-1></periodical><alt-periodical><full-title><style face="normal" font="default" size="100%">International Journal of Food Microbiology</style></full-title><abbr-1><style face="normal" font="default" size="100%">Int. J. Food Microbiol.</style></abbr-1></alt-periodical><pages><style face="normal" font="default" size="100%">93-98</style></pages><volume><style face="normal" font="default" size="100%">111</style></volume><number><style face="normal" font="default" size="100%">2</style></number><keywords><keyword><style face="normal" font="default" size="100%">Copper alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Cross-contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Listeria monocytogenes</style></keyword><keyword><style face="normal" font="default" size="100%">Survival</style></keyword><keyword><style face="normal" font="default" size="100%">agar</style></keyword><keyword><style face="normal" font="default" size="100%">alloy</style></keyword><keyword><style face="normal" font="default" size="100%">aluminum</style></keyword><keyword><style face="normal" font="default" size="100%">copper</style></keyword><keyword><style face="normal" font="default" size="100%">metal</style></keyword><keyword><style face="normal" font="default" size="100%">nickel</style></keyword><keyword><style face="normal" font="default" size="100%">silicon</style></keyword><keyword><style face="normal" font="default" size="100%">sodium chloride</style></keyword><keyword><style face="normal" font="default" size="100%">stainless steel</style></keyword><keyword><style face="normal" font="default" size="100%">zinc</style></keyword><keyword><style face="normal" font="default" size="100%">article</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial cell</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial strain</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial survival</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium contamination</style></keyword><keyword><style face="normal" font="default" size="100%">bacterium detection</style></keyword><keyword><style face="normal" font="default" size="100%">cell survival</style></keyword><keyword><style face="normal" font="default" size="100%">cell viability</style></keyword><keyword><style face="normal" font="default" size="100%">colony forming unit</style></keyword><keyword><style face="normal" font="default" size="100%">food contamination</style></keyword><keyword><style face="normal" font="default" size="100%">incubation time</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">room temperature</style></keyword><keyword><style face="normal" font="default" size="100%">surface property</style></keyword><keyword><style face="normal" font="default" size="100%">survival rate</style></keyword><keyword><style face="normal" font="default" size="100%">Alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Colony Count, Microbial</style></keyword><keyword><style face="normal" font="default" size="100%">Environmental Microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Equipment Contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Food Microbiology</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Metals</style></keyword><keyword><style face="normal" font="default" size="100%">Time Factors</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2006</style></year></dates><isbn><style face="normal" font="default" size="100%">01681605 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">Listeria monocytogenes is an important re-emerging pathogen which is commonly found in the environment. Many outbreaks have been associated with the contamination of food produce, often linked to cross-contamination from surfaces or equipment to prepared foodstuffs. In the present study a number of copper-base metal alloys have been used to assess the survival times of L. monocytogenes on different materials, in comparison with stainless steel. High concentrations (107) of bacteria were placed on metal coupons cut from each alloy. After defined incubation times, coupons were placed in tubes containing phosphate buffered saline and vortexed to remove the cells. Aliquots were then plated onto tryptone blood agar plates and the number of colony forming units counted. The high concentration of bacteria was used to represent a &quot;worst-case&quot; scenario. The results indicate that survival is greatly reduced on a copper-base alloy compared to stainless steel. Viable cells could be detected on stainless steel after 24 h incubation at room temperature. On copper, brass, aluminium bronze and silicon bronze, no viable bacteria could be detected after 60 min incubation, indicating a 5 log reduction (the detection limit of the procedure was 100 bacteria). No cells could be detected from copper nickel and copper nickel zinc alloys, after 90 min incubation. The viability stain, 5-cyano-2,3-ditolyl tetrazolium chloride (CTC), confirmed these results, with actively respiring bacteria being clearly labelled on stainless steel after 24 h. The results suggest that careful choice of surface material could reduce the potential risk of cross-contamination in industrial, commercial and domestic environments. © 2006 Elsevier B.V. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :125&#xD;Export Date: 26 March 2020&#xD;CODEN: IJFMD&#xD;Correspondence Address: Wilks, S.A.; Environmental Healthcare Unit, School of Biological Sciences, University of Southampton, Bassett Crescent East, Southampton, SO16 7PX, United Kingdom; email: saw3@soton.ac.uk</style></notes><work-type><style face="normal" font="default" size="100%">Article</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-33747855251&amp;doi=10.1016%2fj.ijfoodmicro.2006.04.037&amp;partnerID=40&amp;md5=966adfeb20ba0b5e82672b6275c3f267</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">16876278</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1016/j.ijfoodmicro.2006.04.037</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>214</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">214</key></foreign-keys><ref-type name="Serial">57</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Williams, C. L.</style></author><author><style face="normal" font="default" size="100%">Merrell, D. S.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Department of Microbiology and Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD, United States</style></auth-address><titles><title><style face="normal" font="default" size="100%">Testing metal sensitivity of A. baumannii strains: Survival in copper-supplemented liquid media and on copper-containing surfaces</style></title><secondary-title><style face="normal" font="default" size="100%">Methods in Molecular Biology</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Methods Mol. Biol.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">51-60</style></pages><volume><style face="normal" font="default" size="100%">1946</style></volume><keywords><keyword><style face="normal" font="default" size="100%">A. baumannii</style></keyword><keyword><style face="normal" font="default" size="100%">Acinetobacter</style></keyword><keyword><style face="normal" font="default" size="100%">Copper</style></keyword><keyword><style face="normal" font="default" size="100%">Coupon</style></keyword><keyword><style face="normal" font="default" size="100%">Heavy metal</style></keyword><keyword><style face="normal" font="default" size="100%">Surface</style></keyword><keyword><style face="normal" font="default" size="100%">Acinetobacter baumannii</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial growth</style></keyword><keyword><style face="normal" font="default" size="100%">bacterial strain</style></keyword><keyword><style face="normal" font="default" size="100%">nonhuman</style></keyword><keyword><style face="normal" font="default" size="100%">sensitivity analysis</style></keyword><keyword><style face="normal" font="default" size="100%">culture medium</style></keyword><keyword><style face="normal" font="default" size="100%">dose response</style></keyword><keyword><style face="normal" font="default" size="100%">drug effect</style></keyword><keyword><style face="normal" font="default" size="100%">growth, development and aging</style></keyword><keyword><style face="normal" font="default" size="100%">human</style></keyword><keyword><style face="normal" font="default" size="100%">metabolism</style></keyword><keyword><style face="normal" font="default" size="100%">microbial sensitivity test</style></keyword><keyword><style face="normal" font="default" size="100%">microbial viability</style></keyword><keyword><style face="normal" font="default" size="100%">Culture Media</style></keyword><keyword><style face="normal" font="default" size="100%">Dose-Response Relationship, Drug</style></keyword><keyword><style face="normal" font="default" size="100%">Humans</style></keyword><keyword><style face="normal" font="default" size="100%">Metals, Heavy</style></keyword><keyword><style face="normal" font="default" size="100%">Microbial Sensitivity Tests</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2019</style></year></dates><publisher><style face="normal" font="default" size="100%">Humana Press Inc.</style></publisher><isbn><style face="normal" font="default" size="100%">10643745 (ISSN)</style></isbn><abstract><style face="normal" font="default" size="100%">This chapter describes protocols for determining A. baumannii isolates’ overall levels of sensitivity to heavy metals; copper is used as a model heavy metal. Measurements of the ability of strains to grow in the presence of various concentrations of copper in liquid media and on copper-containing surfaces are described. © Springer Science+Business Media, LLC, part of Springer Nature 2019.</style></abstract><notes><style face="normal" font="default" size="100%">Cited By :1&#xD;Export Date: 26 March 2020&#xD;Correspondence Address: Merrell, D.S.; Department of Microbiology and Immunology, Uniformed Services University of the Health SciencesUnited States; email: douglas.merrell@usuhs.edu</style></notes><work-type><style face="normal" font="default" size="100%">Book Chapter</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062068198&amp;doi=10.1007%2f978-1-4939-9118-1_5&amp;partnerID=40&amp;md5=56294fc8a434442d3f21ae5e8475aa68</style></url></related-urls></urls><custom2><style face="normal" font="default" size="100%">30798543</style></custom2><electronic-resource-num><style face="normal" font="default" size="100%">10.1007/978-1-4939-9118-1_5</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>215</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">215</key></foreign-keys><ref-type name="Book Section">5</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wilson, A. P. R.</style></author><author><style face="normal" font="default" size="100%">Moore, G.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Clinical Microbiology and Virology, UCLH NHS Foundation Trust, 60 Whitfi eld Street, London W1T 4EU, United Kingdom</style></auth-address><titles><title><style face="normal" font="default" size="100%">New technologies to control the presence of microorganisms in hospitals</style></title><secondary-title><style face="normal" font="default" size="100%">Decontamination in Hospitals and Healthcare</style></secondary-title><alt-title><style face="normal" font="default" size="100%">Decontam. in Hospitals and Healthc.</style></alt-title></titles><pages><style face="normal" font="default" size="100%">461-482</style></pages><keywords><keyword><style face="normal" font="default" size="100%">Environmental contamination</style></keyword><keyword><style face="normal" font="default" size="100%">Healthcare-associated infection (HAI)</style></keyword><keyword><style face="normal" font="default" size="100%">Innovation and technology</style></keyword><keyword><style face="normal" font="default" size="100%">Nosocomial pathogens</style></keyword><keyword><style face="normal" font="default" size="100%">Ward design and layout</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2013</style></year></dates><publisher><style face="normal" font="default" size="100%">Elsevier Ltd.</style></publisher><isbn><style face="normal" font="default" size="100%">9780857096579 (ISBN)</style></isbn><abstract><style face="normal" font="default" size="100%">This chapter considers how designing the built environment to incorporate new and existing technologies can help control the presence of microorganisms in hospitals. It discusses how modifications to ward layout, the patient environment or specific surfaces can improve hand hygiene and environmental cleanliness. New innovations, including temporary isolation rooms, waterless commodes and light-activated antimicrobial coatings, are described. How existing technologies and materials (e.g. Ultraviolet-C (UV-C) light, copper and silver) are now being used to reduce environmental contamination is also discussed. The advantages and disadvantages of these new and existing technologies are highlighted. © 2014 Woodhead Publishing Limited. All rights reserved.</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020&#xD;Correspondence Address: Wilson, A.P.R.; Clinical Microbiology and Virology, UCLH NHS Foundation Trust, 60 Whitfi eld Street, London W1T 4EU, United Kingdom; email: peter.wilson@uclh.nhs.uk</style></notes><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84902067161&amp;doi=10.1533%2f9780857096692.2.461&amp;partnerID=40&amp;md5=224d73cfaacf9d59476d76ccf62d6a32</style></url></related-urls></urls><electronic-resource-num><style face="normal" font="default" size="100%">10.1533/9780857096692.2.461</style></electronic-resource-num><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record><record><database name="CopperCitations.enl" path="\\staff.ad.bond.edu.au\home\cforbes\Profile\Downloads\CopperCitations.enl">CopperCitations.enl</database><source-app name="EndNote" version="19.3">EndNote</source-app><rec-number>216</rec-number><foreign-keys><key app="EN" db-id="2z9wvt2xv5rzf7errflp9axvt9p2vaa29pez">216</key></foreign-keys><ref-type name="Conference Proceedings">10</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Wrona, A.</style></author><author><style face="normal" font="default" size="100%">Czechowska, K.</style></author><author><style face="normal" font="default" size="100%">Bilewska, K.</style></author><author><style face="normal" font="default" size="100%">Kamińska, M.</style></author><author><style face="normal" font="default" size="100%">Olszewski, T.</style></author><author><style face="normal" font="default" size="100%">Pajzderski, P.</style></author><author><style face="normal" font="default" size="100%">Jaśkiewicz, M.</style></author><author><style face="normal" font="default" size="100%">Kamysz, W.</style></author></authors></contributors><auth-address><style face="normal" font="default" size="100%">Institute of Non-Ferrous Metals, Sowińskiego 5, Gliwice, 44-100, Poland&#xD;ALVO Sp. z o.o. Sp. k., Południowa 21A, Śmigiel, 64-030, Poland&#xD;Lipopharm.pl, Kościelna 16A, Zblewo, 83-210, Poland&#xD;Faculty of Pharmacy, Medical University of Gdańsk, Al. Gen. J. Hallera 107, Gdańsk, 80-416, Poland</style></auth-address><titles><title><style face="normal" font="default" size="100%">Copper-based composite powders for antimicrobial coatings</style></title><alt-title><style face="normal" font="default" size="100%">Proc. Euro PM: Int. Powder Metall. Congr. Exhib.</style></alt-title></titles><keywords><keyword><style face="normal" font="default" size="100%">Bacteria</style></keyword><keyword><style face="normal" font="default" size="100%">Consumer products</style></keyword><keyword><style face="normal" font="default" size="100%">Copper alloys</style></keyword><keyword><style face="normal" font="default" size="100%">Copper compounds</style></keyword><keyword><style face="normal" font="default" size="100%">Crystal structure</style></keyword><keyword><style face="normal" font="default" size="100%">Plasma jets</style></keyword><keyword><style face="normal" font="default" size="100%">Plasma spraying</style></keyword><keyword><style face="normal" font="default" size="100%">Powder coatings</style></keyword><keyword><style face="normal" font="default" size="100%">Powder metallurgy</style></keyword><keyword><style face="normal" font="default" size="100%">Sprayed coatings</style></keyword><keyword><style face="normal" font="default" size="100%">Titanium dioxide</style></keyword><keyword><style face="normal" font="default" size="100%">Antibiotic resistance</style></keyword><keyword><style face="normal" font="default" size="100%">Antimicrobial coatings</style></keyword><keyword><style face="normal" font="default" size="100%">Antimicrobial surface</style></keyword><keyword><style face="normal" font="default" size="100%">Copper-based composites</style></keyword><keyword><style face="normal" font="default" size="100%">Deposited coatings</style></keyword><keyword><style face="normal" font="default" size="100%">Pathogenic bacterium</style></keyword><keyword><style face="normal" font="default" size="100%">Plasma-sprayed coatings</style></keyword><keyword><style face="normal" font="default" size="100%">Structure and microstructures</style></keyword><keyword><style face="normal" font="default" size="100%">Composite coatings</style></keyword></keywords><dates><year><style face="normal" font="default" size="100%">2017</style></year></dates><publisher><style face="normal" font="default" size="100%">European Powder Metallurgy Association (EPMA)</style></publisher><abstract><style face="normal" font="default" size="100%">Antibiotic resistance of a growing number of bacteria strains is on the way to becoming a global threat. Therefore preventive steps are taken to reduce the risk of hospital- and community-acquired infections. The antimicrobial efficacy of copper and copper alloys towards pathogenic bacteria is relatively well-documented and copper-containing consumer products are increasingly used. The presented work reports the examination of copper-based composite coatings deposited by plasma spraying process. A method for synthesis of ultrafine crystal structure Cu-TiO2 composite powder premix for coating deposition is presented. The structure and microstructure of both powder and deposited coatings are described, as well as microbiological results. The conducted research indicates that plasma-sprayed coatings show a high potential for use as antimicrobial surfaces. © 2017 European Powder Metallurgy Association (EPMA).</style></abstract><notes><style face="normal" font="default" size="100%">Export Date: 26 March 2020</style></notes><work-type><style face="normal" font="default" size="100%">Conference Paper</style></work-type><urls><related-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056557161&amp;partnerID=40&amp;md5=06f89b0b26f628b1a391063dcbe91cd5</style></url></related-urls></urls><custom3><style face="normal" font="default" size="100%">Proceedings Euro PM 2017: International Powder Metallurgy Congress and Exhibition</style></custom3><remote-database-name><style face="normal" font="default" size="100%">Scopus</style></remote-database-name><language><style face="normal" font="default" size="100%">English</style></language></record></records></xml>